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	ABSTRACT 
 
The terminal alkyne is one of the most widely used chemical moieties in chemical 
biology. Thanks to the relative absence of this functional group in biology, it has 
become a widespread functional handle for a plethora of biorthogonal 
chemistries. Our group has extended the scope of this functionality by developing 
a biological variant of the Glaser-Hay coupling, which brings together two 
terminal alkynes to form a diyne linkage. However, our initial findings revealed 
that the chemistry is plagued by protein degradation due to a deleterious 
copper(II) hydroxyl intermediate. Herein we extend the scope of the terimanl 
alkyne be developing a biological variant of the Cadiot-Chodkiewicz coupling, 
which brings together a bromoalkyne and a terminal alkyne to form a diyne 
linkage. Unlike the Glaser-Hay, the Cadiot-Chodkiewicz is thought to be net 
redox neutral. We found that this chemistry is biologically compatible and does 
indeed reduce copper(II)-mediated cytotoxicity while increasing rates of diyne 
formation. Finally, we extend our findings on diyne-forming chemistries by 
applying this conjugation to a variety of projects, ranging from undergraduate 
teaching labs, bioconjugate preparation, and protein function, thereby expanding 
the scope of this conjugation strategy. 
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CHAPTER 1: INTRODUCTION TO UNNATURAL AMINO ACIDS AND 
BIOCONJUGATIONS 
 
 
In the sequential arrangement of amino acids that form proteins, nature has 
achieved elegant macromolecules with properties chemists have yet to fully replicate (see 
Figure 1).1 Based on their biological functions, proteins can both bind small molecules 
with incredibly high affinities and catalyze reactions with ease that often require harsh 
conditions in vitro. Moreover, proteins have both synthetic and structural roles within the 
cell, making them essential to life. Based on these characteristics, harnessing the power 
of proteins would allow scientists to develop novel diagnostic and catalytic tools that 
would advance science. Additionally, these unique properties of proteins make them 
responsible for the myriad of cellular functions that enable living systems to exist. As 
such, molecular biology has been revolutionized by the ability to study and observe 
proteins in vivo. Thus, the study of proteins and their development towards novel 
technologies is a crucial area of science that constantly requires additional innovations.  
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Figure	 1.The	 Central	 Dogma.	 DNA	 is	 comprised	 a	 triple	 nucleotide	 code,	 that	 is	 transcribed	 into	 RNA.	 This	 triplet	
nucleotide	code	in	the	RNA		is	then	translated	into	proteins	via	tRNAs	that	recognize	the	triplet	code	in	the	RNA.	These	
tRNAs	are	charged	with	the	appropriate	amino	acid	by	aminoacyl	tRNA	synthetases.	 
Protein bioconjugates, in which a protein in conjugated to another molecule 
(i.e.biomolecule, surface, fluorophore, therapeutic agent, etc), represent a broad area of 
research with huge potential to impact basic science and medicine. For example, a serious 
issue facing researchers wishing to fight cancer is discovering new ways to accurately 
detect the presence of cancer within patients. A report in Nature detailed the use of 
fluorescent probes as a means to live image cancer cells during surgery based on the 
presence and detection of certain proteins.2 The results of such technology will enhance 
removal of malignant tissue while decreasing relapse rates and damage to patient’s 
healthy tissue. Accordingly, fluorescent molecular imaging is proving to be a key player 
in the war against cancer, and while it has come a long way, there are limitations that 
must be overcome before such specialized applications become widespread.  
Another emerging field involving proteins is the development of protein biochips. 
These biochips contain dense spots, or microarrays of thousands of diverse or 
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homogenous proteins immobilized on a solid support.3,4 They offer the potential to 
harness the unique power of protein chemistry. For example, such technology can allow 
for the rapid and high-throughput screening of thousands of biologically interesting 
molecules, allowing for the rapid discovery of new drug candidates. Similar to the Nature 
paper previously discussed, such protein-based technology can be directly applied to 
diagnostics, such as detecting cancer markers in blood.5,6 Due to their high affinity for 
their substrate, protein chips would allow for the rapid and sensitive detection of 
biomolecules and toxins.  
Despite their promise, protein-based chips and protein conjugates are still a 
nascent technology, being highly limited by current immobilization and conjugation 
techniques. Many of these involve simple adsorption.4 In this technique, proteins are 
adsorbed onto a surface via ionic or hydrophobic interactions. When performed on a 
surface, the potential for multiple interacting sites often results in a heterogeneous layer 
with a random protein orientation that may also be easily reversed. This is 
disadvantageous, as the protein may not be correctly oriented to perform the desired 
function. Covalent bonding to form protein conjugates is often the most ideal mechanism 
to ensure an irreversible attachment. By reacting a functionalized partner with key amino 
acid residues on the protein, such as lysine or cysteine residues that respectively contain 
amine and thiol functionalities, more robust attachments can be made.  However, these 
covalent linkages on amino acids can occur at multiple sites, if more than one reactive 
amino acid is present, resulting in proteins that may either be conformationally inactive 
or also inappropriately oriented to bind molecules of interest.4 Bioaffinity based 
attachment, in which key protein structures or properties (i.e. an antibody) are exploited 
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to bind a high affinity ligand, is an option that can allow for the binding of proteins in 
specific orientations. However, this technique relies on non-covalent binding, and is thus 
less robust. Furthermore, it limits the number of proteins that can be bound to the surface, 
since proteins must have particular structures or properties in order to interact with the 
ligand.  
	
Figure	 2.	 There	 are	 numerous	 methods	 for	 immobilizing	 proteins	 on	 a	 solid	 support.	 Covalent	 attachment	 of	 the	
protein	 represents	 the	most	 robust	 technique,	although	 it	 is	often	complicated	by	 the	presence	of	multiple	 reaction	
partners	on	a	single	peptide.	Adapted	Rusmini	et	al.4 
Before this biochip technology can become widespread, scientists must solve 
these immobilization problems. Additionally, the need to find new ways to probe protein 
structure and function also creates the need to develop new ways to manipulate protein 
structure and function. A potential alternative to both of these areas involves the 
application of unnatural amino acid technology.	 	
Unnatural amino acids (UAAs) allow scientists to expand the rather limited 
biochemical functionality found in the 20 canonical amino acids and introduce novel 
reactivity not typically found in proteins.7,8 Incorporated via suppression of a TAG stop 
codon in translation, which can be engineered into the DNA at a desired residue position 
of the target protein, “chemical handles” can be introduced on the surface of the protein. 
These functional handles then serve as sites of chemoselective reactivity. This strategy 
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avoids the issue of multiple reaction partners on a single protein (which is typical when 
trying to conjugate on a cysteine/lysine residue), and allows the chemist to access new 
chemistries typically not available from the canonical 20 amino acids. Furthermore, 
compared to the immobilization strategies discussed above, this technique opens up the 
potential to exploit any protein that the chemist desires in a robust way. 
Unnatural Amino Acids 
 Given the large number of functions proteins serve within an organism, as well as 
the myriad of ways in which they could be combined, it is reasonable to assume that 
evolution would have dictated the need for amino acids with diverse functional groups. 
However, a quick glance at the natural 20 amino acids reveals only four main chemical 
functionalities: nonpolar, polar, acidic, and basic.8,9 
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Figure	 3.	 There	 are	 20	 naturally	 occurring	 amino	 acids.	Only	 five	 elements	 are	 represented	 in	 the	 canonical	 amino	
acids,	as	well	as	a	very	limited	set	of	chemical	functionality.	Adapted	from	chemwiki.ucdavis.edu	
Advances in chemical biology have led to the development of UAAs that can be 
synthesized with novel biochemical properties not available in the 20 canonical amino 
acids. Such syntheses are relatively simple, as amino acids can be purchased with their 
carboxyl and amino ends masked with protecting groups. The result is a selectively 
reactive R-group that can be chemically modified. In particular, my research has focused 
on derivativizing the amino acid tyrosine (Tyr) that has a phenol functionality that can be 
activated by the addition of base. The deprotonated hydroxyl group can then undergo 
nucleophilic substitution reactions with molecules that possess good leaving groups. The 
result is a UAA that can serve as a starting point to introduce a myriad of novel 
biochemical functionality into proteins.  
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Figure	 4.	 Unnatural	 amino	 acids	 allow	 chemists	 to	 access	 novel	 functionality	 and	 elements	 not	 present	 in	 the	 20	
canonical	amino	acids. 
 
Generation of an Unnatural Amino Acid-Containing Protein 
While the synthesis of UAAs is feasible, in order to capitalize on this technology 
it is necessary to be able to introduce these UAAs into proteins of interest. Methods have 
been developed to site-specifically incorporate these UAAs into proteins via insertion in 
response to a TAG stop codon in the genome, giving researchers very precise control 
over the placement and number of these UAAs in a protein’s amino acid sequence.8 
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Early methodology relied on incorporating UAAs in vitro. By utilizing cell-free 
protein assembly machinery, researchers were able to incorporate unnaturals into specific 
sites of the protein via a nonsense codon. The associated tRNA for this nonsense codon 
was then chemically aminoacylated with the UAA of interest. The result is a system that 
ensured the incorporation of the UAA into a single, predefined residue of the 
polypeptide. In particular, the amber suppressor codon (TAG) was typically employed, as 
its frequency in the Escherichia coli genome, the organism of choice for many protein 
expressions, is relatively low. This ensures the incorporation of a single UAA into a 
single site.10,11 While this approach allowed for the site-specific incorporation of a UAA 
into a protein’s primary sequence, the use of in vitro technology has serious limitations. 
Many proteins require the aid of additional proteins in vivo before they can acquire the 
correct conformation. As such, while this technique is ideal for the preparation of small 
peptides, polypeptides may not be able to be generated in a robust manner. This severely 
limits the biological applicability of UAAs. Furthermore, the synthesis of mutated 
proteins in vitro limits the use of this technology beyond biochemical studies. For 
example, novel methods of protein imaging in vivo could not be developed since this 
technique required cell-free machinery. 
An alternative strategy for UAA incorporation that allowed for the in vivo 
incorporation of UAAs involved the complete replacement of a particular amino acid in 
the organism’s proteome with a UAA (see Figure 5). In this non-site specific UAA 
incorporation technique, the canonical amino acids methionine, leucine, isoleucine, 
phenylalanine, tryptophan, or proline are replaced by an amino acid that resembles these 
amino acids in structure.12 Typically, cells transformed with a protein of interest are 
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grown in media containing all 20 amino acids, pelleted, to remove the media prior to 
protein expression. Upon the induction of protein expression, the cells are resuspended in 
a new media that lacks one of these canonical amino acids. In place of the amino acid, an 
unnatural amino acid is included in the broth. By synthesizing amino acids that resemble 
the removed amino acid, scientists can trick the cell into incorporating their UAA in 
place of the canonical amino acid in the protein of interest. Tirrell and Finn demonstrated 
the utility of this approach by synthesizing methionine analogs. In place of the thioether 
functionality, the group included azide and alkyne functionalities in their UAAs. As a 
result, they were able to demonstrate that in place of methionine, E. coli expressing a 
bacteriophage protein capsid could generate capsids labeled with either the azide or 
alkyne functionality in the residues that were originally methionine. While this approach 
also allows researchers to incorporate UAAs in a semi-site specific fashion, the frequency 
of UAA placement in a protein can be highly variable, due to the redundancy inherent in 
the 20 amino acid lexicon. The result can be complete dysfunction of the protein if the 
presence of multiple UAAs alters the protein’s structure too much. Additionally, this 
technique impacts the organism’s proteome, introducing the UAA in place of the 
canonical amino acid in every protein expressed. The result could be highly deleterious 
for the organism, which is not beneficial for in vivo applications.12   
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Figure	5.	Whole	cell	replacement	of	a	canonical	amino	acid	with	a	synthetically	similar	analogue	(UAA).	The	resulting	
cell	 incorporates	 the	 UAA	 in	 place	 of	 the	 canonical	 amino	 acid	 throughout	 its	 entire	 proteome,	 resulting	 in	 UAA	
incorporation	in	a	non-specific	manner.	Adapted	from	13 
Since these early in vitro studies, more recent work has focused on generating 
technology that would allow for the in vivo incorporation of UAAs. Additional 
challenges come into play when considering such techniques. First, as mentioned above, 
the incorporation of the UAA must be site specific, and it must occur only in the residue 
sites that have been previously determined by the researcher. Should the UAA be 
incorporated into additional non-specified sites, the result could be inactivation of the 
protein of interest, or subsequent death of the organism. Additionally, the tRNA 
machinery employed must act solely on the UAA of interest. By translating unnatural 
amino acid technology towards in vivo incorporation, the added problem of having to 
deal with three elements arises: the UAA, the tRNA, and the aminoacyl-tRNA synthetase 
(aaRS) that is responsible for charging the tRNA with the UAA. In order for successful 
incorporation to occur, the aminoacyl-tRNA synthetase should only pair with the UAA 
and with the corresponding suppressor tRNA. Should this orthogonality to the 
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endogenous translation machinery not be maintained, endogenous amino acids could be 
incorporated into proteins in place of the UAA and vice versa. Finally, the UAA must be 
cell permeable and non-cytotoxic in order to be incorporated.8,14  
	
Figure	 6.	 Mechanism	 for	 genetic	 incorporation	 of	 unnatural	 amino	 acids.	 An	 orthogonal	 synthetase	 must	 be	
introduced	 that	 does	 not	 cross-react	 with	 any	 natural	 tRNA	 or	 amino	 acid.	 This	 is	 coupled	 with	 a	 new	 tRNA	 that	
harbors	 an	 anticodon	 for	 the	 TAG	 codon.	 When	 the	 ribosome	 encounters	 the	 TAG	 codon,	 a	 new	 amino	 acid	 is	
incorporated,	rather	than	the	discontinuation	of	translation.	Adapted	from	Chem.	Biol.		2009	16,	323-336.	
Early studies with E. coli models attempted to evolve an endogenous tRNA 
synthetase/tRNA pair that was orthogonal to a UAA of interest utilizing E. coli’s 
translational machinery. However, such tactics were wrought with misaminoacylation, 
and subsequently terminated.15 Instead, researchers focused on examining the protein 
translation machinery of other organisms, which would not interact with the endogenous 
aaRS/tRNA pairs in E. coli. In vitro studies found that a tyrosine aaRS/tRNA pair from 
the archaea M. jannaschii was the first of such pairs used to successfully incorporate a 
Tyr in response to a TAG stop codon in a manner completely orthogonal to the host E. 
coli’s translational machinery.16 
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With acceptable aaRS/tRNA machinery from M. jannaschii in hand, researchers 
next focused on a means to alter the specificity of the pair to recognize different UAAs. 
This was done through a double-sieve selection method. First, a library of tRNA 
synthetases was constructed based off the Tyr-aaRS of M. jannaschii. Within this library, 
five to six residues within the binding site of the aaRS were genetically mutated to be one 
of the 20 amino acids, generating a library size on the order of 106 to 107 mutant aaRS. 
This library size is still viable for conventional double transformation procedures. Next, 
the library underwent a positive selection. In this step, E. coli were co-transformed with 
the library of mutated synthetases and an enzyme encoding for a mutated-
chloramphenicol degrading enzyme that contained an early TAG residue. Following 
double-transformation, the transformed cells were grown on a plate in the presence of a 
novel UAA and chloramphenicol. Survival implied the organism was able to use the 
foreign aaRS machinery to charge the suppressor tRNA and thus produce a functional 
chloramphenicol degrading enzyme.17 However, suppression does not guarantee that the 
aaRS charged the suppressor tRNA using the UAA, as canonical amino acids could also 
have been recognized by the aaRS and charged to the tRNA. As such, those cells that 
grew were then isolated, their plasmids purified, and the remaining plasmid library was 
then transformed for a negative selection. In the negative selection the toxic barnase gene 
was employed. Barnase is a bacterial ribonuclease, and will degrade cellular RNA, 
preventing protein synthesis and leading to cell death. The gene was mutated to harbor 
three stop codons, and grown in the absence of unnatural amino acid. If the organism can 
use the exogenous aaRS/tRNA pair to charge endogenous amino acids and suppress the 
three TAG stop codons, it will produce the barnase protein and die.17 Thus, the end of 
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this two round protocol selected for organisms that possessed an aaRS that could 
selectively incorporate the UAA to some degree. By iterating this process for multiple 
rounds with the UAA of interest, it was possible to evolve an aaRS/tRNA pair that works 
selectively for the UAA of interest. This is the evolution procedure used today for in vivo 
incorporation of UAA. These site-specifically incorporated UAAs can now serve as 
functional “handles” for the development of new protein conjugates.   
	
Figure	 7.	 General	 scheme	 for	 the	 selection	 of	 an	 aminoacyl-tRNA	 synthetase	 that	 recognizes	 and	 incorporates	 a	
specific	unnatural	amino	acid. 
 
Biorthogonal Chemistry 
 A growing area of interest in chemical biology is the ability to perform chemistry, 
particularly conjugation reactions, within living systems. In order for such chemistry to 
be feasible though, certain conditions must be met by the chemical reaction employed. 
Most importantly, the chemistry must be biologically chemoselective, and not interfere 
with any endogenouse biological processes. Furthermore, the reaction must proceed at 
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relatively rapid rates under physiological conditions (typically at 37°C and ~pH 7) as 
well as being inert to the myriad of functionalities encountered in biological systems.18  
 Should the above conditions be met, the chemistry is deemed bioorthogonal. 
However, when considering the numerous functionalities found within living systems, as 
well as the limitations of concentrations and temperatures, the task of identifying 
bioorthogonal chemistries seems daunting.  
 
Cu(I)-1,3-dipolar Cycloaddition or Cu(I) “Click” Chemistry 
Click chemistry, a subset of reactions that can proceed to completion in relatively 
mild conditions to produce a single product with minimal to no side reactions, has 
emerged as a means for performing bioorthogonal chemistry. In particular, the [3+2] 
cycloaddition of azides and alkynes, termed a Huisgen-1,3-dipolar cycloaddition, has 
flourished as a means to tackle the complexity of bioorthoganlitity.19 Not only do these 
reactions produce a stable, covalent triazole moiety, thus ensuring efficient and stable 
conjugation between the two functionalities in vivo where bonds may readily decompose, 
but the azide and alkyne functionalities are also absent from biological systems. 
Furthermore, the two molecules react selectively with each other, thus side-reactions with 
other biological molecules is not a concern. Thus, the 1,3-dipolar cycloaddition using 
azides and alkynes has the potential to be an optimal chemistry for the development of 
bioconjugation reactions. However, the initial reaction reported in the early 20th century 
required temperatures upwards of 98°C in order to achieve useful reaction rates, well 
above the temperature range of physiological viability.19  
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 The viability of this chemistry was restored when the Sharpless and Meldal 
groups concurrently, yet separately, developed a copper(I) catalyzed variant of the 
cycloaddition.20,21 Reduction of copper(II) to copper(I) in the presence of a terminal 
alkyne allows for the formation of an activated copper acetylide intermediate, which has 
an increased reactivity with azides to form the traizole ring product. This copper-
catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC) exhibited an increased 
reaction rate of seven orders of magnitude, as well as being capable of reacting at room 
temperature and even 4°C.22 The fact that the reaction can be made even more favorable 
by the addition of tetradentate ligands, such as tris[(1-benzyl-1H-1,2,3-trizol-4-
yl)methyl]amine (TBTA), that help stabilize the copper(I) catalyst resulted in this 
chemistry rising to the forefront of bioconjugation reactions.23 
Scheme	1	
 
 While the CuAAC reaction afforded desirable temperature ranges and reaction 
rates, it possessed a single hindrance to its use in biological systems. The reaction’s 
dependence on copper was ultimately its greatest flaw, as copper is cytotoxic to most 
organisms. Bacterial cells have been shown to halt cell division following exposure to 
100 µM CuBr, and mammalian cells can only endure very low concentrations of copper 
(below 500 µM) for 1 hour.18 As such, the Bertozzi group sought to develop a copper free 
variant that may proceed with similar favorability by capitalizing on strained ring 
systems. In particular, cyclooctyne, the smallest ring that can contain a triple bond, was 
used to activate the alkyne towards the cycloaddition via strain. The result was a 
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cycloaddition, however, the reaction proceeded at rates considerably slower than 
CuAAC.24 By addition of electron withdrawing fluorines, the Bertozzi group was able to 
generate a difluoronated cyclooctyne (termed DIFO) capable of undergoing copper free 
click reactions at rates comparable to CuAAC. Thus, the cycloocctyne reagent is nontoxic 
and can be derivitized to include additional functionalities, such as conjugated fluorescent 
moieties.25  
Scheme	2.18	
	
 The CuAAC and the strain promoted azido-alkyne cycloaddition (SPAAC) both 
serve as useful reactions for the bioconjugation of proteins bearing UAAs with other 
molecules. Because the placement of UAAs within a protein can be site-specifically 
controlled, UAAs can be inserted into proteins in unique residues that minimize changes 
to the protein’s folding while allowing for maximal exposure of the UAA. These surface 
exposed residue sites allow for UAAs to serve as unique biochemical handles for the 
targeted promotion of these bioconjugation reactions. UAAs synthesized with azide or 
alkyne functionality can be correspondingly clicked to another molecule bearing the 
appropriate cognate handle. Such strategies allow for the directed control of 
bioorthogonal chemistry towards proteins of interest. 
 Indeed, both CuAAC and SPAAC have already begun to receive attention as 
novel methodologies to probe biological systems. Research on intracellular pathogens is 
often complicated due to the difficulty of probing the pathogen in their endosomal 
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environment.26,27 Methods such as antibody labeling are complicated by the need to pass 
through multiple membrane structures. As such, Siegrist et al. demonstrated that UAA 
analogs of D-alanine, which harbor an alkyne functional group, can be used to probe 
peptidoglycan dynamics of intracellular bacterial pathogens in vivo, a technique that was 
not previously accessible using more traditional antibody labeling approaches.26 In 
particular, the authors demonstrated that the incorporation of the alkyne or azide 
derivitized D-alanine UAAs allowed the researchers to perform CuAAC reactions using 
the orthogonal probe on a fluorescent dye. Because the D-alanine analogs are used 
exclusively by bacteria in the synthesis of their peptidoglycan layer, the researchers were 
able to label intracellular pathogens, such as Listeria monocytogenes, in an in vivo 
infection model and then observe peptidoglycan dynamics in real time. 
 
Biorthogonal Transition Metal Chemistry 
Many transition metal cross coupling reactions are biorthogonal, as the reactive 
groups and metals involved are not found in biological systems. While limitations include 
the toxicity and oxidative damage induced by the use of the transition metal, as well as 
the prohibitive costs, overall these technologies are proving to be viable bioorthogonal 
reactions. Through the use of 3-mercaptopropionic acid (3-MprAc) as a small and 
effective palladium scavenger, Spicer and Davis were able to utilize p-iodophenylalanine 
(pIF) to allow for introduction of an aryl halide for Suzuki-Miyaura cross coupling.28–32 
This chemistry was then employed for the installation of hydrophobic groups on the 
surface of a protein without requiring organic solvents or denaturing conditions. Full 
conversion of the protein substrate was achieved and is notable when compared to the 2% 
18	
	
and 25% conversion achieved via the Heck reaction and Sonogashira coupling 
respectively.32 This technology was also used to tag porin channels via OmpC protein 
monomers on the outside of cell surfaces. Using a fluorescent boronic acid as a label and 
by measuring fluorescent intensity, a dramatic increase in labeling via Suzuki-Miyaura 
coupling was achieved once a threshold concentration of 300 µM of Pd was utilized.31 A 
corresponding Suzuki coupling has been performed with the boronate-containing UAA; 
however, this reaction required both a high temperature (70 oC) and a high pH (8.5), thus 
requiring further optimization.33  
	
Figure	8.Labeling	of	pIF-containing		OmpC	using	a	fluoroescnet	boronic	acid	via	a	biological	Suzuki	coupling.  
Another palladium-based bioothogonal chemistry is the Sonogashira cross 
coupling reaction. It was recently reported that an alkyne encoded ubiquitin was 
employed to facilitate the attachment of aryl or vinyl containing groups.34 The reaction 
reached completion in 30 minutes and did not occur in the absence of the palladium 
catalyst, demonstrating the efficiency and Pd-mediated regulation of the reaction. This 
coupling has been accomplished via the incorporation of a variety of UAAs including pIF 
and lysine derivatized with an alkyne and iodo handle.34,35  
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Figure	9.	Surface	labeling	of	E.	coli	using	a	an	alkyne	containing	UAA	in	the	presence	of	an	iodo	containing	fluorogenic	
dye	via	the	biological	Sonogashira	coupling.  
Though palladium mediated reactions that alter cell-surface functionality are 
biologically viable at low levels of palladium, intracellular use of this reaction is limited 
by the differing effects of palladium within the cell. Therefore, optimizing such reactions 
for intracellular purposes can broaden the scope of such bioorthogonal chemistries. 
As such, a recent report developed a Pd-mediated intracellular bioconjugation 
employing lysine-derivatized UAAs containing either an alkynyl or aryliodo 
functionality. These UAAs were readily incorporated into intracellular gram negative 
bacterial proteins in vivo using an evolved pyrolysine tRNA synthetase/tRNA system. In 
the presence of a simple Pd(NO3)2 catalyst, the authors were able to show efficient 
intracellular conjugation of a dye at room temperature (25℃) within 40 mins.  
Furthermore, the use of this Pd-catalyst was biocompatible, with neglible cytotoxicity at 
concentrations below 200µM.35  
 
Development of a Biological Glaser-Hay Coupling 
As demonstrated by the CuAAC, SPAAC, and the transition metal chemistries 
above, it is apparent that reactions involving terminal alkynes are advantageous for use in 
biological systems due to the relative absence of triple bonds within these systems. The 
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Glaser-Hay coupling is a reaction that involves conjugating two terminal alkynes via a 
copper catalyst to afford a conjoined diyne product36,37 Salts of copper(I) are typically 
used as the catalyst, and it has been proposed that the copper(I) complexes with the 
terminal alkyne, activating the functionality towards the formation of a carbon-carbon 
bond with another terminal alkyne.38,39  
Scheme	3.		
 
 The coupling of terminal alkynes was first described by Carl Glaser in 1869.36 
However, the reaction was not suited for biological settings. Glaser’s initial reaction, 
however, involved an explosive copper(I)-phenylacetylide catalyst that required tedious 
isolation following the reaction.36 Then, in 1962, Allan Hay published results using the 
bidentate ligand N,N,N’,N’-tetramethyletheylene diamine (TMEDA) in conjunction with 
the copper catalyst. This methodology improved reaction times, reduced temperature 
requirements, and reduced the amount of copper necessary to allow the reaction to 
proceed.37 It is proposed that the bidentate ligand TMEDA stabilizes the Cu(I) species, 
opening up the complex to favor addition of the activated alkyne species to one end of the 
copper species.38,39 The Glaser-Hay reaction today, in which a Cu(I) salt in the presence 
of TMEDA in an organic solvent is added to two terminal alkynes, allows for the rapid 
and facile synthesis of conjugated diynes. Furthermore, recent work has demonstrated the 
reaction can proceed in good yield under biological temperatures (4℃ to 37℃), and has 
enhanced reaction rates.40 While little work has been done to take advantage of these 
unique features of this chemistry, these characteristics make the Glaser-Hay coupling 
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ideal for the utilization of the bioorthogonal alkyne moiety for bioconjugation 
applications.  
 
Conclusion 
 UAA-mutagenesis technology allows the researcher to create site-specific 
functional “handles” on proteins of interest. Herein we propose applying UAA-
mutagenesis for the development of novel biorthogonal chemistries, biological probes, 
protein technologies, and immobilization techniques. In particular, employing the 
terminal alkyne moiety throughout our studies to further expand the scope of its role in 
chemical biology. By combining this technique with bioorthogonal chemistries, we hope 
to manipulate biological systems and proteins in new ways that can further advance basic 
science and medicine.   
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CHAPTER 2: SYNTHESIS AND INCORPORATION OF UNNATURAL AMINO 
ACIDS TO PROBE AND OPTIMIZE PROTEIN BIOCONJUGATIONS 
 
 
Multiple techniques exist for the introduction of UAAs that range from completely 
synthetic to completely biological via exploitation of endogenous translational 
machinery.(20-22) The evolution of orthogonal aminoacyl-tRNA synthetase/tRNA pairs 
has found a wide degree of success both in bioconjugations and various other 
applications.(22) Specifically, several examples of the use of unnatural amino acids to 
generate well defined bioconjugates including the reaction of an azide containing 
calmodulin onto carbon nanotubes and nanoparticles via the Staudinger-Bertozzi 
ligation,(23, 24) the immobilization of other proteins to M-20 Dynabeads in a cell-free 
system with a click reaction,(25, 26) and the labeling of proteins with an agarose resin 
and azido UAA for secretome MS analysis; (however, in this case the UAA was not site-
specifically incorporated into the pool of proteins).(27) More recently, we demonstrated 
the optimization of protein immobilization utilizing an incorporated azido UAA, 
conferring increased stability to organic solvents.(28) The combination of these studies 
demonstrates the utility of site-specific bioconjugations, and the stabilizing benefits of the 
solid support. Other studies have used similar techniques to label proteins with molecular 
probes or generate novel therapeutic bioconjugates, demonstrating the wide applicability 
of site-specific bioconjugations. (4, 29) Given the power of this technology, we aimed to 
expand the utility of UAA bioconjugations through the alteration of the reactive UAAs to 
optimize reaction parameters.  
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Initial investigations attempted to further utilize UAAs to optimize bioconjugations 
through several different bioorthogonal reactions. Our previous studies immobilizing 
GFP demonstrated that the UAA residue location within the protein dictated its 
immobilization efficiency.(28) Thus, the spatial configuration of the UAA handle is vital 
for its reactivity with its conjugation partner. While it is possible to alter where the UAA 
can be incorporated, this requires extensive genetic manipulation. An alternative 
approach is to simply vary the distance of the UAA reactive group from the protein’s 
surface. By extending the distance from the protein, the handle is less hindered by the 
protein’s steric bulk, which may increase its propensity to react with its orthogonal 
partner. Moreover, removing the reactive partner from conjugation with the aromatic ring 
of the phenylalanine moiety may alter its chemical reactivity. Thus, it becomes important 
to ascertain the ideal distance of the functional handle from the protein for efficient 
reactivity. In order to probe novel bioorthogonal reactions utilizing UAA technology, a 
variety of UAAs with new functional groups were synthesized and designed with variable 
tether lengths to separate the reactive species from the bulk of the protein. These groups 
included an azide, an alkyne, and a bromide respectively, all of which can be derived 
from a modified tyrosine (Scheme 1). These functionalities afford access to the Cu(I)-
catalyzed 1,3-dipolar cycloaddition, the Glaser-Hay coupling, and a nucleophilic 
substitution respectively.  
 
Results and Discussion 
To optimize the immobilization process, UAAs were synthesized with varied  methylene 
units extending from a tyrosine precursor. Derivatives containing 2, 3, and 4 methylenes 
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of the azide, alkyne, and bromide functionalities previously mentioned were readily 
accessible via a SN2 reaction (Scheme 1).  
Scheme	4.		
 
Synthesis of the nine UAAs began from a common N-Boc-OMe protected tyrosine 
precursor. The goal was to synthesize a bromotyrosine derivative via a substitution 
reaction with either dibromoethane, dibromopropane, or dibromobutane. These bromo-
tyrosines (1-3) would then possess alkyl chains of varying lengths, and a good leaving 
group for future reactions. Then, a secondary SN2 reaction with either an azide (4-6) or 
alkynyl nucleophile would install the desired novel reactivity to the tyrosine derivatives. 
However, synthesis of the alkynyl-tyrosine series proved more difficult than initially 
anticipated, and the series was prepared directly via SN2 reactions commercially available 
with bromo-alkynes (see Experimental).  
Initial reactions between the protected tyrosine and the dibromobutane in 
dimethylformamide (DMF) yielded the desired tyrosine derivative 3. However, reactions 
involving the dibromopropane and dibromoethane in DMF did not proceed as expected 
towards the desired tyrosine derivatives 1 and 2 respectively. Instead, starting material or 
the alkene tyrosine derivative, the product of an elimination reaction, was obtained for 
both reactions.  
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Scheme	5.		
 
Initially, the concern was that the DMF was not dry, and the presence of water in 
the solvent may have led to increased elimination of the bromide. However, switching to 
dry solvent systems did not improve the reaction, nor did it reduce the amount of 
elimination product obtained. To optimize the reactions, we attempted adding a catalytic 
amount of potassium iodide to both the dibromopropane and dibromoethane reactions. 
The iodide can serve as a catalyst in this nucleophilic substitution, replacing the bromine 
with iodine, a better leaving group, thereby facilitating the SN2 addition by the phenolate 
of tyrosine. However, only starting material was recovered from these reactions, even 
when reaction times and temperatures were varied. Ultimately, a literature search 
revealed a similar compound had been successfully prepared using acetone as the solvent 
system.37,38 Thus, all three reactions were attempted in acetone, with greater success. All 
three bromotrysoine derivatives were successfully synthesized using acetone as the 
solvent in the presence of base and potassium iodide as a catalyst. We hypothesize that 
the additional polar amine functionality in the DMF allowed for increased solvent-
mediated stability of the free bromine via dipole-dipole interactions following an 
elimination reaction. Thus, DMF aided in the formation of the eliminated product. 
Furthermore, electronics are clearly involved, as the shorter the alkyl chain became, the 
closer in proximity the large, electronegative bromine groups were, increasing the 
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propensity to eliminate. This was observed by a higher rate of elimination product using 
dibromoethane when compared to dibromopropane. The use of acetone, a less polar 
solvent, decreases the solvent-mediated dipole-dipole interactions with the free bromine, 
and thus disfavors the elimination reaction. This was observed as the bromotryosine 
derivatives were able to be successfully synthesized under these modified conditions. 
Once the bromotyrosine compounds 1 to 3 had been synthesized, they were then 
divided and reacted with either sodium azide or propargyl alcohol. Reaction with sodium 
azide in DMF resulted in a nucleophilic substitution reaction between the azide and the 
bromotryosine, affording the azidotyrosine derivatives 4 through 6 following silica gel 
purification and NMR confirmation. The rest was reacted with propargyl alcohol in DMF 
in order to perform a nucleophilic substitution between the hydroxyl group and the 
bromotyrosine, resulting in the formation of the alkynyltyrosine products. 
The alkyne-derivitized tyrosine series was not successfully synthesized under 
these conditions (see Scheme 3), and instead yielded either the previously described 
elimination product or the starting material.  
Scheme	6.		
 Initially, potassium tert-butoxide (pKa ~17) was used as the activating base in the 
reaction. We hypothesized that the propargyl alcohol (pKa ~13.6) may not be fully 
deprotonated under these conditions, perhaps reducing the overall yield of the reaction. 
As such, a small amount of sodium hydroxide was used as the activating base with little 
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success. Ultimately, due to the inability to obtain derivatized tyrosine product, an 
alternative synthesis strategy was adopted. Reaction of 4-bromo-1-butyne and 5-bromo-
1-pentyne with protected tyrosine in acetone with a catalytic amount of potassium iodide 
was allowed to progress overnight (see scheme 1). Following column chromatography, 
the desired alkyne products 7 and 8 were obtained, with the proper length alkyl chains 
(either 3 or 2 methyl) for proper comparison to the azido- and bromo- derivatives of 
similar lengths. In addition, 6-bromo-1-hexyne could be readily synthesized by reacting 
6-hydroxy-1-hexyne with phosphorus (III) bromide (Scheme 4), followed by immediate 
reaction with the protected tyrosine in acetone. Again, following column chromatography 
the desired compound 9 was isolated.  
Scheme	7.		
 
The syntheses described above afford the derivatized tyrosines still harboring protecting 
groups. To prevent reactivity of the amino group of the amino acid, an acid labile tert-
butyloxy (Boc) group was employed. Additionally, to protect the carboxylic acid 
functional group of the amino acid backbone, a base labile methyl ester was used. 
Successive stirring in 1M lithium hydroxide to remove the methyl ester and 50% TFA in 
DCM to remove the Boc group, afforded the nine deprotected UAAs in moderate overall 
yields (see Table 1). 
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Table	1.	Overall	Yields	for	Tethered	UAA	Syntheses	
 
Typically with the new synthesis of UAAs a unique aaRS must be evolved to recognize 
and incorporate the UAA; however, based on the previous demonstration of the 
promiscuity of the pCNF-aaRS in E. coli,(30, 31) it was our hope that the structural 
similarity of the nine prepared UAAs could facilitate incorporation without the need of a 
double sieve aaRS selection. With respect to the bromo-derivatives, a previous report 
used a similar approach to their incorporation in mammalian cells.(32, 33) Based on our 
earlier studies we employed green fluorescent protein (GFP) as a model protein for 
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incorporation due to its well-documented fluorescent properties facilitating rapid 
visualization and quantitation. Our previous findings indicated that residue 151 conferred 
the best conjugation efficiencies, and was thus selected for this study.(28) BL21(DE3) E. 
coli were co-transformed with pEVOL-pCNF-aaRS and pET-GFP-151-TAG plasmids to 
introduce both the GFP protein and the translational machinery necessary for TAG 
suppression with UAAs. Following protein expression (30 oC, 16 h) in the presence or 
absence of the UAA, cells were lysed and GFP was purified via Ni-NTA chromatography. 
Gratifyingly, the application of the polyspecific aaRS was successful, as the nine UAAs 
were able to be incorporated into GFP, albeit with differential expression levels (Table 2). 
The incorporation of the UAA was visualized both by fluorescence and SDS-PAGE 
analysis. As the pCNF synthetase was evolved to recognize pCNF, it was hypothesized 
that the p2yneY-, p3yneY-, and p4yneY-UAA series would be most easily incorporated 
due to the structural similarity between the cyano group and alkyne group in size and 
polarizability. 
Table	2.	Protein	Expression	Yields	for	the	Tethered	UAAs	
n
COOHH3N
O
X
n
1
2
3
0.702 mg/mL
0.767 mg/mL
0.447 mg/mL
0.704 mg/mL
0.291 mg/mL
0.277 mg/mL
0.347 mg/mL
0.685 mg/mL
0.246 mg/mL
Br N3 C CH
X
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This result was observed, with the p3yneY (n = 2) producing a larger quantity of mutant-
GFP, and the p4yneY producing the lowest quantity of mutant-GFP within the alkyne 
series. These qualitative observations were in accordance with our predictions based on 
the evolution of the synthetase. We hypothesize that the increased tether distance may 
have more difficulty fitting into the binding pocket of the tRNA synthetase relative to 
smaller derivatives, preventing the UAA from being incorporated into the polypeptide 
chain. Thus, a tradeoff may exist between the advantages of distancing the functional 
group from the core of the protein and the reduced protein yields of these same 
compounds. This trend was observed for all of the UAAs, as the tether length increased, 
the expression yield decreased. However, all 9 UAAs were capable of being incorporated 
using a single aaRS, not only obviating the necessity of a tedious selection, but also 
increasing the versatility of this approach as only a single cotransformation is required to 
produce 9 different UAA-containing proteins. 
Given the ability to incorporate 3 different functionalities with variable tether lengths into 
GFP, we next sought to employ these new UAAs in bioorthogonal conjugation reactions.  
Studies were initiated with the azido-GFP series, as the cycloadditon reaction is one of 
the most common and well-understood bioorthogonal reactions. Moreover, the various 
tethers could be directly compared to the commonly utilized p-azidophenylalanine 
(pAzF) that has no methylene tether and contains the azido group in direct conjugation 
with the aromatic ring. We hypothesized that in addition to providing distance between 
the protein and the conjugation partner, the removal of the azido conjugation may also 
alter its reactivity. The various azido-containing GFP mutants were conjugated with a 
fluorescent Alexafluor 488 alkyne dye using a CuSO4/TBTA/TCEP catalyst system based 
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on previously reported conditions. 40,41 Gratifyingly, all tethered derivatives could be 
conjugated to the dye, as determined by both fluorimetry and SDS-PAGE analysis 
(Figure 1). Control reactions were also performed in the absence of catalyst system to 
ensure that protein labeling was not due to non-specific reactions or non-covalent 
association by the dye. These controls yielded no fluorescent product following protein 
denaturation, and thus indicated that any fluorescence is indeed a result of the coupling to 
form the triazole ring. Interestingly, the p3AzY handle appears to have the best 
conjugation efficiency, compared to the more sterically hindered p2AzY and the more 
flexible p4AzY handles (Figure 1). 
 
Figure	10.	Expression	and	conjugation	of	GFP-151	mutants	with	an	AlexaFluor488	dye.	The	Coomassie	stained	gel	
(top)	indicates	the	successful	incorporation	of	all	three	azides	in	the	series	as	an	appropriate	band	is	observed	for	GFP	
at	~26	kDa.	The	fluorescence	of	the	same	gels	(bottom)	indicate	each	azido-GFP	mutant	also	was	able	to	undergo	a	
successful	bioconjugation	with	an	AlexaFluor-488	alkyne.	No	coupling	was	observed	in	the	absence	of	copper	catalyst	
despite	the	inclusion	of	the	fluorophore	alkyne,	as	no	fluorescence	is	detected	in	the	absence	of	catalyst.	
With successful bioorthogonal reaction conditions in hand, we next sought to apply the 
chemistry for immobilization purposes. As mentioned previously, the most robust and 
ideal mechanisms for protein immobilization involve covalent linkages. However, this 
technique is often confounded by the potential for multiple reaction sites on a given 
protein, which could render proteins that are oriented incorrectly for their function. UAA 
mutagenesis allows for the development of a bioorthogonal handle in a predetermined 
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site.(34) Based on previous UAA immobilization results, an epoxy-activated sepharose 
resin was derivatized with propargyl alcohol in the presence of trimethylamine (TEA) by 
stirring overnight at room temperature.(28) This afforded a resin with an alkyne 
functionality that could be employed as a reaction partner with the azido-GFP series (see 
Figure 2).  
OH2N
SO2H SO2H
NH
O NH
CO2H
Alexafluor 488  
Figure	11.	Verification	of	alkyne	functiaonlized	resin.	Prepared	alkyne	sepharose	resin	was	reacted	with	an	alkyne	
containing	fluorophore	(Alexafluore	488)	in	the	presence	and	absence	of	Glaser-Hay	conjugating	conditions	(50	mM	
CuI	and	50	mM	TMEDA),	which	has	been	shown	to	conjugate	two	terminal	alkynes.	Following	successive	rinsing	with	
PBS,	fluorescence	was	only	observed	in	the	presence	of	catalyst,	demonstrating	that	the	fluorophore	was	bound	to	the	
resin	via	generation	of	a	diyne	linkage	and	not	through	non-specific	interaction.	This	reaction	verifies	that	the	
sepharose	resin	was	indeed	derivatized	with	a	terminal	alkyne	handle	for	immobilization	experiments.		
It was expected that by extending the tethering distance of the functional handle of the 
UAA, and thus the site of bioorothogonal reactivity, the steric hindrance due to the 
protein’s bulk could be decreased and immobilization efficiency could be improved. As 
such, the p2AzY-, p3AzY -, and p4AzY -mutated GFPs were exposed to copper click 
conditions (50 mM CuSO4, 50 mM TCEP, and 5 mM TBTA) at fixed concentration of 
GFP (roughly 0.250 mg/mL). As a positive control, the pAzF-GFP, which has no tether 
between the aromatic ring and the azide functional group, was also subjected to the same 
copper click conditions. We have previously immobilized the p-azidophenylalanine 
mutated GFP on the alkyne-functionalized sepharose resin using similar conditions.(28) 
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As a negative control, wild-type GFP, in which there is no azido-functional group present, 
was also subjected to the same copper click conditions. This control provided a means to 
rule out non-specific interactions as the reason for immobilization rather than the 
selective copper click reaction. Results indicated that the copper click-based 
immobilization strategy was effective for all of the mutants in the series (Figure 3). 
Interestingly, the tether distance did factor into the efficiency of the immobilization 
reaction but not as expected, as increased distance from the protein did not necessarily 
lead to improved immobilization as measured by relative fluorescence intensity on a 
microplate reader (Figure 3). However, confirming the results observed when coupling to 
the Alexafluor488 dye, the p3AzY (n = 2) derivative again had the highest coupling and 
immobilization efficiency, indicating that the interplay of structural rigidity and distance 
is important when optimizing the bioconjugation reaction. This 3-carbon tether seems to 
exploit the best properties of each factor, conferring a high coupling and immobilization 
efficiency. The p4AzY (n = 3) had decreased immobilization efficiency. We hypothesize 
that the increased flexibility afforded to this variant may decrease the propensity of its 
azido handle to orient in the proper geometry in space for reaction. 
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Figure	 12.	 Click	 immobilization	 of	 GFP-151	mutants	 on	 a	 sepahrose	 resin	with	 either	 an	 azide	 tethered	
tyrosine	 UAAs	 or	 a	 p-azidophenylalanine.	 A)	 The	 immobilization	 of	 GFP	 at	 a	 fixed	 concentration	 of	
0.246mg/mL	of	each	mutant	protein.	Fluorscence	signal	at	528nm	on	a	plate	reader	indicates	that	the	n=2	
GFP-151	azide	tethered	variant	performed	best	for	immobilization	(immobilizations	conducted	in	triplicate,	
average	 standard	 deviation	 +/-	 296).	 B)	 Image	 of	 the	 immobilized	 resins	 as	 irradiated	 at	 365	 nm	 on	 a	
transilluminator.	Overall,	the	tethered	variants	appeared	to	have	a	greater	immobilization	efficiency	than	
the	traditional	pAzF.	
Based on these results, we next investigated the role of the methylene tether on alternate 
reactions. Recently, we reported the first Glaser-Hay bioconjugation, linking two terminal 
alkyne functionalities to yield a conjugated diyne. (18) Consequently, this reaction was 
selected to explore the reactivity of the alkyne-GFP series. The alkyne-containing GFPs 
were first conjugated to the same Alexafluor 488 alkyne dye previously employed in the 
click reactions. All mutant proteins were subjected to conjugation conditions in the 
presence of CuI (50 mM) and TMEDA (50 mM) and a control in the presence of the 
alkyne fluorophore but in the absence of catalyst system. After 4 hours at 4 oC , the 
proteins were denatured at 98 oC for 15 mins and then analyzed via SDS-PAGE (Figure 
4A). These couplings were all successful, as demonstrated by a fluorescent band at ~26 
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kDa; however, the different tethered derivatives reacted with different efficiencies. 
Furthermore, no coupling was observed in the absence of the Glaser-Hay catalyst system, 
even in the presence of the fluorophore, indicating that the bioorthogonal Glaser-Hay 
chemistry is responsible for the conjugation between the fluorophore and the dye. 
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Figure	 13.	 Glaser-Hay	 reactions	 of	 alkyne-containing	 GFP	 mutants.	 A)	 Bioconjugation	 of	 mutant	 GFPs	 with	
AlexaFluor488	 under	 Glaser-Hay	 conditions.	 TheCcoomassie	 stained	 gel	 (top)	 indicates	 the	 incorporation	 of	 all	
tethered	mutants	into	GFP-151.	Moreover,	the	successful	Glaser-Hay	coupling	with	the	fluorophore	was	confirmed	via	
fluorescent	imaging	of	the	same	gel	(bottom),	as	AlexaFluor	fluorescence	is	only	observed	in	reactions	containing	the	
fluorophore	and	the	CuI/TMEDA	system	(immobilizations	conducted	in	triplicate,	average	standard	deviation	+/-	774).	
B)	 Immobilization	 of	 alkyne-GFP	 mutants	 on	 a	 sepharose	 resin	 under	 Glaser-Hay	 conditions.	 Measuring	 resin	
fluorescence	 on	 a	 plate-reader	 (Ex	 395/Em	512),	 all	GFPs	were	 able	 to	 be	 immobilized.	 C)	 Immobilization	was	 also	
confirmed	by	GFP	fluorescent	imaging	on	a	transilluminator.	
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The alkyne series was also reacted with the alkyne-derivatized sepharose resin to assess 
coupling efficiencies. All of the alkynyl-UAA containing GFP mutants could be 
immobilized, as indicated by the presence of fluorescence on the resin after reaction with 
CuI/TMEDA (Figure 4B and C). However, it appears that  there is no relative benefit to 
increasing the tether length, in contrast to the trends observed with the azide tethers. 
Interestingly, the p-propargylphenylalanine, which has an alkynyl moiety closest to the 
phenyl ring of phenylalanine, performed the best. Based on the proposed mechanism for 
the Glaser-Hay reaction, we hypothesize the enhanced rigidity of the pPrF helps properly 
orient the protein-resin interactons as the copper binds in an η1 fashion. Moreover, the 
enhanced flexibility afforded by the novel alkynyl-UAAs may diminish their propensity 
to react, as the steric bulk of the protein may be more predisposed to interact with the 
resin. An odd/even effect is observed as the p3yneY-containing GFP performed the best 
amongst the UAA-mutated GFPs in the immobilization experiment (Figure 4C). This 
suggests that there may be some benefit, although slight, to increasing the distance of the 
protein from the site of reactivity. This increase drops once the alkyl chain gets too 
flexible, as evidenced by the drop in the p4yneY-containing GFP.  
Interestingly, within the series, the conjugation partner also plays a role in efficiency as 
the Glaser-Hay reaction with the small fluorophore was most efficient with the longer 
tether (Figure 4A), whereas, reaction with the bulky resin required decreased flexibility. 
Finally, conjugation with the bromo-GFP series was investigated utilizing a SN2 reaction. 
The incorporation of this series with a different synthetase, followed by reaction with 
thiols has previously been reported in a mammalian system;(32, 33) however, we were 
interested to see if these synthetic intermediates could also be incorporated with the 
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pCNF aaRS. Due to the presence of many nucleophilic functional groups within 
biological settings, this reaction is not truly bioorthogonal as cross-reactivity is likely. 
Nevertheless, we reasoned that successful nucleophilic substitution with an amine resin, 
immobilizing the GFP, was an ideal means to demonstrate the successful incorporation of 
the bromo-UAAs and the generation of the p2BrY-, p3BrY-, p4BrY-GFPs. An amino-
functionalized sepharose resin was generated using etheylenediamine (see Experimental). 
This resin was then subjected to the bromo-GFP series in the presence of a carbonate 
buffer (pH = 9.5). As a control, wild-type GFP was subjected to the same conditions. 
Gratifyingly, all of the bromo-containing GFPs successfully immobilized, with p4BrY 
performing the best (Figure 5 and 6). Compared to the other functionalities and reactions, 
in which the three carbon alkyl chain variant of the UAA consistently performed the best, 
this was the only case where we found a four-carbon alkyl chain to increase the 
propensity to immobilize. This is to be expected, as this bromo-tethered variant is the 
least sterically hindered by the protein’s bulk and will therefore perform the best in a 
nucleophilic substitution reaction. Furthermore, the wild-type GFP was not immobilized, 
as indicated by minimal fluorescence on a microplate reader, verifying that the presence 
of the bromine-functionality was responsible for the immobilization, and thereby 
demonstrating that we had successfully synthesized and incorporated bromo-tyrosine 
UAAs.  
 
Figure	14.	Immobilization	of	bromide-containing	UAAs	on	a	derivatized	sepharose	resin.	A)	Fluoresence	was	
determined	on	a	platereader	(Ex	395/Em	512),	with	the	increased	tether	increasing	immobilization	efficiency	
(immobilizations	conducted	in	triplicate,	average	standard	deviation	+/-	1401).	B)	Image	of	bromo-UAAs	immobilized	
on	the	resin.	
 
B 
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Conclusion 
In conclusion, nine, novel UAAs with various functional handles and alkyl chains 
were synthesized. Furthermore, all UAAs were successfully incorporated into GFP using 
a single promiscuous aaRS. The novel functional handles present in the UAAs allowed 
access to a range of different bioorthogonal chemistries. Additionally, the presence of 
alkyl chains of different lengths seemed to successfully distance the site of reaction from 
the protein surface, having differential effects on the outcome of the different 
bioorthogonal reactions. In particular, we have elaborated upon a previously reported 
immobilization technique using an azido-containing GFP. We improved the 
immobilization efficiency by increasing the distance between the protein and the site of 
the CuAAC reaction. In addition, we have also demonstrated the utility of the Glaser-Hay 
reaction for protein immobilization. 
Based on these results, we have illustrated the potential of UAA-mutagenesis to 
generate unique, site-specific functional handles in proteins for the preparation of various 
bioconjugates. This technology has downstream molecular imaging applications for the 
study of protein dynamics in vivo, as well as applications involving immobilized enzymes 
and the synthesis of well-defined therapeutic agents. 
 
Experimental 
General Solvents and reagents, including the AlexaFluor 488 Alkyne, were obtained 
from Sigma Aldrich or Acros Organics and used without further purification. The Boc-
OMe-Tyr was purchased from Matrix Scientific and the 5-Bromo-1-pentyne was 
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procured from Enamine. Epoxy-activated Sepharose 6B was obtained from GE 
Healthcare. Plasmids were provided by the laboratory of Dr. Peter Schultz at The Scripps 
Research Institute. Reactions were conducted under ambient atmosphere with solvents 
directly from the manufacturer without further purification. All proteins were purified 
according to manufacturer’s protocols using a Qiagen Ni-NTA Quik Spin Kit. Compound 
purities were assessed by NMR and found to be 90% or greater for all compounds. 
Fluorescence measurements were acquired on a Synergy HT microplate reader, with a 
485 nm excitation filter and a 528 nm emission filter. All NMRs were acquired on an 
Agilent Technologies 400 MHz NMR. Compound purities were assessed by NMR and 
found to be 90% or greater for all compounds. MS analysis was conducted on a Thermo 
Finnigan LCQ Deca Quadropole Ion Trap via direct injection of samples at 100 µM in a 
1:1 H2O/MeOH solution.  
Synthesis of p-Bromo-ethyl-Boc-OMe-Tyrosine (1) A solution of Boc-Tyrosine-OMe 
(0.500 g, 1 eq, 1.693mmol) in acetone (5 mL) was prepared in a flame-dried vial. To this 
solution, potassium carbonate (0.70 g, 3 eq, 5.08 mmol) was added, followed by the 
addition of dibromoethane (292 µL, 2 eq, 3.38 mmol). The reaction stirred overnight at 
55 °C, then cooled to room temperature, and filtered into a round-bottom flask. The 
solvent was removed from the filtrate by rotatory evaporation. The solid was then 
purified by silica gel chromatography (gradient of 9:1 hexanes/ethyl acetate to 7:1 
hexanes/ethyl acetate to 5:1 hexanes/ethyl acetate) and afforded the desired product as a 
clear oil (36 mg, 0.089 mmol, 5.3% yield). 
1
H NMR (400 MHz, CDCl3): δ 7.02 (d, J =8 
Hz, 2H), 6.82 (d, J = 8 Hz, 2H), 4.96 (d, J = 8 Hz, 1H), 4.53 (d, J= 8 Hz, 1H), 4.01 (t, J = 
4 Hz, 2 H), 3.70 (s, 3 H), 3.51 (t, J = 8 Hz, 2 H), 2.94 (m, 2 H), 1.41 (s, 9 H)  
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Synthesis of p-Bromo-propyl-Boc-OMe-Tyrosine (2) A solution of Boc-Tyrosine-OMe 
(0.50 g, 1 eq, 1.69 mmol) in acetone (5 mL) was prepared in a flame-dried vial. To this 
solution, potassium carbonate (0.70 g, 3 eq, 5.08 mmol) was added, followed by the 
addition of 1,3- dibromopropane (345 µL, 2 eq, 3.38 mmol). The reaction stirred 
overnight at 55 °C, then cooled to room temperature, and filtered into a round-bottom 
flask. The solvent was removed from the filtrate by rotatory evaporation. The solid was 
then purified by silica gel chromatography (gradient of 9:1 hexanes/ethyl acetate to 7:1 
hexanes/ethyl acetate to 5:1 hexanes/ethyl acetate) and afforded the desired product as a 
clear oil (18 mg, 0.283 mmol, 33.5% yield). 
1
H NMR (400 MHz, CD3OD): δ 6.99 (d, J = 
8 Hz, 2 H), 6.78 (d, J = 8 Hz, 2 H), 5.07 (d, J = 4 Hz, 1 H), 4.59 (d, J = 4 Hz, 1 H), 4.01 
(t, J =4 Hz, 2 H), 3.65 (s, 3 H), 3.53 (t, J =4 Hz, 2 H), 2.97 (m, 2 H), 2.24 (quintet, J = 4 
Hz, 2 H), 1.37 (s, 9 H)  
Synthesis of p-Bromo-butyl-Boc-OMe-Tyrosine (3) A solution of Boc-Tyrosine-OMe 
(0.50 g, 1 eq, 1.69 mmol) in acetone (5 mL) was prepared in a flame-dried vial. To this 
solution, potassium carbonate (0.70 g, 3 eq, 5.08 mmol) was added, followed by the 
addition of 1,4- dibromobutane (369 µL, 2 eq, 3.38 mmol). The reaction stirred overnight 
at 55 °C, then cooled to room temperature, and filtered into a round-bottom flask. The 
solvent was removed from the filtrate by rotatory evaporation. The solid was then 
purified by silica gel chromatography (gradient of 9:1 hexanes/ethyl acetate to 7:1 
hexanes/ethyl acetate to 5:1 hexanes/ethyl acetate) and afforded the desired product as a 
white crystal (342mg, 0.795 mmol, 46.9% yield). 
1
H NMR (400 MHz, CDCl3): δ 7.01 
(d, J = 8 Hz, 2 H), 6.79 (d, J = 8 Hz, 2 H), 4.97 (d, J = 8 Hz, 1 H), 4.52 (d, J = 8 Hz, 1 H), 
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3.95 (t, J = 4 Hz, 2 H), 3.69 (s, 3 H), 3.47 (t, J = 4 Hz, 2 H), 3.01 (m, 2 H), 2.04 (m, 2 H), 
1.92 (m, 2 H), 1.40 (s, 9 H) 	
Synthesis of p-Azido-propyl-Boc-OMe-Tyrosine (5) Dry dimethylformamide (DMF, 5 
mL) was added to a vial containing 2 (60 mg, 1 eq, 0.137 mmol). This solution was then 
transferred to a flame dried vial, and sodium azide (11 mg, 1.2 eq, 165 mmol) was added. 
The reaction stirred overnight at 65°C. The organic layer was quenched with brine and 
then extracted with methylene chloride (DCM, 10 mL x 3). The organic layer was back 
extracted with brine (10 mL). Theorganic layer was then dried with magnesium sulfate, 
filtered, and rotovapped. Column chromatography (silica gel, 1:1 hexanes ethyl acetate) 
afforded the desired product as a crystal (32 mg, 0.085 mmol, 61.7% yield). 
1
H NMR 
(400 MHz, CDCl3): δ 7.03 (d, J = 12 Hz, 2 H), 6.82 (d, J = 12 Hz, 2 H), 4.96 (d, J = 8 
Hz, 1 H), 4.53 (d, J = 8 Hz, 1 H), 4.01 (t, J = 4 Hz, 2 H), 3.71 (s, 3 H), 3.46 (t, J = 8 Hz, 2 
H), 3.02 (m, 2H), 2.03 (quintet, J = 4 Hz, 2 H), 1.41 (s, 9 H). 
13
C (400 MHz, CDCl3): δ 
172.4, 157.7, 155.1, 130.3, 128.2, 114.5, 79.9, 64.4, 54.5, 52.2, 48.2, 37.4, 28.8, 28.3.  
Synthesis of p-Azido-butyl-Boc-OMe-Tyrosine (6) Tyrosine derivative 3 (252 mg, 1 eq, 
0.59 mmol) was dissolved in a solution of DMF (12 mL) in a flame-dried vial. Sodium 
azide (76 mg, 2 eq, 1.17 mmol) was then added to the solution. The reaction was stirred 
overnight at 65 °C, then quenched brine and extracted with methylene chloride (DCM, 10 
mL x 3). The organic layer was then back extracted with brine (10 mL). The organic 
layer was dried with magnesium sulfate, filtered, and rotovapped. Column 
chromatography (silica gel, 3:1 hexanes ethyl acetate) afforded the desired product (132 
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mg, 0.349 mmol, 57% yield). 
1
H NMR (400 MHz, CDCl3): δ 7.03 (d, J = 8 Hz, 2 H), 
6.84 (d, J = 8 Hz, 2 H), 4.97 (d, J = 8 Hz, 1 H), 4.54 (d, J = 8 Hz, 1 H), 3.95 (t, J = 8 Hz, 
2 H), 3.72 (s, 3 H), 3.36 (t, J = 8 Hz, 2 H), 3.05 (m, 2 H), 1.80 (m, 4 H), 1.43 (s, 9 H). 
13
C (400 MHz, CDCl3): δ 172.4, 157.9, 130.3, 114.5, 67.1, 54.5, 52.2, 51.1, 37.4, 28.3, 
26.5, 25.7. 	
Synthesis of p-Alkynyl-ethyl-Boc-OMe-Tyrosine (7) To a flame dried vial, DMF (5 mL) 
and Boc-Tyrosine-OMe (295 mg, 1 eq, 1.00 mmol) was added without stirring followed 
by the slow addition of potassium tert-butoxide (337 mg, 3 eq, 3.00 mmol). The reaction 
immediately turned dark green. This mixture was allowed to stir at 100 °C for 10 mins, 
then 4-bromo-1-butyne was added (94 µL, 133 mg, 1 eq, 1.00 mmol). The mixture 
immediately turned a lighter, more brownish green. The mixture was then capped and 
allowed to stir at 80 °C overnight. Following reaction, brine (10 mL) was added followed 
by the addition of ether (10 mL). The aqueous layer was then drained and the ether layer 
was washed with brine (10 mL x 3). The ether layer was collected and then the aqueous 
layer was back extracted with additional ether. The combined ether layers were then dried 
and rotovapped. Column chromatography (silica gel, 5:1 hexanes/ethyl acetate) yielded 
the desired product as an oil (23 mg, 0.066 mmol, 3.9% yield). 
1
H NMR (400 MHz, 
CDCl3): δ 6.99 (d, J = 8 Hz, 2 H), 6.75 (m, 2 H), 4.47 (m, 1 H), 4.45 (m, 1 H), 4.07 (t, J = 
4 Hz, 2 H), 3.70 (s, 3 H), 3.54 (m, 2 H), 3.31 (m, 2 H), 2.66 (td, J = 8 Hz, J = 4 Hz, 2 H), 
2.05 (s, 1 H), 1.43 (s, 9 H). 
13
C (400 MHz, CDCl3): δ 171.2, 155.0, 131.3, 130.2, 115.5, 
115.3, 81.7, 58.84, 28.5, 27.7, 26.1, 25.5, 19.5.  
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Synthesis of p-Alkynyl-propyl-Boc-OMe-Tyrosine (8) Boc-Tyrosine-OMe (114 mg, 2 
eq, 0.385 mmol) was added to a flame-dried vial. Cesium carbonate (254 mg, 3 eq, 0.578 
mmol) was then added, followed by dry DMF (3 mL). This mixture was stirred at 100 °C 
for 20 mins. 5- Bromo-1-pentyne (20 µL, 1 eq, 0.193 mmol) was then added to the 
mixture, as well as a catalytic potassium iodide. The reaction was stirred overnight at 100 
°C, then cooled to room temperature and washed with brine (10 mL) and ether (10 mL). 
The ether layer was then washed with brine (10 mL x 3). The brine layer was then back-
extracted with ether (10 mL). The organic layers were combined, dried with magnesium 
sulfate, filtered, and rotovapped. Column chromotagrophay (silica gel, 5:1 hexanes/ethyl 
acetate) to yield the desired product as a white crystal (22 mg, 0.061 mmol, 31.6% yield). 
1
H NMR (400 MHz, CDCl3): δ 7.02 (d, J = 12 Hz, 2 H), 6.82 (d, J = 12 Hz, 2 H), 4.95 
(d, J = 8 Hz, 1 H), 4.53 (d, J = 8 Hz, 1 H), 4.03 (t, J = 4 Hz, 2 H), 3.71 (s, 3 H), 3.02 (m, J 
= 8 Hz, 1 H), 2.39 (t, J = 4 Hz, 2 H), 1.97 (m, J = 8 Hz, 2 H), 1.55 (s, 1 H), 1.41 (s, 9 H). 
13
C (400 MHz, CDCl3): δ 172.4, 157.9, 130.3, 127.9, 114.5, 83.5, 79.9, 68.8, 66.0, 54.5, 
52.2, 37.4, 28.3, 28.2, 21.1, 15.1.  
Synthesis of p-Alkynyl-butyl-Boc-OMe-Tyrosine (9) Ether (10 mL) was added to a 
flame- dried round bottom flask followed by pyridine (18 µL, 16.2 mg, 0.21 mmol) and 
6-hexyne-1-ol (342 µL, 300 mg, 3 eq, 3.06 mmol) then heated to 40 
o
C. Phosphorous 
(III) bromide (97 µL, 276 mg, 1 eq, 1.02 mmol) was then slowly added through the reflux 
condenser, producing a white gas and precipitate in the process. The reaction was then 
refluxed for 2 hours, cooled in an ice bath and diluted with ether (25 mL). The organic 
mixture was then washed twice with a solution of saturated sodium bicarbonate (20 mL x 
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2) and a single wash with brine (20 mL). The organic layer was then dried and 
rotovapped, to yield a clear, pungent oil that was the 6-Bromo-hexyne product (295 mg).  
A solution of Boc-Tyrosine-OMe (1.089g, 2 eq, 3.69 mmol) in acetone (1 mL) was then 
prepared in a flame-dried vial. The 6-Bromohexyne product (295 mg, 1 eq, 1.84 mmol) 
was then dissolved in 4 mL of acetone, and transferred to the vial containing the tyrosine 
solution. To this mixture, cesium carbonate was added (1.802g, 3 eq, 5.53 mmol). The 
reaction was stirred overnight at 60 °C then cooled to room temperature and filtered. The 
precipitate was washed with ethyl acetate and the collected filtrate was concentrated by 
rotatory evaporation. Column chromatography (silica gel, gradient of 7:1 hexanes/ethyl 
acetate to 5:1 hexanes/ethyl acetate to 1:1 hexanes/ethyl acetate) afforded the desired 
product as a white crystal (62 mg, 0.165 mmol, 9.0% yield). 
1
H NMR (400 MHz, 
CDCl3): δ 7.01 (d, J = 8 Hz, 2 H), 6.81 (d, J = 8 Hz, 2 H), 4.95 (d, J = 8 Hz, 1 H), 4.53 
(d, J = 8 Hz, 1 H), 3.95 (t, J = 8 Hz, 2 H), 3.70 (s, 3 H), 3.02 (m, 2 H), 2.27 (td, J = 8 Hz, 
4 Hz, 2 H), 1.96 (t, J = 4 Hz, 1 H), 1.90 (m, 2 H), 1.71 (m, 2 H), 1.41 (s, 9 H). 
13
C (400 
MHz, CDCl3): δ 172.4, 158.0, 130.7, 127.8, 114.5, 84.1, 68.6, 67.2, 52.2, 37.4, 28.3, 
25.0, 18.1.  
General Protocol for Removal of Methyl Protecting Group To deprotect the C-terminus 
of the unnatural amino acids, 500 µL of dioxane and 500 µL of 1M lithium hydroxide 
were added to a vial containing the unnatural amino acid on ice. The vial was then stirred 
at room temperature for 2 hours. The dioxane was removed by rotatory evaporation and 
6M hydrochloric acid was added to dropwise until a pH of 4 was obtained. The product 
was then extracted with ethyl acetate into a vial, and the organic layer was dried with 
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magnesium sulfate and filtered and rotovapped.  
General Protocol for Removal of tert-Butyloxy Protecting Group To the methyl-free 
unnatural amino acid, 1 mL of 2% trifluoroacetic acid (200 µL trifluoroacetic acid into 10 
mL of DCM) was added on ice to deprotect the N-terminus of the unnatural amino acid. 
The reaction was stirred at room temperature for 1 hour, and the DCM was then removed 
by rotatory evaporation, affording the final deprotected unnatural amino acid, typically in 
as a white crystalline solid.  
Synthesis of p-Bromoethyltyrosine (p2BrY, 10) According to the general protocol 
outlined above, 1 was deprotected to yield a white crystalline powder (26 mg, 0.090 
mmol, ~100% yield). 
1
H NMR (400 MHz, CD3OD): δ 7.11 (d, J = 8 Hz, 2H), 6.82 (d, J 
= 8 Hz, 2H), 4.23 (t, J = 4 Hz, 2 H) 	
Synthesis of p-Bromopropyltyrosine (p3BrY, 11)
1 
According to the general protocol 
outlined above, 2 was deprotected to yield a white crystalline powder (21 mg, 0.069 
mmol, 24.5% yield). 
1
H NMR (400 MHz, CD3OD): δ 7.10 (d, J = 8 Hz, 2 H), 6.81 (d, J 
= 8 Hz, 2 H), 3.57 (t, J = 4 Hz, 2 H), 2.23 (quintet, J = 4 Hz, 2 H).  Values corroborated 
by literature (1) 1		Xiang, Z.; Lacey, V.; Ren, H.; Xu, J.; Burban, D.; Jennings, P.; Wang, 
L., Proximity-Enabled Protein Crosslinking through Genetically Encoding Haloalkane 
Unnatural Amino Acids. Angew Chem Int Ed 2014, 53, 2190-2193.  
Synthesis of p-Bromobutyltyrosine (p4BrY, 12)
1 
According to the general protocol 
outlined above, 3 was deprotected to yield a white crystalline powder (58 mg, 0.183 
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mmol, 23.0% yield). 
1
H NMR (400 MHz, CD3OD): δ 7.09 (d, J = 8 Hz, 2 H), 6.79 (d, J 
= 8 Hz, 2 H), 3.94 (t, J = 4 Hz, 2 H), 2.80 (t, J = 8 Hz, 1 H), 1.98 (m, 2 H), 1.86 (m, 2 H). 
Values corroborated by (1) 
Synthesis of p-Azidopropyltyrosine (p3AzY, 14)
1 
According to the general protocol 
outlined above, 5 was deprotected to yield a white crystalline powder (21 mg, 0.08 mmol, 
94.1% yield). 
1
H NMR (400 MHz, CD3OD): δ 7.10 (d, J = 8 Hz, 2 H), 6.81 (d, J = 8 Hz, 
2 H), 4.90 (s, 1 H), 4.16 (t, J = 4 Hz, 2 H), 1.97 (m, J = 4 Hz, 2 H). 
13
C (400 MHz, 
CD3OD): δ 172.5, 156.1, 128.37, 127.7, 112.5, 110.0, 62.8, 26.9, 25.7; MS: calcd for 
C12H17N4O3: 265.293, found 265.290. Values corroborated by (1). 
Synthesis of p-Azidobutyltyrosine (p4AzY, 15) According to the general protocol 
outlined above, 6 was deprotected to yield a white crystalline powder (28 mg, 0.100 
mmol, 30.0% yield). 
1
H NMR (400 MHz, CD3OD): δ 7.09 (d, J = 12 Hz, 2 H), 6.79 (d, J 
= 12 Hz, 2 H), 3.93 (t, J = 4 Hz, 2 H), 1.99 (m, 2 H), 1.87 (m, 2 H). 
13
C (400 MHz, 
CD3OD): δ 172.4, 156.3, 154.8, 128.3, 127.5, 112.4, 77.5, 65.0, 31.1, 27.8, 26.1, 25.7; 
MS: calcd for C13H19N4O3: 279.145, found 279.142  
Synthesis of p-Alkynylethyltyrosine (p2yneY, 16) According to the general protocol 
outlined above, 7 was deprotected to yield a white crystalline powder (15 mg, 0.064 
mmol, 97% yield). 
1
H NMR (400 MHz, CD3OD): δ 7.00 (d, J = 4 Hz, 2 H), 6.67 (d, J = 
4 Hz, 2 H), 4.25 (m, 2 H), 2.59 (td, J = 4 Hz, J = 8 Hz, 2 H), 2.27 (t, J = 4 Hz, 2 H). 
13
C 
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(400 MHz, CD3OD): δ 172.5, 170.0, 128.2, 126.2, 113.1, 77.5, 58.5, 52.0, 49.9, 43.7, 
41.7, 25.7, 17.8, 11.4; MS: calcd for C13H16NO3: 234.113, found 234.113  
Synthesis of p-Alkynylpropyltyrosine (p3yneY, 17) According to the general protocol 
outlined above, 8 was deprotected to yield a white crystalline powder (13 mg, 0.053 
mmol, 86.2% yield). 
1
H NMR (400 MHz, CD3OD): δ 7.53 (d, J = 12 Hz, 2 H), 7.24 (d, J 
= 12 Hz, 2 H), 4.44 (t, J = 4 Hz, 2 H), 2.76 (td, J = 8 Hz, 4 Hz, 2 H), 2.63 (t, J = 4 Hz, 1 
H), 2.34 (m, 2 H). 
13
C (400 MHz, CD3OD): δ 172.4, 128.3, 112.4, 66.9, 64.5, 26.5, 25.7, 
12.7; MS: calcd for C14H18NO3: 248.128, found 248.129  
Synthesis of p-Alkynylbutyltyrosine (p4yneY, 18) According to the general protocol 
outlined above, 9 was deprotected to yield a white crystalline powder (15 mg, 0.057 
mmol, 34.5% yield). 
1
H NMR (400 MHz, CD3OD): δ 7.09 (d, J = 8 Hz, 2 H), 6.79 (d, J 
= 8 Hz, 2 H), 3.93 (t, J = 4 Hz, 2 H), 2.21 (td, J = 8 Hz, 4 Hz, 2 H), 2.18 (t, J = 4 Hz, 2 
H), 1.83 (m, 2 H), 1.64 (m, 2 H). 
13
C (400 MHz, CD3OD): δ 172.4, 156.3, 128.2, 127.4, 
112.4, 81.7, 77.5, 66.7, 65.4, 26.3, 25.7, 23.3, 15.8; MS: calcd for C15H20NO3: 262.144, 
found 262.142  
General GFP Expression A pET-GFP-TAG plasmid (0.5 µL) was co-transformed with a 
pEVOL-pCNF plasmid (0.5 µL) into Escherichia coli BL21(DE3) cells using an 
Eppendorf eporator. The cells were then plated and grown on LB agar in the presence of 
chloramphenicol (34 mg/mL) and ampicillin (50 mg/mL) at 37 ̊ C overnight. One colony 
was then used to inoculate LB media (4 mL) containing both ampicillin and 
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chloramphenicol. The culture was incubated at 37 ̊ C overnight and used to inoculate an 
expression culture (10 mL LB media, 50 mg/mL Amp, 34 mg/mL Chlr) at an OD600 0.1. 
The cultures were incubated at 37 ̊ C to an OD600 between 0.6 and 0.8, and protein 
expression was induced by addition of UAA (100 µL, 100 mM) and 20 % arabinose (10 
µL) and 0.8 mM isopropyl β-D-1-thiogalactopyranoside (IPTG; 10 µL). The cultures 
were incubated at 30 ̊ C for 16-20 h then centrifuged at 5,000 rpm for 10 minutes and 
stored at -80 ̊ C for 3 hours. The cell pellet was resuspended using 500 µL of Bugbuster 
(Novagen) containing lysozyme, and incubated at 37 ̊ C for 20 minutes. The solution was 
transferred to an Eppendorf tube and centrifuged at 15,000 rpm for 10 minutes, then the 
supernatant was added to an equilibrated His- pur Ni-NTA spin (Qiagen) column and 
GFP was purified according to manufacturer’s protocol. Purified GFP was analyzed by 
SDS-PAGE (BioRad 10% precast gels, 150V, 1.5h), and employed without further 
purification. Protein concentrations were determined both by a BCA assay and 
fluorescence measurements.  
Biological Cu(I)-1,3-dipolar Cycloaddition Reaction Clicks on azido-tyrosine GFP-
mutants were performed in 1.5mL Eppendorf tubes. To the experimental tube, in order, 
the following were added: 2 µL of 50mM CuSO4, 20 µL of 5mM Tris[(1-benzyl-1H-
1,2,3-triazol-4- yl)methyl]amine (TBTA), 5 µL of azido-tyrosine mutated GFP (with 
either an ethyl, propyl, or butyl tether) in PBS, 10 µL of 488-Alexafluorophore-alkyne, 
50 mM of tris(2- carboxyethyl)phosphine (TCEP), and 11 µL of phosphate buffer 
solution (PBS; 10 mM Na2HPO4, 2 mM KH2PO4, 2.7 mM KCl, 137 mM NaCl, pH = 
7.4) to bring the reaction to a 50 µL volume. Control reactions were performed with 20 
µL azido-tyrosine mutated GFP samples (either ethyl, propyl, or butyl) and 10 µL 1 mM 
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488-Alexafluorophore in the absence of the Cu- 1,3-dipolar cycloaddition catalysts 
(CuSO4, TBTA, and TCEP) to ensure that successful reactions were not the result of 
non-specific interactions between the protein and fluorophore. The control reaction was 
brought to 50 µL volume using PBS. All mixtures were reacted for 10 hours at 4°C. The 
reactions were then transferred to concentrator column (10k MWCO, Corning Spin-X) 
pre-wet with PBS and spun at maximum speed in a tabletop centrifuge for 2 minutes. 
They were then washed with 100 µL portions of PBS and spun for another 2 minutes. 
This process was repeated for a total of seven washes, and the final spin time was 
adjusted to bring the samples to a concentration of ~25 µL.  
Biological Glaser-Hay Coupling Glaser-Hay couplings on alkyne-tyrosine mutated GFP 
were performed in 1.5mL Eppendorf tubes. To the experimental tube, the following was 
added in order: 3 µL of 50mM CuI, 3 µL 50 mM trimethylethylenediamine (TMEDA), 
10 µL of 1 mM 488-Alexafluorophore alkyne, 20 µL of alkyne-tyrosine mutated GFP 
(with either ethyl, propyl, or butyl tether) in PBS for a total reaction volume of 36 µL. 
Control reactions were performed with 6 µL PBS, 10 µL 488-Alexafluorophore alkyne, 
and 20 µL of alkyne-tyrosine mutated GFP (with either ethyl, propyl, or butyl tether) to 
ensure that successful reactions were not the result of non-specific interactions between 
the protein and fluorophore. All mixtures were reacted for 4 hours at 4°C. The reactions 
were then transferred to concentrator column (10k MWCO, Corning Spin-X) pre wet 
with PBS and spun at maximum speed in a tabletop centrifuge for 2 minutes. They were 
then washed with 100 µL portions of PBS and spun for another 2 minutes. This process 
was repeated for a total of seven washes, and the final spin time was adjusted to bring the 
samples to a concentration of ~25 µL (as indicated by the marking on the column).  
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Immobilization of Alkynyl- or Amino- Functionality onto Epoxy Sepharose 6B Resin 
Epoxy-activated 6B Sepharose (GE Healthcare, 200 mg) was added to a filter syringe and 
washed with distilled water (5 washes, 3 mL). Alkyn-ol (700 µmol) or ethylenediamine 
(700 µmol) and coupling buffer (3.5 mL, 1x PBS brought to pH 13.0 w/ NaOH) was 
added to a vial followed by the washed resin. The mixture was shaken at room 
temperature for 16 h. The resin was transferred to a filter syringe and washed with 
coupling buffer (4 mL). The sepharose was transferred to a vial and capped with 
ethanolamine (3.5 mL). The resin was incubated at 30 ̊C for four hours then washed in a 
filter syringe with 0.1 M acetate buffer (10 mM) and 0.1 M Tris- HCl buffer (pH 4 and 
pH 8 respectively, 3 alternating washes with 3 mL each).  
To verify that we had successfully immobilized ethelyenediamine on the sepharose resin, 
amino-, alkynyl-, and unreacted sepharose resin were placed in carbonate buffer (0.2 M 
Na2CO3, 0.2M NaHCO3, pH = 9.) in the presence of 5 µL of FITC. After washing, 
imaging with a transilluminator demonstrated the successful derivitization of the 
sepharose resin with ethylenediamine as little fluorescence is observed on the alkynyl 
resin and practically no fluorescence was observed on the unreacted sepharose (see 
Figure 7). 
	
Figure	15.	Validation	that	the	sepharose	resin	was	derivatized	with	an	amine	functional	group	using	the	FITC	dye,	
which	contains	an	isothiocyanate	group	susceptible	to	nucleophilic	attack	by	an	amine.	Because	the	coupling	buffer	is	
generated	using	a	hydroxide	ion,	we	wanted	to	verify	the	propensity	of	reacted	coupling	buffer	on	the	resin	to	react	
with	the	FITC	dye	(alkynyl-).	As	can	be	seen,	the	amino-resin	is	much	more	fluorescent	than	the	alkynyl	resin,	due	to	
the	presence	of	the	nucleophilic	amine	group.	This	verifies	that	we	did	indeed	generate	an	amine	resin	for	our	
immobilization	studies.	
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Protocol for Immobilization of Azido-Tyrosine Mutated GFP Series All azido-tyrosine 
GFP mutants were brought to a final concentration of 0.250 mg/mL using PBS. To a 1.5 
mL Eppendorf tube, 15 µL of each azido-tyrosine GFP mutant was added (with either an 
ethyl, propyl, or butyl tether). To this, the Cu(I)-1,3-dipolar cycloaddition reaction 
conditions were then added. In the following order, 5 µL of 4 mM TCEP, 6 µL 1 mM 
CuSO4, 15 µL PBS, and 20 µL 5 mM TBTA were then added to the mix. This liquid 
mixture was then mixed and transferred to a 1.5 mL Eppendorf that contained 15 mg pre-
weighed alkyne-derivatized sepharose resin. A positive control consisting of the 
conditions above using p-azidophenylalanine-GFP, which was previously demonstrated 
to immobilize on the alkyne-derivatized sepharose resin, was also prepared. All samples 
were allowed to react overnight at 4 °C, then transferred to spin columns by adding PBS 
(200 µL x 2) to the reaction in order to aid the transfer. The reaction was then purified at 
1.1 rcf on a table-top microcentrifuge for 1 minute, and washed two times with 100 µL 
portions at 1.1 rcf for 1 minute each. The protein-immobilized sepharose resin was then 
transferred to a clear Eppendorf tube for visualization and fluorescence quantification on 
a microplate reader. 	
Protocol for Immobilization of Alkynyl-Tyrosine Mutated GFP Series All alkynyl-
tyrosine GFP mutants were brought to a final concentration of 0.400 mg/mL using PBS. 
To a 1.5 mL Eppendorf tube, 5 µL of 50 mM CuI, 5 µL of 50 mM TMEDA and 10 µL of 
PBS were added. Followed by 20 µL of the alkynyl-GFP. This liquid mixture was then 
mixed and transferred to a 1.5 mL Eppendorf tube that contained 20 mg pre-weighed 
alkyne-derivatized sepharose resin. A positive control consisting of the conditions above 
using p-propargylphenylalanine-GFP, which was previously demonstrated to immobilize 
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on the alkyne-derivatized sepharose resin, was prepared. All samples were allowed to 
react at 4 °C for 4 hrs, then transferred to spin columns by adding PBS (200 µL x 2) to 
the reaction in order to aid the transfer. The reaction was then purified at 1.1 rcf on a 
table-top microcentrifuge for 1 minute, and washed two times with 100 µL portions at 1.1 
rcf for 1 minute each. The protein-immobilized sepharose resin was then transferred to a 
clear Eppendorf tube for visualization and fluorescence quantification on a microplate 
reader.  
Protocol for Immobilization of the Bromo-Tyrosine Mutated GFP Series To a 1.5 ml 
Eppendorf tube, 15 mg of amino-functionalized sepharose resin was added. To the 
sepharose resin, 10 µL of a carbonate buffer solution (pH = 9.5) and 40 µL of bromo-
containing GFP in an imidazole elution buffer were added. A negative control consisting 
of the conditions above using wild type GFP was also prepared. The reactions were 
incubated overnight at 4 °C, then transferred to spin columns by adding PBS (200 µL x 2) 
to the reaction in order to aid the transfer. The reaction was then purified at 1.1 rcf on a 
table-top microcentrifuge for 1 minute, and washed two times with 100 µL portions at 1.1 
rcf for 1 minute each. The protein- immobilized sepharose resin was then transferred to a 
clear Eppendorf tube for visualization and fluorescence quantification on a microplate 
reader.  
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CHAPTER 3: EXPANDING THE SCOPE OF ALKYNE-MEDIATED 
BIOCONJUGATIONS THROUGH A BIOLOGICAL CADIOT-CHODKIEWICZ 
REACTION 
 
 
 The Glaser-Hay coupling of two terminal alkynes in the presence of CuI and 
TMEDA affords a diyne.29, 30 The reaction brings together two terminal alkynes to 
form a diyne linkage; however, is not redox neutral and has chemoselectivity 
issues. These issues arise as there is not a means to differentiate the two terminal 
alkynes, resulting in 3 possible products. Recently, we demonstrated a 
bioorthogonal variant of the Glaser-Hay reaction that can be conducted in an 
aqueous setting under physiological conditions.22 Using a terminal alkyne-
containing UAA, we were able to demonstrate that the reaction proceeds to 
completion within approximately 6 hrs at 4 oC. As previously mentioned, the 
Glaser-Hay coupling of terminal alkynes has a chemoselectivity issue when the 
terminal alkynes differ, resulting in the formation of unwanted homodimers. 
However, due to the steric bulk of the protein, we found that the homodimerization 
of the reaction was mostly inhibited, leading to primarily the desired protein 
heterodimer product. As such we were able to demonstrate that the Glaser-Hay 
reaction could be employed as a novel bioorthogonal chemistry, yielding stable 
conjugates with well-defined geometries. However, the reaction was limited by the 
oxidative damage of the protein, due to the mechanistic cycling of the copper 
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through three different redox states. As a result, reactions proceeding for longer 
than 6 hrs resulted in oxidative damage and protein degradation. 
 An alternative to the Glaser-Hay coupling is the Cadiot-Chodkiewicz reaction, 
which affords a conjugated diyne via the reaction of a terminal alkyne and a halo-
alkyne (Figure 1). In the presence of a copper(I) salt and a monodentate 
nitrogenous ligand, usually triethylamine (TEA), the reaction proceeds to form a 
covalent linkage in the form of a conjugated diyne in a relatively chemoselective 
fashion.23, 24 Furthermore, the overall reaction is net redox neutral, as a single 
copper(I) catalyst goes through a series of oxidative additions and reductive 
eliminations with the bromoalkyne and terminal alkyne reactant to yield the 
conjugated diyne.25  
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Figure	 16.	 The	 Cadiot-Chodkiewicz	 reaction.	 A)	 Overall	 reaction	 scheme.	 B)	 Proposed	 reaction	 mechanism	 for	 the	
reaction.	Adapted	from	Organic	Mechanisms:	Reactions,	Stereochemistry,	and	Synthesis	by	Reinhard	Bruckner. 
 The Cadiot-Chodkiewicz reaction has diverse applications to many areas of 
chemistry. It can be utilized in polymerization reactions, such as in the formation 
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of the backbone of a solid-state polymer crystal, or in the fabrication of 
polymerized monolayer assemblies.26, 27 Additionally, several acetylenic natural 
products exhibiting valuable biological properties can be obtained via a Cadiot-
Chodkiewicz reaction.28  
 A key component of the Glaser-Hay mechanism is the formation of a 
copper(II)-hydroxyl intermediate, which has been shown to produce hydroxyl 
radicals that are deleterious to living systems (Figure 2).33 Because the copper (I) 
of the Cadiot-Chodkiewicz reaction is not thought to utilize copper(II) 
intermediates, we reasoned that the chemistry could be employed in a biological 
context to minimize previously observed oxidative damage. Furthermore, the 
reaction is more chemoselective, as the use of a halo-alkyne minimizes the 
formation of homodimer side products by differentiating the two alkynes. 
Ultimately, this has the potential to increase the yield of the conjugated protein 
product. Based on these facts and the limitations of the bioorthogonal Glaser-Hay, 
we sought to develop a bioorthogonal variant of the Cadiot-Chodkiewicz reaction 
that could be conducted in an aqueous setting and under physiological conditions.  
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Figure	17.	Proposed	reaction	intermediates	in	the	Glaser-Hay	coupling	reaction.	Adapted	from	(31).  
 
Results and Discussion 
 In order to conduct and optimize a Cadiot-Chodkiewicz bioconjugation, new 
UAAs harboring a terminal haloalkyne needed to be synthesized and incorporated 
into a protein. In order to probe UAA-dependent effects on the reaction, aliphatic 
and aromatic brominated alkynyl UAAs were prepared from the previously 
reported protected p-propargyloxyphenylalanine (pPrF, 1) and the p-
ethynylphenylalanine (pEtF, 2) respectively.34, 35 Gratifyingly, the well-established 
bromination of phenylacetylene using N-bromosuccinamide (NBS) and silver 
nitrate worked well for the synthesis of both UAAs in moderate yields.36, 37  
Scheme	8.		
NBS
10% eq AgNO3
Acetone
RT
Br
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Following deprotection, the final UAAs, p-bromo-propargyloxyphenylalanine 
(pBrPrF, 3) and p-bromo-ethynylphenylalanine (pBrEtF, 4), were recovered in 
overall good yields (67% and 34% respectively) (Figure 1). 
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Figure	 18.	 p-Propargyloxyphenylalanine	 (1,	 pPrF),	 p-ethynylphenylalanine	 (2,	 pEtF),	 p-
bromopropargyloxyphenylalanine	(3,	pBrPrF),	p-bromoethynylphenylalanine	(4,	pBrEtF)	incorporated	into	GFP-151	for	
Glaser-Hay	and	Cadiot-Chodkiewicz	reactions.			
 With the pBrPrF and pBrEtF in hand, it was imperative to incorporate these 
UAAs into a model protein. Due to both its fluorescent properties and well-
documented prior use in UAA development technologies, green fluorescent protein 
(GFP) was selected as a model system. Specifically, attempts were made to 
incorporate newly synthesized UAAs at residue 151 by supressing the amber stop 
codon. Furthermore, our previous work immobilizing GFP revealed that this 
surface exposed site is ideal for UAA placement, as the rigidity of the residue 
helps orient the bioorthogonal functional handle.38 In lieu of undergoing a tedious 
aaRS selection process, we hoped to incorporate the brominated UAAs using the 
previously described promiscuous pCNF aaRS.39, 40 The pCNF aaRS was 
investigated first to incorporate pBrPrF and pBrEtF due to their structural 
similarity to other UAAs that the pCNF aaRS incorporates.  
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 BL21(DE3) E. coli  were co-transformed with a pEVOL-pCNF plasmid and a 
pET-GFP-TAG151 plasmid and used to initiate an expression culture at OD600 
=0.1 which was grown to an OD600 =0.7. The culture was subsequently centrifuged 
and the cell pellet was resuspended in 4 mL of LB broth supplemented with 
antibiotics, IPTG, arabinose, and the presence or absence of a UAA.34 This 
previously reported expression protocol allowed for the minimization of the 
amount of UAA employed, and was found to be very effective. After 18-20 h at 30 
oC, cells were pelleted and the expressed GFP was purified. 
 Gratifyingly, the promiscuous pCNF aaRS incorporated both brominated-UAA 
variants with a higher fidelity than the simple terminal alkyne analogs (Figure 2). 
As is to be expected, the smaller pBrEtF UAA, had a higher incorporation than the 
pBrPrF. We hypothesize that the 1-bromo-alkyne moiety provides a degree of 
hydrophobic character to the UAA, making the interaction between the amino acid 
and the hydrophobic binding pocket of the aaRS more favourable. 
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Figure	 19.	 Expression	 of	 UAA-containing	 GFP151	 using	 the	 promiscuous	 pCNF	 aaRS.	 A)	 A	 stained	 SDS-PAGE	 gel	
indicated	 successful	 incorporation	 of	 3	 and	 4	 over	 background	 (-).	 A	 positive	 control,	 1,	 was	 also	 utilized	 in	 an	
expression.	B)	Data	for	overall	incorporation	of	UAAs	via	the	pCNF	aaRS	as	measured	via	absorbance	at	280	nm	on	a	
nanodrop	spectrophotometer	(ε/1000	=	20,	MW	=	26.80	kDa).	Data	obtained	were	normalized	to	the	pPrF	UAA	(1)	to	
demonstrate	the	difference	in	incorporation	efficiency	over	the	previously	reported	UAA. 
 With both brominated alkyne UAAs in hand, it was feasible to develop a 
bioorthogonal Cadiot-Chodkiewicz reaction. Initial studies employed the pBrPrF-
containing GFP variant, to mimic previous Glaser-Hay pPrF-GFP studies and 
provide an effective comparison. The Cadiot-Chodkiewicz reaction was carried out 
in PBS (pH = 7) using copper iodide and triethylamine (TEA) (both at a final 
concentration of 5 mM) in the presence of a terminal alkyne-containing 
fluorophore (AlexaFluor 488 alkyne) at 4 oC for 6 hrs. The reaction was successful, 
as fluorescence could be detected on a denatured SDS-PAGE gel only when 
protein and fluorophore were exposed to the CuI/TEA system (Figure 5). Even 
more exciting was the minimal protein degradation relative to the previously 
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reported Glaser-Hay reaction. Also, due to the chemoselective nature of the 
reaction no protein dimerization was detected, and fluorophore dimerization was 
minimal and easily removed. 
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Figure	20..	Bioorthogonal	Cadiot-Chodkiewicz	reaction.	 	The	reaction	performed	on	GFP	(0.2	mg/mL)	and	AlexaFluor	
488	(0.2	mM)	in	the	presence	of	5	mM	of	CuI	and	5	mM	TEA	at	4	oC,.	Fluorescence	is	only	observed	in	the	presence	of	
the	CuI/TEA	system. 
 In an attempt to further optimize the reaction, both copper concentrations and 
temperatures were varied. A 5 mM working Cu(I) concentration was found to be 
ideal, which represents a marked improvement over the ~50 mM concentrations 
required for the Glaser-Hay reaction (see Figure 6).  
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Figure	21.	Copper(I)	salt	optimization	for	the	Cadiot-Chodkiewicz	reaction.	Data	are	normalized	to	the	best	performing	
working	concentration	(50	mM). 
Previous reports have indicated that in vivo use of copper-mediated bioorthogonal 
chemistries required working concentrations of near 0.1 mM of copper(I) salt to 
minimize cytotoxicity.10, 41 Thus, the minimized copper concentrations help bring -
bioorthogonal conjugated diyne chemistry into the range of in vivo use. These 
copper concentrations also had no impact on GFP fluorescence as determined by 
control reactions.  
 Additionally, the optimal temperature profile for the reaction was also 
investigated. To do so, reactions were performed over a time course at both 37 ℃ 
and 4 ℃ by starting with the 24 hr reaction and ending with the 2 hour reaction 
before running a denatured SDS-PAGE. We found that it was not necessary to 
perform any washing steps, as the free fluorophore was run beyond the length of 
the gel. This allowed us to visualize protein bound to fluorophore, and upon 
staining with Coomassie blue, to image protein degradation relative to a zero time 
point control.  
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 To analyze our data, we had to develop a meaningful interpretation that could 
illustrate the interplay between conjugation efficiency and protein degradation. As 
protein degradation increased, our Coomassie signal decreased, artificially 
inflating the amount of conjugation observed (based on fluorescent signal alone). 
To overcome this, fluorescent signals were first corrected to the zero time point, in 
which free fluorophore was eliminated from the gel. This allowed us to correct for 
higher fluorescent signals based on the non-covalent dye interactions to the gel and 
not the protein. To correct for protein degradation, we normalized our Coomassie 
signals to the zero time point in which no degradation could have occurred. These 
corrected fluorescent and Coomassie signals were able to be used to gauge relative 
conjugation efficiency, taking into account increased protein degradation.  
After performing a time course of the reaction at both 37 ℃ and 4 ℃, we were 
able to determine very little difference in degredation between either temperature 
at early time-points. However, as the reaction was extended to 24 h, greater protein 
degradation at 37 oC occurred, most likely due to an increase in the rate of 
disproportionation of the Cu(I) catalyst at this temperature, producing a reactive 
copper(II) species (Figures 7-9). 
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Figure	 22.	 Bioorthogonal	 Cadiot-Chodkiewicz	 reactionReaction	 profile	 at	 4	℃	 over	 a	 24	 hr	 time	 period.	 Following	
analysis	via	SDS-PAGE,	fluorescent	imaging,	and	staining	with	Coomassie	blue,	protein	levels	were	normalized	to	the	0	
time	point	control.	The	protein	 levels	 indicate	minimal	to	no	protein	degradation	occurs,	even	at	 longer	time	points.	
Analysis	of	coupling	efficiency	was	determined	by	calculating	the	ratio	of	fluorescence	to	Coomassie	staining	for	each	
time	point.		All	reactions	were	performed	in	triplicate.		
	
Figure	 23.	 SDS-PAGE	 of	 Cadiot-Chodkiewicz	 time	 course	 with	 pBrPrF	 containing	 GFP	 and	 at	 4°C.	 As	 can	 be	 seen,	
conjugation	efficiency	increases	over	time.	
	
Figure	24.	.	Bioorthogonal	Cadiot-Chodkiewicz	reaction	Reaction	profile	at	37	℃	over	a	24	hr	time	period.	Following	
analysis	via	SDS-PAGE,	fluorescent	imaging,	and	staining	with	Coomassie	blue,	protein	levels	were	normalized	to	the	0	
time	point	control.	The	protein	 levels	 indicate	minimal	to	no	protein	degradation	occurs,	even	at	 longer	time	points.	
Analysis	of	coupling	efficiency	was	determined	by	calculating	the	ratio	of	fluorescence	to	Coomassie	staining	for	each	
time	point.		All	reactions	were	performed	in	triplicate. 
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However, for the 4 oC temperature profile the reaction reached approximately 86% 
completion in 4h with minimal protein degradation, indicating that the 
bioorthogonal Cadiot-Chodkiewicz reaction can be performed quickly and in a 
relatively mild conditions.  Extended times and temperatures resulted in higher 
yields, however were accompanied by protein degradation. 
 We next sought to explore the effects of an aromatic variant of the pBrPrF. As 
such, pBrEtF-GFP151 was expressed, and subjected to identical coupling 
conditions at 4 oC in the presence of an alkyne fluorophore. Once again a 
successful conjugation was observed as determined by SDS-PAGE (Figure 10). 
Lanes 1                 2
	
Figure	 25.	 Bioorthogonal	 Cadiot-Chodkiewicz	 reaction	 using	 the	 aromatic	 pBrEtF	UAA	 contaiing	GFP.	 	 The	 reaction	
performed	on	GFP	(0.2	mg/mL)	and	AlexaFluor	488	(0.2	mM)	in	the	presence	of	5	mM	of	CuI	and	5	mM	TEA	at	4	oC	
overnight,.	Fluorescence	is	only	observed	in	the	presence	of	the	CuI/TEA	system. 
 Only samples exposed to the CuI/TEA system exhibited fluorescence while 
other controls did not, indicating the fluorescence was not due to non-specific 
interactions. Interestingly, the use of an aromatic containing bromoalkyne appears 
to be less effective in the Cadiot-Chodkiewicz reaction than its aliphatic analog.  
 Next, we became interested in exploring how the novel biological Cadiot-
Chodkiewicz conjugation compared to our previously described Glaser-Hay 
reactions. In direct comparison, the Cadiot-Chodkiewicz exhibited far less protein 
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degradation as compared to the Glaser-Hay versions of either an aliphatic (pPrF) 
or aromatic (pEtF) terminal alkyne containing UAAs. 
	
Figure	26.	Coupling	profile	of	 the	pPrF	Glaser-Hay	at	4°C.	Conjugation	yields	drastically	 increase	after	6	hr,	but	are	
accompanied	by	a	significant	degree	of	protein	degradation. 
 Furthermore, the data indicates that the biological Cadiot-Chodkiewicz reaction 
proceeds at a faster rate than the Glaser-Hay, with the aliphatic version (pBrPrF) of 
the coupling reaching completion the fastest in 4 hrs (Figure 12). Gratifyingly, 
these results correlate well with the mechanistic understanding of both reactions, 
as the Cadiot-Chodkiewicz requires a single copper atom, while the Glaser-Hay 
necessitates two copper-alkyne conjugates to form the diyne product. Moreover, 
the Cu(I)/(III) redox couple of the Cadiot-Chodkiewicz reaction most likely aids in 
the minimized protein oxidation relative to the Glaser-Hay coupling that involves a 
reactive Cu(II) intermediate. However, it is important to note that the Cadiot-
Chodkiewicz requires brominated UAAs, requiring additional synthetic 
preparation. In comparison to other bioconjugation techniques, the Cadiot-
73	
	
Chodkiewicz reaction may be slower; however, it employs more synthetically 
accessible UAAs and results in a well-defined linear geometry primed for further 
reactions. Thus, the selection of the Cadiot-Chodkiewicz reaction may be 
dependent on the downstream application and available resources.  
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Figure	27.	Comparison	of	alkyne	reactions.	Reactions	were	conducted	either	under	the	described	Cadiot-Chodkiewicz	
conditions	or	the	Glaser-Hay	conditions	at	4	oC	depending	on	 incorporated	UAA.	Due	to	differences	 in	protein	 levels	
resulting	from	oxidative	damage,	the	ratio	of	fluorophore	coupling	for	each	data	set	was	normalized	to	the	24	hour	
time	point	in	order	to	compare	coupling	trends	between	reactions.			
 
Conclusion 
 Overall, we have demonstrated the successful application of the Cadiot-
Chodkiewicz reaction to a biological context. Furthermore, we have demonstrated 
that the reaction can be performed with minimal protein oxidation. Finally, we 
have demonstrated that the Cadiot-Chodkiewicz variant requires less harsh 
copper(I) concentrations, bringing the reaction near the range for in vivo use. 
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Future work will involve optimization of conditions to increase the compatibility 
of the reaction with biological systems, and extension of the reaction towards in 
vivo applications. 
 
Experimental 
General All solvents and reagents, including the AlexaFluor 488 Alkyne, were obtained 
from Sigma Aldrich or Acros Organics and used without further purification. Plasmids 
were provided by the laboratory of Dr. Peter Schultz at The Scripps Research Institute. 
Reactions were conducted under ambient atmosphere with solvents directly from the 
manufacturer without further purification. All proteins were purified according to 
manufacturer’s protocols using a Qiagen NiNTA Quik Spin Kit. Compound purities were 
assessed by NMR and found to be 90% or greater for all compounds. All NMRs were 
acquired on an Agilent Technologies 400 MHz NMR. MS analysis was conducted on a 
Thermo Finnigan LCQ Deca Quadropole Ion Trap via direct injection of samples at 100 
µM in a 1:1 H2O/MeOH solution. Unless indicated otherwise, all solutions were 
prepared in deionized water (pH ~ 7).  
Synthesis of p-bromopropargyloxyphenylalanine (pBrPrF) p-Propargyloxyphenylalanine 
(pPrF, 0.050g, 0.150 mmol) was synthesized according to the literature1 , and dissolved 
in acetone (5 mL). This solution was then transferred to a vial containing AgNO3 (0.03g, 
0.015 mmol) and N-bromosuccinamide (NBS, 0.030g, 0.165 mmol). The mixture was 
allowed to stir for 3 hours at room temperature, after which it was diluted with hexanes 
(10 mL) and the resulting crystals were filtered off. The filtrate was then evaporated 
under reduced pressure and purified via flash chromatography (5:1 hexanes/ethyl acetate) 
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yielding the desired product as a white crystal (0.042 g, 0.102 mmol, 68% yield). The 
product was then subjected to 1M LiOH in dioxanes (500 µL each) on ice, and then 
stirred for two hours at room temperature. The dioxanes were subsequently removed by 
rotatory evaporation. Additional deionized water (1 mL) was then added to the product, 
and this solution was then brought to a pH = 4 with 6 N HCl. The solution was extracted 
in ethyl acetate, dried with MgSO4, filtered, and evaporated under pressure to dryness. A 
1 mL solution 2% trifluoroacetic acid (TFA) in dimethylene chloride (DCM) was then 
added to the vial, and the mixture was allowed to stir at room temperature for 1 hour, 
prior to evaporation under reduced pressure to yield the final product as a yellowish 
crystal (0.030g, 0.101 mmol, 99% yield, 67% overall yield). 1H NMR (400 MHz, 
CD3OD): δ 7.19 (d, J =8 Hz, 2H), 6.93 (d, J = 8 Hz, 2H), 4.91 (s, 1 H), 4.14 (m 1 H), 
3.06 (m, 2 H). 13C NMR (400 MHz, CD3OD): δ 168.4, 155.7, 128.6, 125.4, 113.5, 73.4, 
54.4, 52.3, 45.4, 25.4; MS: calcd for C12H13BrNO3: 299.14, found 298.1 and 300.1.  
 
Synthesis of p-bromoethynylphenylalanine (pBrEtF) p-ethynylphenylalanine (pEtF, 
0.052g, 0.171 mmol) was synthesized according to the literature protocol2 , and dissolved 
in acetone (5 mL). This solution was then transferred to a vial containing AgNO3 
(~0.03g, 0.0171 mmol) and N-bromosuccinamide (NBS, 0.034g, 0.189 mmol). The 
mixture was allowed to stir for 3 hours at room temperature, after which it was diluted 
with hexanes (10 mL) and the resulting crystals were filtered off. The filtrate was then 
evaporated under reduced pressure and purified via flash chromatography (3:1 
hexanes/ethyl acetate) yielding the desired product as a yellow crystal (0.024 g, 0.063 
mmol, 38% yield). The product was then subjected to 1M LiOH in dioxanes (500 µL 
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each) on ice, and then stirred for two hours at room temperature. The dioxanes were 
subsequently removed by rotatory evaporation. Additional deionized water (1 mL) was 
then added to the product, and this solution was then brought to a pH = 4 with 6 N HCl. 
The solution was extracted in ethyl acetate, dried with MgSO4, filtered, and evaporated 
under pressure to dryness. A 1 mL solution 2% trifluoroacetic acid (TFA) in dimethylene 
chloride (DCM) was then added to the vial, and the mixture was allowed to stir at room 
temperature for 1 hour, prior to evaporation under reduced pressure to yield the final 
product as a yellowish crystal (0.015g, 0.056 mmol, 89% yield, 34% overall yield). 1H 
NMR (400 MHz, CD3OD): δ 7.35 (d, J = 8 Hz, 2H), 7.21 (d, J = 8 Hz, 2H), 4.34 (m, 
1H), 3.16 (m, 2H), 2.90 (m, 2H). 13C NMR (400 MHz, CD3OD): δ 173.63, 138.42, 
132.16, 131.4, 129.2, 79.2, 54.6, 37.2, 27.22; MS: calcd for C11H11BrNO2: 269.12, 
found 268.1 and 270.1.  
 
Expression of UAA-containing GFP-151 Escherichia coli BL21(DE3) cells were co-
transformed with a pET-GFP-TAG-151 plasmid (0.5 µL) and a pEVOL-pCNF plasmid 
(0.5 µL) using an Eppendorf electroporator. Cells were then plated on LB-agar plates 
supplemented with ampicillin (50 mg/mL) and chloramphenicol (34 mg/mL) and grown 
at 37℃. After 16 h, a single colony was selected and used to inoculate LB media (4 mL) 
supplemented with ampicillin and chloramphenicol. The culture was grown to confluence 
at 37℃ over 16 h. This culture was then used to initiate an expression culture in LB 
media (20 mL) at OD600 = 0.1, then incubated at 37℃ until an OD600 ~0.7 was 
obtained. At this point, the cells were then pelleted at 4℃ at 5000rpm for 10 mins. The 
supernatant was removed and the cells were gently resuspended in 4 mL of LB media. 
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Ampicillin and chloramphenicol (4 µL each), 1M IPTG (4 µL), 20% arabinose (4 µL), 
and 100mM of the UAA (40 µL) were then added. Induced cells were grown for an 
additional 16 h at 37℃, then harvested via centrifugation (10 min at 5000 rpm). The 
media was decanted and the cell pellet was placed in the -80℃ freezer for 20 min. 
Purification of the UAA-containing GFP was then performed using commercially 
available Ni-NTA spin columns according to the manufacturer’s protocol. Protein yield 
and purity was then assessed by SDS-PAGE and spectrophotometrically by Nanodrop 
spectrophotometry. Protein was then transferred into phosphate-buffered saline solution 
(PBS, pH = 7) using 10k MWCO spin columns prior to use in the biological Cadiot-
Chodkiewicz coupling.  
 
General Protocol for the Biological Cadiot-Chodkiewicz Coupling To a sterile 1.5 mL 
Eppendorf tube, the following was added in order: 10 µL of bromo-alkyne UAA-
containing GFP151 (~0.5 mg/mL), 5 µL of a vigorously shaken CuI solution (50 mM), 2 
µL of trimethylamine (TEA, 50 mM), 5 µL of 488-Alexafluor alkyne (1 mM in DMSO), 
and 3 µL of PBS (pH = 7). Control reactions were set up in the absence of CuI and TEA 
and with the addition of a total of 10 µL of PBS. Reactions were performed at various 
temperatures and times as indicated in the main text, with the 4℃ for 6 hr variant being 
the ideal reaction conditions. Denatured SDS-PAGE were run following reaction, without 
cleaning or condensing the reaction, as it was found that the fluorophore would run off 
the gell and stil allow for adequate imaging. 
 
78	
	
General Protocol for the Biological Glaser-Hay Coupling To a sterile 1.5 mL Eppendorf 
tube, the following was added in order: 10 µL of termainl alkyne UAA-containing 
GFP151 (~0.5 mg/mL), 5 µL of a vigorously shaken CuI solution (500 mM), 2 µL of 
trimethylethylenediamine (TMEDA, 500 mM), 5 µL of 488-Alexafluor alkyne (1 mM in 
DMSO), and 3 µL of PBS (pH = 7). Control reactions were set up in the absence of CuI 
and TMEDA and with the addition of a total of 10 µL of PBS. Reactions were performed 
at 4℃ for various times as indicated in the main manuscript. Denatured SDS-PAGE were 
run following reaction, without cleaning or condensing the reaction, as it was found that 
the fluorophore would run off the gell and stil allow for adequate imaging. 
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CHAPTER 4: USING UAAS TO ILLUSTRATE AND ALTER PROTEIN 
STRUCTURE-FUNCTION RELATIONSHIPS 
 
 
Part I: Utilizing Unnatural Amino Acids to Illustrate Protein Structure-Function 
Relationships: An Experiment Designed for an Undergraduate Biochemistry Laboratory 
 
A learning outcome in most biochemistry courses is instilling an understanding of 
protein structure-function relationships. In order to master this concept, students must be 
able to recognize how changing even a single amino acid in the protein’s primary 
sequence directly impacts the structure of the protein. Moreover, linked to this concept is 
the central dogma, a core tenant of any molecular biology or biochemical program. To 
understand how alterations in a protein’s primary sequence arise, students must recognize 
that the genetic material coding each amino acid of a protein is stored in the DNA. This 
DNA then gets transcribed into RNA, which is ultimately translated into the amino acid 
sequence. Thus, an understanding of protein structure and function is intrinsically tied to 
an understanding of the central dogma. That being said, it is often difficult to illustrate 
this connection in a purely classroom setting. Consequently, we have developed a 
laboratory experiment to highlight these connections simultaneously. 
Unnatural amino acids (UAAs) represent a unique means to convey all of these 
concepts.1,2 In particular, the ability to introduce novel chemical functionality unavailable 
in the 20 canonical amino acids allows students to observe how altering amino acids can 
affect the microenvironment around an amino acid residue, drastically affecting how the 
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protein folds and behaves. This represents an advantage over simply changing one 
naturally-occurring amino acid for another, as these changes tend to be more nuanced, 
and thus make it harder for students to fully comprehend the chemical alteration they 
have performed. Furthermore, utilization of the Schultz methodology of UAA 
incorporation, whereby successful incorporation of a UAA hinges on the suppression of a 
TAG point mutation, encourages students to engage with the transcription and 
translational processes (Figure 1).1–3 In doing so, they can better visualize how mutations 
at the DNA level are carried through into a protein’s final structure and function. 
Moreover, due to the necessity to introduce orthogonal translational machinery (a tRNA 
and aminoacyl tRNA synthetase pair capable of recognizing and charging the UAA to the 
tRNA), the laboratory also provides a mechanism to introduce multiple molecular cloning 
techniques to the students.3 Moreover, the use of UAAs in biological chemistry is 
becoming increasingly prevalent in multiple applications (therapeutics, bioconjugates, 
protein probes, etc), and thus exposing students to this valuable technique has 
pedagogical advantages beyond the scope of the laboratory. 
 
Herein we report a laboratory that uses the Schultz methodology to incorporate 
commercially available UAAs into Tyr66 of green fluorescent protein (GFP; Figure 1). 
This tyrosine, along with Ser67 and Gly68, is essential in fluorophore formation, and thus 
is directly linked to protein function.4,5 Consequently, students can directly visualize the 
alteration in UAA structure as a change in the GFP fluorescence spectrum, illustrating 
how protein function is altered by relatively minor changes to the amino acid sequence. 
Furthermore, compared to other methods to illustrate structure-function relationship using 
GFP, such as PCR mutagenesis, the Schultz methodology employing UAAs is more 
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direct and requires less genetic manipulation on the part of the student given the time 
constraints of a laboratory setting.5,6  As a result, it is more likely to produce a functional 
mutated-protein product, and therefore concretely illustrate for the students the effects of 
altering even a single amino acid on protein function. 
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Figure	 28.	 Structure	 of	 GFP	 fluorophore.	 Tyrosine-66	 (green)	 will	 be	 replaced	 with	 different	 unnatural	
amino	acids	to	alter	spectral	properties.	
	
Learning Objectives 
The utilization of UAAs is a cutting edge technology, and is an excellent mechanism 
to foster discussion involving protein structure-function relationships.  To the best of our 
knowledge, there has been no reported undergraduate teaching lab incorporating UAA 
technology.7,8 As a result, we sought to generate a simple and inexpensive laboratory 
exercise that would introduce students to this rapidly expanding technology while 
simultaneously reinforcing the principles of protein structure and function and the central 
dogma. Moreover, this laboratory confers practical experience in bacterial 
transformation, protein expression, protein purification, and fluorescence spectrometry. 
The laboratory also seeks to solidify key concepts from the classroom, specifically 
involving translational processes. 
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Overview 
In this experiment the expression and purification of a UAA-containing GFP as well 
as a wild type GFP will be performed. While typically a unique aminoacyl-tRNA 
synthetase (aaRS) must be evolved for a specific UAA, recent reports have demonstrated 
that the pCNF aaRS is capable of incorporating up to 20 different UAAs.9 This is optimal 
for this experiment to minimize the storage, purification, and organization of multiple 
aaRS plasmids. The other requirement for UAA incorporation is a gene containing a 
TAG codon at the residue desired for UAA incorporation, allowing for the suppression of 
the stop codon by UAA integration if the system is properly functioning. Using plasmids 
harboring the previously reported promiscuous aaRS, pCNF aaRS, and GFPTAG66, 
students will perform a co-transform of competent E. coli.  This can be accomplished by 
either electroporation or chemical transformation with competent cells, facilitating 
discussions on mechanisms of bacterial transformation, transformation efficiency, and the 
requisite antibiotics to facilitate plasmid uptake and maintenance. The transformed cells 
will then be used to induce GFP expression in the presence of an assigned UAA. 
Depending on laboratory size, each pair of students may be assigned a different 
commercially available UAA. Additionally, students will transform and express wild-
type GFP for comparison of the fluorescence emission profile of their UAA-containing 
GFP versus the wild-type. All plasmids required for the experiment are available from 
Addgene (Plasmid #48215), or can be obtained from the authors, and the UAAs are all 
commercially available. 
Protein purification may be carried out by numerous methods. Hydrophobic 
interaction columns, which are commercially available and simple for the undergraduate 
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student, will be used to partially purify both UAA-containing GFP and wild-type GFP. 
Our results indicate that this procedure affords GFP in good yield with only minor 
contaminants, and with approximately no effect on the fluorescence profile of the 
protein.9 
This experiment will incorporate several key biochemistry laboratory skills for the 
undergraduate researcher including electroporation, protein expression and purification, 
fluorimetry, and UAA-mutagenesis.  
 
Laboratory Set-Up and Procedure 
A wild-type GFP transformation and expression protocol was adapted from the 
commercially available pGLO plasmid kit (Bio-rad; Cat # 166-0003EDU).  
UAA-mutagenesis using the Schultz methodology requires the preparation of plasmid 
stocks harboring the pEVOL-pCNF-aaRS plasmid with chloramphenicol-resistance, the 
pET-GFPWT plasmid with ampicillin resistance, and the pET-GFPTAG66 plasmid with 
ampicillin resistance. Additionally, 100mM stocks of p-azidophenylalanine (pAzF), p-
biphenylphenylalanine (pBiPhF), p-acetylphenylalanine (pAcF), p-iodophenylalanine 
(pIF) in deionized water should be prepared prior to the start of the laboratory period (see 
Experimental).  
Students work in pairs over the course of three weeks, and require typically two-hours 
for each lab meeting. Week 1 of the laboratory focuses on bacterial transformation, and 
mutant GFP expression. Week 2 involves both wild-type and mutant GFP purification 
and fluorescence. Week 3 entails a “GFP symposium” facilitating discussion about the 
techniques utilized in lab and student presentations. 
87	
	
 
 
Week 1 
On the first week, students perform the transformations and induce expression of GFP 
mutants harboring an unnatural amino acid. The chemical transformation of pET-GFPWT 
are performed in direct accordance with the Bio-Rad pGLO kit (substituting 1 mM IPTG 
for arabinose in the agar plates). This plasmid encodes the wild-type GFP and does not 
require the aaRS machinery. The plasmid can also transformed by electroporation to 
provide a direct comparison to the chemical transformation. This portion of the lab 
emphasizes the transformation of plasmid DNA into E. coli for heterologous expression. 
If available, students may also perform an optional double transformation using 0.5 µL of 
pEVOL-pCNF  plasmid and 0.5 µL of pET-GFPTAG66 plasmid, both at approximately 100 
ng/µL with an electroporator at 1800V. These transformations should be recovered at 37 
oC for 1 hr, then plated on plates containing ampicillin and chloramphenicol.  
While transformations are being performed, students also induce the expression of a 
mutant GFP with their specified UAA using a second bacterial culture that was 
previously prepared. Two days prior to the laboratory, the instructor must co-transform 
the pEVOL-pCNF plasmid and pET-GFPTAG66 as described above. The next day, a 
colony should be selected and grown in 10 mL of LB Media containing ampicillin and 
chloramphenicol at 37 oC overnight. The day of the lab, approximately 1-2 hours before 
the scheduled time, a 10 mL expression culture of the cells should be innoculated for 
each group at OD600 0.1. During the actual laboratory students will begin expressing their 
UAA-containing GFP using an expression culture that has grown to log phase (OD600 = 
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0.6 – 0.8). Expression of the GFPTAG66 is induced with the addition of 10 µL each of 
1000x stocks of IPTG and 20% arabinose. Also, at this time students add 100 µL of their 
assigned 100 mM UAA stock. This laboratory period facilitates a discussion of typical 
transformation procedures (students are exposed to both heat shock and electroporation in 
the exercise) as well as a discussion of molecular genetics for gene expression. Finally, 
the use of the Schultz methodology for incorporation of the UAA into GFPTAG66 
facilitates a discussion of gene transcription and protein translation.  
The next day the laboratory supervisor centrifuges the expression cultures of the 
UAA-containing GFP (5000 g for 10 min). The cell pellets are then stored at -80 oC until 
the next laboratory session. Additionally, at some point in-between lab periods students 
observe the fluorescence of the E.  coli cell pellet, and count the colonies on their 
transformation plates. This allows them to identify the differences between 
electroporation (UAA plasmids, and possibly the wild-type plasmid) and heat-shock 
(wild-type plasmid), as well as single and double transformations. These colony counts 
are used to calculate the transformation efficiency for the single transformations versus 
the double transformations. 
Week 2 
In the second week students use hydrophobic interaction columns (HIC) to purify 
both their wild-type and UAA-containing GFP. This week follows the protocol described 
in the Green Fluorescent Protein Chromatography Kit (Bio-Rad; Cat # 166-0005EDU). 
Using their partially purified protein at a concentration of 0.5 to 1 mg/mL, students 
prepare a sample for fluorescence detection by diluting 10 µL of their protein in 3 mL of 
1 x PBS. Students then observe the fluorescence spectra of their wild-type and UAA-
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containing GFPs using a fluorimeter set to excite at 395 nm and scan between 410 nm to 
600 nm. 
This week also has the potential to facilitate a discussion on protein purification 
techniques, as the HIC process pulls down many contaminating proteins along with the 
UAA-mutated GFP. As such, column fractions can be analyzed via SDS-PAGE and 
stained with Coomassie blue to highlight the limitations of this purification technique 
(see Figure 2).  
 
Figure	 29.	 Coomassie	 stained	 SDS-PAGE	 of	 the	 UAA-containing	 GFP66	 produced	 by	 the	 biochem	 students.	 The	 gel	
highlights	 that	 the	 hydrophobic	 interaction	 column	 is	 an	 adequate	 means	 to	 purify	 the	 GFP	 and	 facilitates	 a	
conversation	 about	 what	 the	 properties	 of	 the	 other	 contaminants.	 Our	 fluorescence	 data	 indicates	 that	 the	
contaminants	did	not	affect	the	spectra.		
Furthermore, if time is not available to stain and destain with Coomassie blue, the GFP 
fluorescence can be directly observed through the SDS-PAGE gel using a UV 
transluminator or lamp (see Figure 3).  
90	
	
 
Figure	30.	Fluorescent	imaging	of	SDS-PAGE	of	the	UAA-containing	GFP66	produced	by	the	biochem	students.	Gel	was	
excited	at	302	nm	for	optimal	fluorescent	detection	of	all	UAA-variants.	Samples	were	treated	with	a	2x	SDS-dye	mix	
prior	 to	 loading,	which	 retained	 protein	 structure	 allowing	 for	 the	 detection	 of	 the	 GFP	 via	 fluorescence,	 and	 thus	
obviating	the	need	for	Coomassie	staining.	
 
Week 3 
In the third week students present their results as well as a discussion of topics related 
to protein expression, purification, and fluorescence. Each student is assigned a specific 
topic to prepare a 5-10 min presentation. Examples of topics include: biological relevance 
of lysozyme, methods of cell lysis, DNA mutagenesis for the introduction of the TAG 
codon, aaRS evolution, mechanism of chemical transformations, antibotics and antibiotic 
resistance, protein induction by IPTG/Arabinose, vectorology, the chemical basis of GFP 
fluorescence, and numerous other topics related to the laboratory. Additionally, the 
results of the laboratory are discussed and compiled fluorimetry data is presented to truly 
illustrate the effect of the different amino acids on GFP fluorescence 
 
Results and Discussion 
Overall, the experiments described above translated well in a laboratory setting. 
While the traditional pGLO GFP lab has been employed in our Advanced Biochemistry 
Laboratory for the past several years, the unnatural amino acid component has been 
included in the past two years. Each year averages between 8-12 students in the lab, for a 
total of approximately 20 total student participants. The double transformations that the 
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students performed yielded approximately 5 colonies per lab group, which is to be 
expected of double transformations. Single transformations afforded much higher 
transformation efficiencies, to those referenced in the literature and ranged from 0 to 109 
cfu.  The efficiencies were typically student dependent based on previous experience and 
their ability to follow directions. These results promote discussions into antibiotic 
resistance and requisites for colony growth on antibiotic plates. Protein expression levels 
were robust, the GFPWT and the UAA-containing GFP66 both yielding between 0.5 to 1 
mg/mL of purified protein.  
The UAA-mutagenesis of the GFP66 was successful for all UAA used in this 
laboratory, as demonstrated by the successful shift in the UAA-containing GFP66 relative 
to the GFPWT. Gratifyingly, spectral shifts of GFP fluorescence were observed for each 
mutant, demonstrating the relationship between protein structure and function, and the 
influence of a single amino acid mutation (see Figure 4). The most dramatic blue shift 
was observed for the pAcF mutant, most likely due to the resonance into the carboxylic 
oxygen. Overall, students were able to effectively transform bacteria with the plasmids, 
as well as express and purify functional protein, and analyze its spectral properties.  
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Figure	31.	Fluorescence	results	for	the	expression	of	GFP	mutants.	(A)	Fluorescence	spectra	obtained	on	a	fluorimeter	
exciting	 at	 395	 and	 scanning	 emission	 from	 410	 to	 600	 nm.	 (B)	 Visualization	 of	mutant	 protein	 fluorescence	 on	 a	
transluminator	with	an	excitation	wavelength	of	365	nm.	
This experiment was piloted in an upper-level biochemistry lab targeted for juniors 
and seniors with a background in the subject. Compared to a standard protein 
expression/purification lab, in which students transform GFPWT into E. coli and 
subsequently purify the protein, this exercise provides students with exposure to 
considerably more biochemical and molecular biology techniques. In particular, the use 
of the Schultz methodology for UAA incorporation allowed students to engage with 
topics from lecture, such as translation and protein structure-function relationships, in a 
way that was not accessible via a more traditional lab (Table 1).  Based on student 
evaluations of the laboratory, an appreciation of how the experiment concretely illustrates 
protein structure-function relationships was the most powerful learning outcome. 
Moreover, the use of the fluorimeter allowed students to visualize the impact of their 
UAA incorporation, thereby reinforcing how even a single amino acid alteration can 
drastically impact a protein’s function. This concept is perfectly illustrated by the 
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integration of UAAs into the laboratory and can easily be achieved over the course of 2 
lab meetings.  
Table	3.	Comparison	of	Standard	GFP	Laboratories	Versus		the	UAA	Laboratory	
Learning Outcomes for Standard GFP 
Transformation Experiment 
Learning Outcomes for UAA-
Mutagenesis of GFP Experiment 
• Basic understanding of transformation 
techniques as well as protein purification 
(which obviously pairs well with protein 
properties). 
 
• All those listed in the “Standard” GFP 
Transformation Experiment 
• Provides student with an opportunity to 
understand selection processes in 
conjunction with plasmid design (i.e. 
antibiotic resistance as a means to ensure 
plasmid maintenance). 
 
• Facilitates discussion of translational 
processes via the Schultz’ methodology for 
UAA incorporation 
 
• Provides an illustration of molecular 
genetics by providing a means to discuss 
operators and promoters 
• Facilitates discussion of protein structure-
function relationship, as the incorporation 
of different UAAs alters the GFP-
chromophore, affecting fluorescence profile 
 
 • Provides students with the opportunity to 
practice use of a fluorimeter, a standard 
laboratory instrument in most chemical 
settings. Also facilitates a discussion of 
fluorescence, a topic typically relegated to 
physical chemistry 
 
 • Provides students with exposure to current 
technologies (e.g. UAA incorporation) that 
are widely employed within the field of 
chemical biology.  
	  
 
The experiment also provides practical introductions to bacterial transformations and 
illustrates the differences in transformation efficiency between various protocols. 
Additionally, the necessity for double-transformations facilitates discussions for 
mechanism of antibiotic resistance and the necessity of antibiotic resistance onto the 
plasmids to facilitate bacterial selections. Finally, key aspects of fluroimetry are also 
introduced in the experiment as differing functional groups result in spectral shifting of 
the fluorophore emission.  
94	
	
Upon completion of the laboratory during week 3, the learning outcomes were 
assessed both by presentation projects and by a laboratory evaluation form (see 
Experimental). Students were asked to distil the big picture ideas as well as assess the 
effectiveness of the laboratory. Overall, students were overwhelmingly positive in the 
assessment of the lab and all of the students were able to clearly and concisely 
communicate both the purpose of the lab and fundamental concepts about plasmids and 
protein translation. Finally, learning outcomes were assessed by the completion of a 
typical laboratory report summarizing the experiment and the overall results for each 
student. 
 
Conclusion 
Unnatural amino acids are an excellent mechanism for the study of protein structure-
function relationships. This developed laboratory for an upper division biochemistry 
course provides a simple means of demonstrating this feature of UAAs. Moreover, the 
mechanism of UAA incorporation facilitates substantial learning and solidifies several 
key concepts including: bacterial transformations, molecular cloning, and fluorescence. 
Experimental 
Experimental Handout Adapted for Laboratory Exercise – Week 1 
 
 
 
 
 
 
 
 
 
 
95	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experiment 4 – Transformation of E. coli with the gene for Green Fluorescent Protein 
(GFP) 
 
Week 1 – Transformation of E. coli, plating and calculations of transformation efficiency, 
and protein expression 
 
Week 2 – Purification of GFP by 
column chromatography and 
fluorescence measurements.  
 
Background: 
Unnatural amino acids (UAAs) 
allow scientists to expand the 
rather limited biochemical 
functionality found in the 20 
Figure 1. Mechanism for genetic incorporation of unnatural amino acids. 
An orthogonal synthetase must be introduced that does not cross-react 
with any natural tRNA or amino acid. This is coupled with a new tRNA that 
harbors an anticodon for the TAG codon. When the ribosome encounters 
the TAG codon, a new amino acid is incorporated, rather than the 
discontinuation of translation. Adapted from  Chem. Biol.  2009 16, 323-
336 
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canonical amino acids and introduce novel reactivity not typically found in proteins1,2. 
Incorporated via suppression of a TAG stop codon in translation, which can be 
introduced into the DNA at a desired residue position of the target protein. In order to 
incorporate UAA’s, the cell needs to be supplied with new orthogonal machinery (so that 
there is there is no cross-talk between the endogenous translation machinery of the cell 
and the machinery necessary to incorporate the UAA). A foreign aminoacyl-tRNA 
synthetase (aaRS) must be expressed in the cell that will recognize the UAA and 
“charge” it to an exogenous tRNA with the antisense codon for TAG. Now, as the cell’s 
translation machinery reads our desired protein’s mRNA, it will incorporate the UAA in 
any codons that code for TAG (thankfully the TAG, or Amber, stop codon is rarely used 
in E. coli, and therefore this new machinery will not impact cell viability/normal 
functioning). Scientists can readily manipulate the DNA to introduce TAG stop codons 
into desired residue positions on the protein’s DNA. Overall, this process allows for the 
site-specific incorporation of UAA’s in pre-defined positions. Figure 1 provides a great 
overview of the new cellular machinery described above. The alteration of a single amino 
acid can have significant impact on protein function. This week, we will introduce 
UAA’s in place of Tyrosine 66 in Green Fluorescent Protein (GFP). Position 66 is a 
residue essential in the formation of the GFP fluorophore. Based on the properties of the 
incorporated UAA, the fluorescence of GFP will change. We will employ one of several 
commercially available UAAs, and each laboratory group will be assigned an amino acid. 
While typically, a unique aaRS must be evolved for an individual amino acid, recent 
work has found that the pCNF-aaRS is promiscuious and able to recognize multiple 
different UAAs, a property that we will exploit for UAA incorporation. We will be 
measuring these altered fluorescence spectra after purification of the protein in Week 2.  
 
Helpful definitions 
 
Competent cells: Capable of taking up plasmid DNA. Typically, cells are treated with 
calcium chloride which alters their membrane in such a way that DNA can pass through.  
 
Transformation: Once the bacteria have taken up endogenously added DNA, they are 
called "transformed."  
 
LB plates – contain agar and a nutrient broth named after Luria and Bertani. 
 
LB/amp plates – contain LB growth media, agar and ampicillin 
 
LB/amp/ara plates – contain LB growth media, agar, ampicillin and a sugar inducer 
called arabinose 
 
Transformed E. coli will grow on LB/amp plates; ampicillin is an antibiotic similar to 
penicillin. Transformed bacteria will express an enzyme that is capable of destroying the 
ampicillin present in the plate media. Thus, only those bacteria will grow on LB/amp 
plates. However, to express GFP, an inducer must be present as well. Thus, GFP should 
only be expressed on LB/amp/ara plates.  
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UAA – unnatural amino acid 
 
aaRS- aminoacyl-tRNA synthetase, a protein responsible for charging tRNA molecules with 
specific amino acids 
 
pEVOL-pCNF – a plasmid coding for the tRNA synthetase that recognizes our UAA, as well as 
the tRNA with an antisense codon for TAG. This plasmid gives the bacteria resistance to 
chloramphenicol. 
 
pET-GFP-66-TAG – a plasmid coding for GFP with a TAG codon in residue 66. This plasmid 
gives the bacteria resistance to ampicillin. 
 
Transformation procedure 
This week you will be performing two transformations. One will be a single 
transformation and will produce the wild-type GFP. The second transformation will be a 
double transformation involving two plasmids, and will involve the electrical shock 
(electroporation) of competent cells to introduce both the GFP protein (with a mutated 
TAG codon at position 66) and the necessary translational machinery.  
 
The procedure for transforming E. coli is very simple and is described in the 
“Transformation Kit-Quick Guide.”  You will use 10 µl of the pET-GFP-WT plasmid 
solution provided. We will use Pipetmen to dispense solutions because they are more 
precise than the plastic pipets shown in the “Transformation Kit-Quick Guide”. There are 
a few changes to the kit procedure that I will announce in lab before we begin the 
procedure. 
 
For the electric shock transformation, all of the following must be placed on ice: an 
aliquot of competent cells, some media, an electrocuvette, pET-GFP-66-TAG plasmid, 
and pEVOL-pCNF. The process is as follows: 
NOTE: to allow you to move faster, it is useful to preset and place pipet tips on all 
the pipetmen that you will be using. 
1) Take up 0.5 µL of pEVOL-pCNF – inject this into the aliquot of cells 
2) Take up 0.5 µL of pET-GFP-66-TAG – inject this into the aliquot of cells 
3) Take up all 50 µL of the cells (set pipette to 55uL to ensure you get the full 
volume) –and then transfer the full volume to the electrocuvette (NOTE: the 
opening for the electrocuvette is very slim, so do your best to make sure that the 
very tip of the pipette-tip is in between the slot). 
4) Place the now-full electrocuvette into the electroporator, which should be preset to 
1600V. Shock your cells! 
5) RAPIDLY add 500uL of chilled media to the cells – this will help them recover 
from the shock. 
6) Transfer the ~550uL of transformed cells to a labeled eppendorf tube and allow to 
recover for 1 hr at 37 oC. 
 
If your cells “spark/arc”: Redo the procedure above, using 0.4uL of DNA each (for a 
total of 0.8uL of DNA) and shock the cells at 1400V.  
98	
	
 
After the 1hr recovery, plate a 100 µL aliquot of the transformed cells onto an 
AMP/CHLOR LB Agar plate.  
 
YOU MUST CHECK YOUR PLATES TOMORROW AFTERNOON FOR 
COLONIES!  
 
 
Expression Protocol: 
Additionally, you will set up a protein expression that you will purify next week. Protein 
expression is an extremely time dependent process, as expression must be induced at an 
optimal time in the cell growth cycle to maximize yield. Prior to lab, your instructor has 
inoculated a liquid culture of LB media (containing ampicillin and chloramphenicol) with 
the bacteria containing both the pEVOL-pCNF plasmid and the pET-GFP-66-TAG 
plasmid.  
 
1) Monitor the growth of the cells by measuring the OD600 of the bacterial 
culture on the spectrophotometer (this may require you to make a 1:10 dilution of 
the cells prior to measurement) 
2) When an OD600 of 0.8 has been achieved, obtain 10 mL of bacterial 
culture and induce GFP production by the addition of 10 µL of 20% arabinose (to 
induce the production of the translational machinery), 10 µL of  1M IPTG (to 
induce the production of GFP), and 100 µL of an assigned unnatural amino acid 
(100 mM). 
3) The culture will now be placed in an incubator at 30 oC for 16 h to allow 
for protein expression. 
4) Your instructor will centrifuge the culture tomorrow at 4,000 rpm for 10 
min, discard the supernatant, and store the cell pellet at -80 oC for you to use next 
week in the GFP purification. 
 
Things to do: 
 
1.  Check for transformed E.coli on the thermal transformations of wild-type protein 
LB/amp and LB/amp/ara plates. Check all plates with the UV light to look for “glowing” 
GFP containing colonies.  
 
2.  You will count the total number of colonies on the LB/amp and LB/amp/ara plates. 
With these numbers, you can calculate transformation efficiency. We will go over this 
calculation in lab. 
 
3. Observe your UAA GFP pellet for fluorescence using the transilluminator. 
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Experimental Handout Adapted for Laboratory Exercise – Week 2 
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Experiment 4 Week 2– Bacterial cell lysis and partial purification of GFP by 
hydrophobic interaction chromatography  
Please follow the instructions below. The GFP purification quick guide is posted but I 
have made significant changes. Use Pipetmen for all volume transfers. Green fluorescent 
protein (GFP) will bind to a hydrophobic interaction column(HIC) in the presence of 2 M 
ammonium sulfate (hydrophilic proteins will not bind. Then we elute GFP from the HIC 
with a buffer of lower salt concentration.  
Solutions used:  
TE buffer – 10 mM Tris, 1 mM EDTA pH 8.0  
Binding buffer – 4 M (NH3)SO4 in TE; 
TE Column Equilibration buffer - 2 M (NH3)SO4 n TE  
Column Wash buffer -1.3 M (NH3)SO4 In TE 
Lysozyme in TE buffer  
Bacterial cell lysis  
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1. Each student will receive a 2 ml portion of bacterial culture. The cells will have been 
grown (name that verb tense!) for 24-36 hours at 30 °C with shaking. Look at the cell 
suspension under UV light. Does it glow?  
Observation: ____________________________________________________  
2. Spin the cells in a microfuge tube for 5 minutes at maximum speed to obtain a pellet. 
Since there are 2 mL, I suggest you pipet 1 mL into a microfuge tube, spin for 5 minutes, 
decant the supernatant and then add the second ml of bacterial culture. Spin again for 5 
minutes and decant the supernatant.  
3. Resuspend the cell pellet in 250 µl TE buffer by pipetting up and down several times. 
Modified lysozyme step – lysozyme degrades the cell wall. Then freeze/thaw cycles 
should “finish the job.”  
 
4. Add 100 µl lysozyme solution to the resuspended cells. Incubate the sample at 37 °C 
for 30 minutes. Be sure to vortex the sample about every 5 minutes during the 30 minute 
period.  
5. Freeze the sample in liquid nitrogen to rupture the cell walls. Thaw quickly in warm 
water. Repeat the freeze/thaw cycle.  
6. Spin the sample for 10 minutes at maximum speed to pellet the insoluble bacterial 
debris.  
While the tubes are spinning, prepare the HIC column (see below)  
Page 2 of 2 
After the spin, carefully pipet the supernatant into a new, clean microfuge tube. Look at 
the pellet and the supernatant under UV light.  
Observations:  
pellet _________________________________________________  
supernatant __________________________________________________  
The total volume is now 350 µl, so add 350 µl binding buffer, 4 M (in TE, before loading 
the column. 
Final concentration of (NH3)SO4 =_________________________________  
You will load ALL 700 µl onto the column.  
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7. Column prep and loading  
You will need 3 tubes for collecting fractions from the column. Label them 1, 2 and 3.  
Clamp the HIC column in an upright position. Remove the top and bottom caps and allow 
the column to drain (into a waste beaker). Prepare the column by adding 2 ml 
Equilibration buffer (2 M (NH3)SO4 in TE) to the top of the column. After it has drained 
through, re-cap the column and place collection tube 1 under it.  
8. Load your entire supernatant sample (700 µl) on the column bed carefully. Allow the 
supernatant to drip down the side of the column wall so as not to disturb the HIC column 
bed.  
9. Uncap the column and allow the column to drain slowly. It is during the loading step 
that the column packing material (HI resin) and the GFP “find each other” so you do not 
want to rush this step.  
Check fraction 1 under UV light. Observation 
______________________________________  
10. Place tube 2 under the column. Apply 700 µl Column Wash solution (1.3 M 
(NH3)SO4 in TE) to the top of the column. Collect as fraction 2. 
Check fraction 2 under UV light.  
Observation ______________________________________  
11. Place tube 3 under the column. To elute GFP, apply 700 µl TE buffer. Collect as 
fraction 3. Check fraction 3 under UV light.  
Observation ______________________________________  
Label your GFP column fractions with your initials and place them in the designated rack 
before you leave. Did you check them with the UV lamp to see if they GLOW?? Really?  
Who will have the highest yield of GFP??  
12. Record the emissions spectrum of both the WT GFP sample and the mutant GFP 
sample on the fluorimeter 
1) Turn on the fluorimeter and let it warm up. 
2) To a quartz cuvette, add 10 uL of GFP into 3 mL of (TRIS OR PBS) 
3) Place into holder in the fluorimeter 
4) Operation of fluorimeter software 
a. Open FL WinLab 
b. Pick any scan method 
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c. A window will pop up – select the heading titled “Emission”  
i. Parameters: start (nm): 405; end (nm): 650; excitation 
(nm): 395; ex slit (nm): 10; em slit (nm): 10; scan speed (nm/min): 
50 
d. Name the file a 4 letter name for your group (EX: GRPA) 
e. Press the “go” on the stop light to begin the read 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Report Guidelines – End of Lab 
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Experiment 4 Report and oral presentation guidelines 
 
Written report 
1. Write a brief summary (one paragraph) of the goals of the two-week 
experiment and the outcome. 
2. Note anything unusual that may have happened. 
3. Week 1 – report the results of the transformation. In a table, summarize 
what you saw on the 4 plates. Also explain why some colonies expressed GFP 
and others didn’t. Show calculations of transformation efficiency. Remember: 
Transformation efficiency is the number of colonies/amt of DNA used. If you saw 
nothing on the plates, explain why. 
4. Week 2 – report the results of the purification of GFP from the bacterial 
culture. Why did the protein bind to the column? Do you think it was pure? How 
would you check? Discuss the observed fluorescence spectra. Was there a 
difference between the UAA protein and the WT protein?  
 
The entire written report need not be more than 1-2 pages. 
 
In addition to presenting the report information (especially #3 above), each of you will 
also answer a question. You should think of it as “teaching the rest of the class” about a 
particular topic related to the two-week GFP experiment. That means that you should 
prepare figures with essential chemical structures or be willing to draw them on the 
board. Total presentation time should be 7-8 minutes/student. Questions from the 
audience are encouraged. If you don’t ask them of each other, I definitely will. Heck, I 
probably will anyway.  
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Student 1 
We used lysozyme and freeze/thaw cycles to rupture the bacteria. How does lysozyme 
work? What other methods could we have used to lyse the bacteria without destroying 
GFP? 
 
Student 2 
Explain how the “heat shock” procedure for transforming bacteria works (this was week 
1). What is the purpose of the CaCl2 transformation solution? What are other common 
methods to get plasmid DNA into bacterial cells? 
 
Student 3 
How is the GFP fluorophore formed (see the J. Chem. Ed. article)? This may require you 
to look at the sequence/structure of GFP. Is there any reason why this protein evolved? 
 
 
Student 4 
In the J. Chem. Ed. article posted on Blackboard, the researchers explain the amino acid 
mutations in GFP that have been done and how those mutations affect the 
fluorescence/color of the resulting GFP proteins. Using the amino acid sequences, the 
article and what you know about chemistry, explain the color changes. (It is essential that 
you show the class the sequences in Table 1.) 
 
Student 5 
Explain how site-directed mutagenesis of GFP was performed to make the mutants 
described in the J. Chem. Ed article posted on Blackboard and used in the experiment.  
 
Student 6 
How does arabinose induce expression of GFP? (Be sure to include the structure of 
arabinose) Compare the arabinose induction system with the lac operon. 
 
Student 7 
What is the chemical mechanism of ampicillin resistance? Compare the structures of 
ampicillin and penicillin. This will require some explanation of the structure of the 
bacterial cell wall. 
 
Student 8 
What is the drug Augmentin? Provide some information about the structure and 
mechanism of the enzyme, Β-lactamase that destroys ampicillin. What other inhibitors of 
Β-lactamase are available? Or under development? Tell us about at least one more.  
 
Student 9 
Explain how hydrophobic interaction chromatography works. Be sure to explain the 
purpose of the buffers used (equilibration, binding, wash and TE). If you used ion 
exchange chromatography, under what conditions, if any, would you expect GFP to bind 
to the column? This may require you to look at the sequence/structure of GFP. 
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Student 10  
Explain the process of incorporating unnatural amino acids into proteins. How are 
synthetases evolved to recognize unnatural amino acids? 
 
Student 11 
Explain the basis of polyspecificity of a synthetase. How else have unnatural amnio acids 
been employed than to alter the fluorescence of GFP (pick 1-2 examples). 
 
 
 
You may use PowerPoint or write on the board. If you have any questions about the 
written report or the presentation, please ask! 
 
The complete pdf guidebooks (50-60 pages) for the two GFP experiments that you did 
are posted on Blackboard under course documents. You need not print out the whole 
thing but you will find the majority of the information you need to answer the questions 
there. 
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Evaluation form used to gather student feedback 
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Lab Evaluation Form 
   Unnatural Amino Acids and GFP 
 
 
 
The purpose of this evaluation is to gather input so that we can improve this lab and your 
learning outcomes. Please answer these questions without referring to the lab manual. 
Your response will be kept anonymous and are not graded. Thank you for participating! 
Your Name _________________________ 
 
1.  What is the purpose of having 2 plasmids? What proteins are specifically encoded on 
each? 
 
 
 
 
2. Summarize the major findings of this lab. 
 
 
 
3. What is the strongest feature of this lab? In other words, what contributed most to your 
learning?  
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4. Was bringing unnatural amino acids into the lab useful? 
 
 
 
 
 
5. Do you have any additional comments about this lab?  
 
 
 
 
 
 
List of Chemicals Used in Laboratory Exercise 
 
Chemical CAS MW 
(g/mol) 
Density 
(g/mL) 
Hazard 
4-iodo-L-
phenylalanine 
•  242
50-85-9 
 
• 29
1.09 
 
--- Potential irritant 
4-acetyl-
phenylalanine 
22888-49-9 
 
207.23  1.226 Potential irritant 
L-4,4’-
biphenylalanine 
155760-02-4 241.2896 --- Potential irritant 
4-azido-L-
phenylalanine 
33173-53-4 206.2 --- Potential irritant 
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isopropylthio-β-
galactoside 
1552
9-019 
 
238.32 --- Potential irritant 
L-(+)-arabinose • 532
8-37-0 
 
150.13 --- Potential irritant 
ampicillin 7177-48-2 403.45 --- allergies 
chloramphenicol • 56-
75-7 
 
323.13 --- irritant 
acrylamide • 79-
06-1 
71.08 --- neurotoxin 
 
 
Instructor Prep Guide 
Week 1 – Transformation of E. coli, plating and calculations of transformation efficiency, 
and        protein expression 
To prepare (beyond the items required by the pGLO kit):  
o Electrocompetent cells 
o 100 mM Stocks of the UAAs to be used 
o For 100 mM pIF dissolve 29 mgs of pIF into 1 mL of deionized water 
o For 100 mM pAcF dissolve 21 mgs of pAcF into 1 mL of deionized water 
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o For 100 mM pBiPhF dissolve 24 mgs of pBiPhF into 1 mL of deionized 
water 
o For 100 mM pAzF dissolve 21 mgs of pAzF into 1 mL of deionized water  
§ NB: sometimes the UAAs have issues going into solution. As such, 
we found it useful to both sonicate the UAAs as well as adding 
approximately 5 µL increments of a 10 M NaOH solution to the 
UAA (prior to bringing to full volume).  
o Pure plasmid stocks of PET-GFPTAG66 and pEVOL-pCNFaaRS 
o Prepare IPTG (200mg/mL)   
1. Dissolve 2g IPTG (Isopropylthio-B-D-galactoside) in 8 mL of water. 
2. Adjust final volume to 10 mL with more H2O if needed. 
3. Transfer mixture to 12 mL syringe with filter attached to end. 
4. Filter 1 mL aliquots into epis. 
5. Store in freezer. 
o Prepare 20% (w/v) Arabinose  
o Amp/Chlor supplemented agar plates for selection of cells cotransformed with 
GFP66+pCNFaaRS 
o Expression cultures of cells (at an OD600 ~ 0.7) already harboring plasmids for 
GFP66 and pCNFaaRS 
o Thus you will already need to have done the cotransformation yourself, 
plated these transformed cells on Amp/Chlor agar, selected an isolated 
colony for starter culture growth, and begin the expression cultures ~ 2hr 
prior to the start of lab. 
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Week 2 – Purification of GFP by column chromatography and fluorescence 
measurements.  
To prepare (beyond the items required by the pGLO kit): 
o GFPwt expression cultures must be prepared prior (according to direction in the 
pGLO kit) one day before the lab meets. 
Common student pitfalls While electroporation is, for the most part, a fairly easy 
technique, the risk of “sparking” cells is high for the beginner. As such, we found it 
useful to have a more experienced person demonstrate a proper electroporation, and then 
had students attempt their own. However, because “sparking” is often common with 
beginners, we did not have students redo their transformations if their cells sparked. 
Instead, because we were already providing the students with a pre-transformed 
expression culture, we reasoned it was not necessary for all students to have successful 
transformations. Indeed, the pGLO kit transformants would provide the students with 
transformed cells that could then serve as a discussion point for selection methods.  
We found that the pGLO kit did not always yield successfully transformed colonies for 
all students. As such, we prepared our own expressions of GFPwt (using a PET-GFPwt 
plasmid and electroporation) and pelleted the cells prior to start of lab on week 2. Then, if 
any students did not have good colonies, and hence GFP expression, they could use the 
pelleted-GFP expressing cells we had already prepared for them. 
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Part II: Editing GFP Fluorescence using the Biological Glaser-Hay 
 
Protein engineering is a powerful tool for the development of new therapeutics, 
catalysts, and biosensors.1 While many advances in the field have been made, designing 
novel protein functionality is still a challenge, as it requires an intricate understanding of 
the subtle interplay between protein structure and function. Current engineering 
114	
	
techniques often focus on using selection and screens to optimize or enhance existing 
protein functionality.1 While this method has proved useful for optimizing existing 
function, generating new function where it does not exist is still a hurdle. 
Unnatural amino acids (UAAs) represent a unique means to introduce new chemical 
functionality into proteins. Using the Schultz methodology, UAAs are co-translationally 
incorporated into a protein’s primary sequence, typically in response to a stop codon 
introduced at the DNA level.2,3 As such, UAA mutagenesis allows for the site-specific 
incorporation of a novel chemical functionality into proteins, which can then be exploited 
towards the development of novel protein activities. By inserting new chemical reactivity 
into a protein, UAAs allow for a condensed and facile workflow for engineering new 
protein functionality without the need to perform tedious and lengthy selections and 
screens. For example, recent reports from our group and others have site-specifically 
incorporated fluorescent UAAs into proteins, yielding novel fluorescent properties in a 
protein in a direct and highly controlled fashion.4,5  
While UAAs have allowed for the development of unique protein function, the evolved 
protein are often limited to a single new function, depending on the UAA incorporated.1 
In addition, the functionality is limited to the UAA itself, which suffers from constraints 
such as the requisite for an aminoacyl tRNA synthetase capable of recognizing the UAA, 
the synthetic accessibility of the UAA, and the size of the UAA which may preclude its 
uptake by a biological system.1–3,6 A more appealing strategy would allow for the 
generation of a UAA-containing protein “template” upon which researchers could 
synthetically introduce different chemical moieties that would in turn lead to altered 
protein function depending on the moiety employed.  
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Bioorthogonal chemistry, which employs reactions that proceed to completion under 
physiological conditions (pH ~7, 37°C), offers a unique mechanism to add new chemical 
functionality to proteins.6,7 Indeed, a variety of reactions have been developed that can 
add new chemistry to living systems. In particular, the cycloaddition between azides and 
alkynes that is either copper(I) mediated or strain promoted, has become a widespread 
technique to introduce new chemistry to proteins. More recently, our group has 
developed a biorthogonal variant of the Glaser-Hay reaction, which brings together two 
terminal alkynes to form a diyne on a protein in the presence of copper(I) under 
physiological conditions.8 The resulting stable diyne linkage has a well-defined 
conjugated linear geometry, and due to the abundance of commercial available terminal 
alkynes, a variety of chemical moieties can be reacted onto a protein using this technique. 
As such, our group sought to use the power of this new chemistry to generate new and 
different protein function dependent upon the alkyne reaction partner and not purely the 
UAA.  
Specifically, we designed a proof-of-concept experiment to alter the function of green 
fluorescent protein (GFP) via reaction of different terminal alkynes, onto the GFP 
chromaphore. GFP is a 27kDa protein isolated from Aequorea victoria with novel 
photochemical properties arising from an internal chromophore composed of Ser65-
Tyr66-Gly67.9 New chemical properties afforded simply by UAA introduction in place of 
Tyr66 have already been documented to alter GFPs fluorescence profile. All UAAs 
incorporated were found to blueshift the fluorescence profile of GFP, with more highly 
conjugated UAAs exhibiting a greater degree of blueshifting.5 Based on these results, the 
ability to modulate the conjugation of GFPs fluorophore using UAA mutagenesis is 
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apparent, and represents a convenient means to rationally design new protein function. 
However, this mutagenesis approach is limited by the size and complexity of the UAA. A 
potentially better approach involves exploiting the chemical functionality in preexisting 
UAAs to serve as a handle for biorthogonal reactions, acting as a “template” for the 
chemical derivatization of new protein function.   
This chemically directed protein evolution could be achieved via the genetic 
incorporation of p-propargyloxyphenyalanine (pPrF, 1) or p-ethynylphenylalanine (pEtF, 
2) into residue 66 of GFP (Figure 5). This provides a terminal alkyne reaction handle for 
reaction with different chemical moieties via the biorthogonal Glaser-Hay reaction. The 
resulting diyne linkage is highly conjugated, and a prime candidate to introduce larger 
conjugation patterns into GFP’s fluorophore without the need to evolve a new aaRS or 
use large UAAs. Moreover, the pEtF (2) is directly conjugated with the aromatic ring of 
the UAA, allowing for a comparison of the conjugation between the different UAAs. We 
hypothesized that the altered conjugation and chemical properties around the fluorophore 
will lead to new photophysical properties, demonstrating the utility of terminal alkyne 
containing UAAs and biorthogonal chemistry in a chemically programmable protein 
engineering strategy.  Herein we report our findings on utilizing the Glaser-Hay reaction 
on GFP’s fluorophore to introduce novel function. 
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Figure	32.	Modification	of	GFP	function	via	UAA	mutagenesis.	A)	GFP	Β-barrel	(green)	with	the	chromophore	(red)	and	
chromophore	structure.	B)	Unnatural	amino	acids	employed	as	bioconjguation	handles.	
In order to obtain protein possessing an alkynyl moiety, a GFP plasmid harboring a 
TAG mutation at position 66 was co-transformed with the polyspecfic pCNF-aaRS/tRNA 
pair. Conveniently, this aaRS is capable of recognizing both 1 and 2 and for expression of 
an alkyne-containing GFP.5 As the alkynyl UAA is incorporated into position 66 in 
GFP’s fluorophore, the extended conjugation afforded by the UAA alters the spectral 
properties of GFP. To assess that pPrF-GFPTAG66 was successfully produced, spectra for 
the GFP-variant were compared to the wild type. These spectra exhibited blue-shift, in 
agreement with the literature precedent, in the pPrF variant relative to the wild type. 
Incorporation was also confirmed by SDS-PAGE analysis of protein expression in the 
presence and absence of the UAA. A similar expression was performed using the pCNF 
aaRS/tRNA pair and pEtF to produce a separate GFP mutant with a bioconjugation 
handle. Conveniently, due to the modularity of this approach, only a single protein 
expression is necessary and all functional modification can be achieved synthetically. 
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This is in contrast to previous experiments, which required an individual protein 
expression for each UAA in order to modify function.  
With a pPrF-GFPTAG66 and pEtF-GFPTAG66 in hand, we then sought to use our 
previously reported biorthogonal Glaser-Hay reaction to install new and varied chemical 
functionality into the chromaphore of GFP (Figure 2). To investigate, we performed 
biorthogonal Glaser-Hay reactions on the chromaphore’s alkyne handle to couple 
aliphatic, aromatic, and alcohol containing alkynes. Briefly, Glaser-Hay reactions were 
performed by using a working concentration of 500 mM of CuI and TMEDA in the 
presence of alkyne-UAA bearing GFPTAG66 and the cognate alkynyl partner (scheme 1). 
Reactions were run for 4 hr at 4°C and then 10 µL of the reacted GFP was placed in 3 mL 
of phosphate-buffered saline solution (pH ~7.2) for analysis using fluorescence 
spectroscopy. Gratifyingly, our initial attempts with aliphatic terminal alkynes worked 
well. Furthermore, the different characteristics of the alkyne moieties installed 
successfully shifted the fluorescence profile away from the parent alkynyl-GFPTAG66 
spectra, each in a unique way. While it might be expected that the requisite for the 
reaction to occur within the β-barrel of GFP may hinder this reaction from occurring, we 
hypothesize that the hydrophobic nature of interior of GFP actually promotes the soluble 
alkyne localization, thereby facilitating the reaction by increasing effective concentration. 
Additionally, SDS-PAGE analysis with Coomassie revealed that the Glaser-Hay reaction 
only minimally altered protein concentration suggesting only minimal protein 
degradation. 
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Figure	33.	 Structures	of	 the	 fluorophores	generated	when	performing	a	Glaser-Hay	 reaction	with	 the	 two	UAAs.	A)	
Product	 from	 the	 coupling	 of	 a	 terminal	 alkyne	 to	 a	 GFP	mutant	 containing	1.	 B)	 Product	 from	 the	 coupling	 of	 a	
terminal	alkyne	to	a	GFP	mutant	containing	2.	
Scheme 9 
O
N
N
OR
O
RHN
HO
pPrF66
O
N
N
OR
O
RHN
HO R
pPrF66
CuI/TMEDA
4C,	4hr
R
R =
H2C NH2
H2C
N
N
OR
O
RHN
HO R
pEtF66
N
N
OR
O
RHN
HO
CuI/TMEDA
4C,	4hr
R
R =
H2C NH2
H2C
A
B
 
120	
	
We found that our initial Glaser-Hays on pPrF-GFPTAG66 had different effects on the 
fluorescent profile of GFP (Figure 7A). Reacting 1-hexyne on the chromaphore caused a 
general broadening and quasi-red shift of the fluorescent spectra. Reacting propragyl 
amine on the chromaphore caused a slight band broadening, as well as potential increase 
in fluorescence intensity, likely due to the additional resonance available on the 
chromaphore thanks to the lone pair on the amine group. 
We next sought to explore the effects of reacting directly onto the phenyl ring of 
residue 66. This was feasible with the GFP mutant harboring 2. Interestingly, the direct 
attachment of a terminal alkyne onto the ring resulted in an even greater blue shift of the 
pEtF-GFPTAG66 compared to the both the pPrF and wild-type variants, likely due to the 
increased conjugation due to the direct attachment of that terminal alkyne (Figure 7B). 
Because of this shift, a different excitation wavelength was necessary, as 395nm was 
found to not excite the pEtF-containing chromaphore. Based on absorption experiments, 
we selected 280 nm as the wavelength to excite the pEtF-GFPTag66 and all its Glaser-Hay 
derivatives. In the same fashion as the pPrF, the biorthogonal Glaser-Hay was performed 
on pEtF-GFPTAG66 using the same reaction partners. Once again, the 1-hexyne was found 
to broaden the fluorescence spectra. Interestingly, the propargyl amine reaction had a 
drastic red shift relative to the pEtF parent chromaphore. We believe this helps validate 
our initial speculation that resonance thanks to the lone pair on the amine has a drastic 
impact on the fluorescent properties of the chromaphore, as in this instance the whole 
system is in direct conjugated.  
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Figure	34.	Fluorescent	profile	obtained	after	reacting	various	alkyne	containing	partners	with	pPrf	or	pEtF-containing	
GFPTAG66.	A)	Fluorescent	spectra	for	Glaser-Hay	modified	pPrF-GFP	chromaphore.	B)	Fluorescent	spectra	for	Glaser-Hay	
modified	pEtF-GFP	chromaphore. 
122	
	
We have attempted Glaser-Hays with aromatic conjugation partners using the same 
reaction conditions as above. However, it was found that the signals obtained following 
these reactions were just for the free aromatic partner floating in solution. As such, we 
cleaned and concentrated these reactions using a 10 kDa molecular weight cut off spin 
column to remove any unreacted aromatic group for a test reaction between pEtF-
GFPTAG66 and 4-ethynylanisole. The data is still inconclusive, as the spectra does not 
appear to have shifted relative to the the parent pEtF chromaphore (Figure 7B). We are 
worried that the aromatic alkynes may be shielded by solvent, perhaps preventing these 
alkynes from entering the hydrophobic region within GFP’s Β-barrel. We are continuing 
to attempt these Glaser-Hay couplings, and will be attempting a different reaction 
protocol with a greater concentration of protein to see if this enhances our yields, and 
thus signal, of the aromatic derivatized GFP chromaphores.  
 
Conclusion 
 We have extended our work on the biological Glaser-Hay to utilize the 
biorthogonal chemistry to modulate protein function. Using two previously reported 
alkyne-containing UAAs within the chromaphore of GFP (position 66), we have 
successfully performed the Glaser-Hay reaction on the chromaphore of GFP. The 
resulting diyne linkage alters the fluorescence profile of GFP depending on the moiety 
attached to the terminal alkyne. Our future work seeks to extend the reaction to aromatic 
containing alkynes, which we hope will have a greater impact on GFP fluorescence due 
to the increased conjugation found in an aromatic system. Our findings highlight the 
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potential of biorthogonal chemistry, particularly diyne forming chemistries, to modulate 
protein function without the need for tedious selections and screens. 
 
Experimental  
General Biological Glaser-Hay Protocol To 1.5 mL Eppendorf tube was added 3 µL of a 
500 mM CuI solution in water and 3 µL 500 mM TMEDA solution in water. This 
mixture was then allowed to sit in the fridge for 10 mins. After waiting, 22 µL of PBS 
was added, followed by 10 µL of the alkyne containing GFPTAG66  in PBS (~0.5mg/mL) 
and 4 µL of a 40 mM solution of the cognate alkyne in DMSO. The mixture was allowed 
to react at 4°C for 4 hr.  
Protocol for Fluorimetry Scans After reacting for 4 hr, 10 µL of the reaction mixture was 
added to a quartz cuvette and diluted up to 3 mL with PBS. This was then excited at 
either 395 nm (for the pPrF-containing chromaphore) or 280 nm (for the pEtF-containing 
chromaphore) with a 10 nm slit width for the excitation and emission wavelengths. Slit 
widths were increased or decreased as necessary depending on the intensity of the 
reaction product’s signal. The scan speed was set at 500 nm/min.  
General Protocol for Biological Glaser-Hay with Aromatic Reaction Partners To 1.5 mL 
Eppendorf tube was added 3 µL of a 500 mM CuI solution in water and 3 µL 500 mM 
TMEDA solution in water. This mixture was then allowed to sit in the fridge for 10 mins. 
After waiting, 22 µL of PBS was added, followed by 10 µL of the alkyne containing 
GFPTAG66  in PBS (~0.5mg/mL) and 4 µL of a 40 mM solution of the cognate alkyne in 
DMSO. The mixture was allowed to react at 4°C for 4 hr. Following this, the unreacted 
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aromatic alkyne was washed away using a 10 MWCO spin column (Corning) and rinsing 
with 50 µL portions of PBS 8 times. After the eight rinse, the solution was concentrated 
down to ~25 µL, as indicated on the spin column. Of this cleaned solution, 10 µL was 
placed into a quartz cuvette and diluted to 2 mL with PBS for fluorescence analysis.  
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CHAPTER 5: IMMOBILIZATION OF THE RNA-GUIDED ENGINEERED 
NUCLEASE CAS9 
 
 
RNA-guided engineered nucleases (RGEN) represent a novel form of targeted 
gene editing tools. In these systems, an RNA molecule provides targeting specificity to a 
protein endonuclease via RNA:DNA complementarity1,2. Synthetic oligonucleotides are 
commercially available, and the ease with which these systems can be programmed to cut 
DNA has allowed for rapid developments in the field of molecular biology. The facility 
with which DNA editing can be programmed has allowed for rapid new developments in 
transgenic models that were previously tedious or inaccessible due to embryonic lethality. 
For example, a recent technique employs Cas9 deleting adult-cardiac specific genes, 
developing new adult mouse models for cardiac disease that were previously inaccessible 
due to embryonic lethality.3 In addition, the ability to selectively excise portions of DNA 
has made the technology an attractive new therapeutic. A recent report in Nature: 
Scientific Reports detailed the use of CRISPR/Cas9 to remove latenetly infected HIV-1 
from T-lymphocytes, effectively providing a cure for HIV/AIDS.4 The clustered regularly 
interspaced short palindromic repeats (CRISPR), which act in association with CRISPR-
associated (Cas) genes, is a type of RGEN that has gained recent attention as a new tool 
for genetic manipulation.  
 Within the system, the Cas endonuclease, called Cas9, acts in conjunction with a 
CRISPR RNA (crRNA), which provides specificity by base pairing with the DNA target, 
in effect serving as a bacterial adaptive immunity. When a bacterium survives a viral 
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infection, it stores a short segment of the viral genome in the CRISPR region of the 
bacterial genome; subsequent infection activates transcription of this short viral segment 
which serves as a crRNA, directing the Cas9 nuclease to destroy the viral genome (Figure 
1A). In addition to the crRNA, a trans-activating CRISPR RNA (tracrRNA) is required to 
allow proper interaction between the crRNA and the DNA (Figure 1A). Recently, the 
Cas9 from Streptococcus pyogenes has been made amenable to laboratory use (Figure 
1B) 2. 
 Oligonucleotides can be easily designed and synthesized to facilitate directed 
Cas9 targeting of specific DNA sequences in a range of organisms. Furthermore, the ease 
with which DNA binding can be programmed with Cas9 is also making the technology 
an attractive option as a new biomolecular tool. For example, CRISPR interference 
(CRISPRi) has become a valuable new technique for sequence specific gene 
transcriptional modulation. By using a catalytically inactive variant of Cas9 (also called a 
“dead” or dCas9), researchers were able to sterically hinder transcription of a gene 
targeted by a guide RNA.5 The technique has even been extended to transcriptional 
activation (CRISPRa) by fusing dCas9 to viral transcriptional activators, such as VP64.6 
In this example, the protein serves as a platform for the docking of transcription 
activators, and is directed to the gene of interest by the sequence of the guide RNA. Even 
more recently, researchers were able to generate a variant of Cas9 containing the ligand-
binding domain of human estrogen receptor-α (ER-LBD).7 Upon binding of the 
antagonist 4-hydroxytamoxifen, the ER-LBD undergoes a conformational change brining 
the N and C termini of the domain closer together, thereby rendering the Cas9 active once 
again. This mechanism was shown to serve as an allosteric switch for the exogenous 
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control of either Cas9 or dCas9, granting an even greater degree of user-control over 
genetic manipulation.  
 Cas9, therefore, represents a new tool to perform user defined genetic 
manipulations. An ideal requisite for genetic manipulation is the propensity of the RGEN 
to have maximal on-target cleavage with no off-target cleavage. Given that Cas9 is 
directed by RNA:DNA complementarity, and that there are often redundant sequences 
within the entire genome or between homologous chromosomes, there is growing 
concern that Cas9 mediated cleavage may have off-target effects.8 However, recent high-
throughput studies have provided new insight into Cas9 specificity that will lead to 
optimal guide RNA design.  
Guide RNA mismatch is linked to off-target cleavage 
 Early studies on the CRISPR/Cas9 system sought to elucidate the role of the 
crRNA and tracrRNA in mediating directed DNA cleavage. By using an electrophoretic 
mobility shift assay, researchers were able to demonstrate that the constant tracrDNA is 
necessary for crRNA binding to target DNA, presumably by helping to orient the crRNA 
via formation of a hairpin loop structure. By sequentially truncating the tracrRNA, it was 
then possible to determine the minimum tracrRNA sequence required to maintain DNA 
cleavage. This was then fused to the last 20 nucleotides of the crRNA 3’ end, which were 
shown to provide the system’s specificity to target DNA (see Fig. 1). The resulting 
chimeric single guide RNA (sgRNA) produced targeted DNA cleavage at levels 
comparable to the naturally occurring system (see Fig. 1) 2. 
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Figure	 35.	 (A)	 Chimeric	 single	 guide	 RNA	 design	mimics	 critical	 RNA	 structures	 in	 the	 crRNA:tracrRNA	 duplex.	 The	
yellow	 bar	 denotes	 the	 20	 nucleotide	 targeting	 sequence	 in	 the	 sgRNA,	 which	 can	 be	 programmed	 by	 the	 user.	
Presence	 of	 the	 PAM	5’NGG3’	 sequence	 is	 a	 restriction	 on	 sgRNA	 design,	 as	 only	 sequences	 5’	 of	 the	 PAM	 can	 be	
targeted.	 (B)	 Chimeric	 sgRNA+Cas9	 cuts	 a	DNA	 template	 as	 efficiently	 as	 the	 crRNA:tracrRNA+Cas9	 system.	 This	 is	
observed	via	the	presence	of	a	cleaved	13	nt	sequence	after	gel	electrophoresis.	Adapted	from	Jinek	et	al.,	2012. 
 In theory, the sgRNA would allow programmed Cas9 cleavage to any DNA target 
by base pair complementarity. However, additional studies revealed the requisite of a 
protospacer adjacent motif (PAM) on the 3’ end of the target DNA sequence in the form 
of 5’-NGG-3’ (see Fig. 1). Even a single mutation in the GG sequence abolishes Cas9 
cleavage 2.  
 While these studies demonstrated programmable Cas9 cleavage, it was still 
unclear if there would be any off-target effects that would minimize the specificity and 
thus applicability of the enzyme. However, this requires scientific ingenuity, as exploring 
every positional mismatch within the sgRNA and the whole genome is incredibly 
challenging. Early studies focused on examining mismatches within the sgRNA targeting 
sequence towards a target gene. This served as a proxy for off-target cleavage within the 
genome. Researchers designed sgRNAs targeting the human hemoglobin β (HBB) gene 
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with different mismatches. Using the T7E1 assay (see Fig. 2), the authors demonstrated 
that the mismatched sgRNAs could lead to indel formation in the HBB gene, indicating 
non-perfect complementarity is permissible for Cas9 cleavage (Cradick et al., 2013). 
These findings were corroborated in a functional assay that relied on Cas9 disruption of 
GFP via indel formation. Relative to the perfectly matched sgRNA, the authors observed 
that the sgRNA tolerated single and double mismatches within the 20 nucleotide 
specificity sequence, especially if they were in the 5’ end most distal from the PAM 8.    
Current findings reveal less promiscuity in cleavage  
 Unlike previous studies, researchers generated guide RNAs with single and 
double mismatches at every position and combination in the RNA’s 20 nucleotide 
targeting sequence using automated oligonucleotide synthesis. Using a functional assay 
in which fluorescence serves as a metric for off-target cleavage, the researchers 
performed a comprehensive analysis of guide RNA positional mismatch effects. Once 
again, their findings revealed that the most PAM distal nucleotides were tolerated for off-
target cleavage. However, upon exploring every possible double mismatch combination, 
they found that only sequential double mismatches at this distal site had any real effect on 
off-target cleavage (see Fig. 2). Triple mismatches abolished off-target cleavage in this 
study. Their data further validate that mismatches between the sgRNA and off-target sites 
are only tolerated at the most PAM distal nucleotides within the target sequence. 
Furthermore, the authors argued that off-target effects would be minimized by the 
requisite combination of favorable mismatches adjacent to a PAM sequence 10. This 
positional data can be employed in the future to design less promiscuous sgRNAs.  
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Figure	36.	Positional	effect	of	mismatches	between	the	guide	RNA	and	the	DNA	template	as	detected	via	a		functional	
Ub-GFP	assay.	Numbers	denote	position	of	the	mismatch,	with	1	corresponding	to	the	nucleotide	most	distal	from	the	
PAM	and	20	corresponding	to	the	nucleotide	directly	adjacent	to	the	PAM.	All	GFP	values	are	normalized	to	the	perfect	
match	levels.	(A)	As	previously	observed,	nucleotides	more	distal	from	the	PAM	sequence	tolerate	mismatches	more	
readily,	 as	 observed	 by	 an	 increase	 in	 GFP	 fluorescence.	 (B)	 Double	 mismatches	 are	 less	 permissible	 than	 single	
mismatches,	with	 a	 sequential	mismatch	 in	 nucleotides	 1,2	 tolerated	 the	most.	 The	 inset	 demonstrates	 all	 possible	
combinations	of	double	mismatches	within	the	guide	RNA,	demonstrating	that	vast	majority	of	double	mismatches	are	
not	tolerated.	Adapted	from	Anderson	et	al.,	2015.	
 These authors’ conclusions were further validated by a powerful new assay 
capable of capturing Cas9 off-target cleavage sites within the entire genome. This 
technique, termed Digenome-seq, allowed the authors to probe the entire genome for off-
target cleavage of a sgRNA targeting the HBB gene. Using Digenome-seq, the authors 
were able to capture the on-target site as well as two previously validated off-target sites. 
Another 122 other potential off-target sites were also captured. However, whole genome 
sequencing (WGS) of Cas9 transfected cells revealed that these 122 other sites were not 
accompanied by indels, suggesting that mutations at these off-target sites are rare. Based 
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on their findings, off-target cleavage would not be expected to exert an effect on the cell 
11. In comparison to previous techniques, this method was the first to allow researchers to 
probe the genome for off-target sites of a sgRNA they wish to employ in the future.  
 Recently, the Doudna group revealed insight into the mechanism of Cas9:DNA 
binding that negates off target cleavage. By using Forster resonance energy transfer 
(FRET) experiments to explore conformational changes in Cas9 upon binding DNA, the 
group revealed that Cas9 adopts a unique conformation with perfect sgRNA:DNA 
complementarity (see Fig. 3). Mismatches, even in the distal portion of the sgRNA 
targeting sequence, have distinct conformations that presumably disfavor enzymatic 
cleavage. This provides structural evidence for a conformation-dependent proofreading 
mechanism for Cas9 based on the complementarity of the sgRNA and the DNA. As such, 
it is thought that this proofreading mechanism helps minimize off-target cleavage 
(Sternberg et al, 2015).  
	
Figure	37.	FRET	experiments	involve	attaching	two	fluorophores	to	a	protein.	As	the	protein	undergoes	conformational	
changes,	 the	 distance	 between	 the	 fluorophores	 changes.	 This	 alters	 their	 fluorescence	 intensity	which	 serves	 as	 a	
metric	 for	structural	changes	within	 the	protein.	FRET	data	 from	the	Doudna	group	demonstrates	a	conformational	
control	of	DNA	target	cleavage	 in	Cas9.	 In	comparison	 to	 the	perfect	complementarity	between	 the	sgRNA	and	 the	
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target	DNA	(on-target),	mismatches	demonstrate	a	different	degree	of	conformational	change	(y-axis).	Adapted	from	
Sternberg	et	al.,	2015.	
DNA-Fishing using Cas9 
 The ease with which Cas9 can be programmed to target certain genetic loci has 
made it an increasingly attractive tool, especially towards molecular genetics. Recent 
work has established a methodology to use an inactive form of Cas9 (“dead” or dCas9), 
which can still bind specified DNA sequences using a gRNA, to pulldown specific 
genetic loci. These loci are pulled down with their associated proteins, allowing 
researchers to efficiently isolate certain genetic regions and their associated proteins, 
expanding our limited understanding of the varied roles proteins play in regulating 
expression.13 The technique, termed engineered DNA-binding molecule-mediated 
chromatin immunoprecipitation (enCHIP), was applied to the human interferon (IFN) 
regulatory factor-1 (hIRF-1) and was demonstrated to pull down new and validated 
protein targets.14 While the technique works and exhibits minimal off-target effects, it 
requires binding of the dCas9 complex to the DNA in vivo, perhaps precluding certain 
protein factors that may interact at that region or altering the favorability for other 
regulators to bind.  
 Due to the increasing widespread applicability in a variety of molecular biology 
endeavours, we sought to develop a UAA-containing Cas9. Our hope was that by 
incorporating UAAs into Cas9, we could generate either a photoactivatable Cas9, using 
photocaged UAAs, or immobilize Cas9 onto a solid support for DNA-pulldown 
applications. It is our hope that the by installing new biochemistries into Cas9 via UAAs 
that will further increase the applicability of this technology for a more diverse array of 
applications. 
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Results and Discussion  
Our group has already established a protein immobilization protocol using UAA 
technologies. Immobilization of Cas9 on a bead may allow specific targeting of certain 
genetic loci, producing a more complete picture of the role of protein function in 
regulating DNA, as well as affording a new means to purify genetic material of interest.  
Cas9 immobilization to a resin or bead may also allow for the regeneration of the system, 
allowing researchers to purify defined DNA sequences multiple times. 
Initially, sites within the amino acid sequence of the Cas9 enzyme that would 
amenable to UAA-mutagenesis were identified. As a consequence of most bacterial 
aaRSs having been evolved for tyrosine derivatives, we relegated our investigation to 
tyrosine residues within the protein. In addition, the search was further constrained by the 
necessity to utilize a surface exposed tyrosine residue that did not perturb canonical Cas9 
DNA cleavage. It was our hope that this exposed residue could serve as a handle for 
biorthogonal functionalization.  
Our initial search identified Tyr1265 as a prime candidate for immobilization, as 
it is distal to Cas9’s catalytic domains and is surface exposed (see Fig 4). Our choice was 
further validated by a recent study that sought to identify engineering hotspots within 
Cas9.7 It was found that amino acid residues in the CTD of Cas9 were particularly 
amenable to alteration without drastically impairing protein function. While Y1265 was 
not directly explored, residues 1262 and 1267 were, and they both continued to exhibit 
functionality, albeit a bit decreased. Moreover, because the screen was performed by 
insertion of a large protein domain, we hypothesize that the small size of the UAA 
insertion will have a minimal effect on Cas9 function. 
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Tyr1265
	
Figure	 38.	 Cas9	with	HNH	 (magenta)	 and	 RuVCIII	 (cyan)	 highlighted.	 Proposed	 site	 of	 UAA	mutagenesis	 (Y1265)	 is	
shown	in	red.	
	 Having selected Tyr1265 as the ideal site for UAA incorporation, we then 
designed primers for PCR mutagenesis, converting Y1265 into a TAG for UAA-mediated 
amber suppression. PCR mutagenesis using Kappa Hi-Fidelity polymerase was 
performed according to the Kappa protocol.  Subsequent sequencing and alignment of the 
plasmid obtained from this mutagenesis showed that we had indeed inserted a TAG into 
position 1265, generating a Cas9Y1265X variant.  
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Forward	primer	(3’-5’)	
Reverse	primer		(5’-3’)
Original	AA	sequence	with	AA	position		
Original	DNA	sequence	(5’-3’)	
Original	DNA	sequence	with	nt position	 (5’-3’)	
New	complementary	DNA	sequence	(3’-5’)	
Site	of	mutagenesis
	
Figure	 39.	 Results	 from	 sequencing	 and	 alignment	 for	 our	 PCR	 mutagenesis.	 Flow	 chromatogram	 on	 the	 bottom	
highlights	in	the	red	the	incorporation	of	our	TAG	mutation	on	the	complementary	DNA	sequence	(3’-5’).	
 Following insertion of the TAG mutation, it was then necessary to optimize our 
expression protocol. Cas9 is an approximately 160kDa protein, and thus expression 
represents a serious energetic toll for the cell. Combining the expression of this large 
protein with the added layer of UAA incorporation increases the complexity of the 
process. To optimize UAA incorporation into Cas9Y1265X we performed an expression 
experiment with the pET-Cas9Y1265X and the pEVOL-WT plasmids. pEVOL-WT is the 
wild type aaRS from M. jannaschii, and will charge tyrosine to the cognate tRNA with an 
antisense codon for the TAG stop codon. Thus, after this process the protein produced is 
the wild type Cas9, but amber suppression is required. This method, therefore, serves as a 
good proxy for our capability to incorporate a UAA without the added complexity of a 
UAA in the system. 
 To optimize Cas9Y1265X expression, we performed expression experiments 
using 100mL expression cultures of E. coli BL21(DE3). These cultures were either 
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grown in Luria-Burtani (LB) broth or 2x Yeast tryptone (2XYT), a more nutritionally 
rich broth that is often advantageous for the expression of large proteins. In addition, we 
also explored the effects of concentration our expression cultures prior to induction, as 
our previous work with GFP has shown that a 5x concentration enhances protein yields 
while minimizing the amount of UAA required. 
 Our results from the expression experiment show that we were indeed able to 
generate wild type Cas9 using the amber suppression method. To our surprise, the 1x LB 
expression protocol performed best. We hypothesize that the large demands imposed by 
the expression of such a large protein makes our concentration protocol very demanding 
on the cell, as it now finds itself in a nutritionally diminished environment while 
expressing Cas9. In addition, the 2XYT expressions did not outcompete the 1x LB 
version, perhaps because the increased nutritional supplies of the 2XYT broth allowed 
the cells to focus energetic resources towards continued growth and division instead of 
increasing cellular size and protein expression. 
Lane																						1							2						3							4							5								6							7							8							9
LB																																				- - - - +							+							+							+	
2XYT																															+						+							+							+								- - - -
Concentration														1x				1x					5x					5x						1x					1x					5x						5x
L						FT														FT															FT														FT
150kDa
	
Figure	 40.	 Protein	 expression	 experiment	 for	 pET-Cas9Y1265X	 and	 pEVOL-WT.	 Our	 data	 indicates	 that	 the	 1x	 LB	
protocol	 performs	 best,	 as	 evidenced	 by	 denatured	 SDS-PAGE	 following	 staining.	 FT	 in	 the	 figure	 refers	 to	 flow-
through,	which	demonstrates	that	we	have	captured	all	the	Cas9	produced	by	the	cells.		
 With an optimized expression protocol for the incorporation of a UAA into 
Cas9Y1265X, we next sought to produce a UAA-containing Cas9. A pET-Cas9Y1265X 
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was co-transformed with the polyubiquitous pCNF-synthetase. The 1x LB protocol was 
then used with 100 mL expression cultures either in the presence or absence of the UAA 
pAzF, introducing an azide functionality into the protein. Gratifyingly, our data show that 
the UAA is incorporated (see Fig 7, Lanes 3-5) in the presence of UAA. Furthermore, in 
the absence of UAA, no protein is produced, as the cell encounters an early stop codon in 
protein translation (see Fig 7, lanes 7-9). Furthermore, no truncated protein products can 
be detected since our Cas9 contains a C-terminal hexaHis tag, meaning only completely 
successful read-throughs produce our purification tag.  
Lane																						1							2							3								4							5								6								7								8							9
pAzF +								+							+								+									- - - -
L						FT																																			FT
150kDa
	
Figure	41.	Expression	of	a	pAzF-containing	Cas9Y1265X. 
 
Experimental 
General Protocol for PCR Mutagenesis PCR mutagenesis was performed in a Bio-Rad 
iCycler 96 well reaction module thermocycler. The protocol was adapted from the Kappa 
Polymerase HiFi PCR mutagenesis protocol. Two, 1x master mix for the PCR reaction 
were created by adding 5 µL Kappa HiFi Buffer, 0.75 µL 10 mM dNTPs, 0.75 µL,  0.75 
µL of 10 mM of forward primer dissolved in sterile deionized water, 0.75 µL of 10 mM 
of reverse primer also dissolved in sterile deionized water, and 12.25 µL of sterile 
deionized water. To the reaction master mix was added 0.5 µL of kappa polymerase at 
the very end, prior to starting the reaction in the thermocycler. To the control master mix 
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was added 0.5 µL of sterile deionized water in place of the kappa polymerase. This recipe 
for the 1x master mix was increased by 2.5x or 5x depending on the number of reactions 
that were being run. For example, for the PCR mutagenesis converting Tyr1265 to 
TAG1265, four experimental PCR tubes were prepared, two with 5 ng of pET28b-Cas9-
His (5 µL of 1ng/µL of template DNA) and two with 10 ng of pET28b-Cas9-His (5 µL of 
2ng/µL of template DNA). To these PCR tubes was then added the corresponding 
reaction or control master mix, which was then loaded into the thermocycler using the 
following protocol: 1) initial denaturation at 95°C for 2 mins; 2) denaturation at 98°C for 
2 mins followed by annealing at 65°C or 15 secs [note, 2°C were added to whatever the 
IDT reported annealing temperature was because the Kappa HiFi buffer is a high salt 
buffer that increases annealing temperatures] followed by an extension at 72°C for 4.5 
mins (30 sec/kbp), this step was cycled for a total of 20 cycles; 3) a final extension was 
performed at 72°C for 5 mins; 4) the thermocycler completed the run by holding at 4°C. 
Following the PCR mutagenesis, the samples then underwent a DpnI digestion at 37°C 
for 2 hours to remove any methylated template DNA. The DpnI was deactivated at 80°C 
for 15 mins, and the samples were then PCR cleaned and concentrated (Zymo Research 
DNA clean and Concentrator Kit) and eluted in 10 µL of sterile deionized water. Two 
microliters of each sample were then transformed into competent E. coli (BL21(DE3)), 
recovered in 500 µL of 2XYT media for 1 hour, and then this full volume was plated on 
agar plates supplemented with kanamycin. After allowing to grow overnight, plates were 
compared for differential growth between the reaction and control. If differential growth 
was observed, four colonies were picked at random in four different quadrants of the 
plate. These were grown to confluence overnight at 37°C, a glycerol stock was prepared 
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using 1 mL of culture, while the rest was used to extract DNA for sequencing and 
expression tests.  
Primers Designed for PCR Mutagenesis of pET28b-Cas9-His 
Primer	ID Mutation Explanation Template	Plasmid IDT	Calculated	Tm Verified	Tm Sequence
A9 D10TAG_F to convert Cas9 to dCas9 via inactivation of catalytic D(restor with YOBNY?) pET28b-Cas9-His 67.3 aagtactccattgggctctagatcggcacaaacagcgtc
A10 D10TAG_R pET28b-Cas9-His 67.3 gacgctgtttgtgccgatctagagcccaatggagtactt
A11 Y72TAG_F Tyr interacting with DNA base (pi-pi stacking) pET28b-Cas9-His 68.0 68.0gaacagcacggcgcagatagacccgcagaa
A12 Y72TAG_R pET28b-Cas9-His 68.0 68.0gaacagcacggcgcagatagacccgcagaa
A13 Y450TAG_F Tyr inactivated in dCas9?? pET28b-Cas9-His 64.5 catttcggataccctagtatgtaggccccctcg
A14 Y450TAG_R pET28b-Cas9-His 64.5 cgagggggcctacatactagggtatccgaaatg
A15 Y1131TAG_F Tyr near DNA pET28b-Cas9-His 66.2 68.2agattgggaccccaagaaatagggcggattcga
A16 Y1131TAG_R pET28b-Cas9-His 66.2 68.2tcgaatccgccctatttcttggggtcccaatct
A17 Y1265TAG_F Tyr surface exposed and away from DNA/HNH and RuvC catalytic domains pET28b-Cas9-His 63.2 65.0ACACAAACACTAGCTTGATGAGATCATCGAGCAAATAAGC
A18 Y1265TAG_R pET28b-Cas9-His 63.2 65.0GCTTATTTGCTCGATGATCTCATCAAGCTAGTGTTTGTGT  
Sequencing of PCR Mutagens 
Samples were sent off to sequencing to GeneWiz using their “premixed” DNA 
Sequencing Services following their sample submission guidelines. For the Cas9Y1265X 
mutagen the universal T7 terminator primer was selected for sequencing. This primer will 
be utilized to sequence Cas9Y1131X as well. For mutagens Cas9D10X and Cas9Y450X 
the universal T7 promoter primer will be used for sequencing. The Cas9Y450X mutant is 
located too far into the DNA sequence of the Cas9 gene for reliable sequencing using 
either of the universal primers above, as such we will design a sequencing primer nearer 
to this mutation site.  
Optimization Cas9TAG Cotranslational UAA Incorporation A pET-Cas9Y1265X 
plasmid (0.5 µL) was co-transformed with a pEVOL-WT plasmid (0.5 µL) into 
Escherichia coli BL21(DE3) cells using an Eppendorfeporator. The cells were then plated 
and grown on LB agar in the presence of chloramphenicol (34 mg/mL) and kanamycin 
(50 mg/mL) at 37 ̊ C overnight. One colony was then used to inoculate LB media (5 mL) 
containing both kanamycin and chloramphenicol. The culture was incubated at 37 ̊ C 
overnight and used to inoculate an expression culture. Expression cultures were either 
grown in LB media (100 mL 50 mg/mL Kan, 34 mg/mL Chlr) or 2XYT media (100 mL 
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50 mg/mL Kan, 34 mg/mL Chlr) at an OD600 0.1. The cultures were incubated at 37 ̊ C 
to an OD600 between 0.6 and 0.8. Protein expression was either induced immediately via 
addition 20 % arabinose (100 µL) and 0.8 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG; 100 µL) or the cultures were concentrated 5x to a volume of 20 mL and expressed 
via addition of 20% arabinose (20 µL) and IPTG (20 µL). The cultures were incubated at 
room temperature for 24 h then centrifuged at 5,000 rpm for 20 minutes, as the larger 
expression cultures required longer centrifuge times to ensure all the cells were pelleted. 
The pelleted cells were then stored at -80 ̊ C for 20 mins. The cell pellet was resuspended 
using 500 µL of Bugbuster (Novagen) containing lysozyme, and incubated at room for 30 
minutes. The solution was then centrifuged at 5,000 rpm for 20 mins. The supernatant 
was added to an equilibrated His- pur Ni-NTA spin (Qiagen) column and Cas9 was 
purified according to manufacturer’s protocol. Purified GFP was analyzed by SDS-PAGE 
(BioRad 6% precast gels, 150V, 1.5h), and employed without further purification. 
Expression of UAA-Containing Cas9Y1265X A pET28b-Cas9Y1265X-His plasmid (0.5 
µL) was co-transformed with a pEVOL-pCNF plasmid (0.5 µL) into Escherichia coli 
BL21(DE3) cells using an Eppendorf eporator. The cells were then plated and grown on 
LB agar in the presence of chloramphenicol (34 mg/mL) and kanamycin (50 mg/mL) at 
37 ̊ C overnight. One colony was then used to inoculate LB media (10 mL) containing 
both kanamycin and chloramphenicol. The culture was incubated at 37 ̊ C overnight and 
used to inoculate an expression culture (100 mL LB media, 50 mg/mL Kan, 34 mg/mL 
Chlr) at an OD600 0.1. The cultures were incubated at 37 ̊ C to an OD600 between 0.6 
and 0.8, and protein expression was induced by addition of UAA (1 mL, 100 mM) and 20 
% arabinose (100 µL) and 0.8 mM isopropyl β-D-1-thiogalactopyranoside (IPTG; 100 
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µL). The cultures were incubated at room temperature for 16-20 h then centrifuged at 
5,000 rpm for 10 minutes and stored at -80 ̊ C. Purification was performed according to 
the protocol above using a Ni-NTA resin.  
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CHAPTER 6: TOWARDS THE DEVELOMPENT OF GLASER-HAY “TURN-
ON” PROBES 
 
 
In order for a fluorescent probe to prove beneficial, it must possess certain key 
features. The first constraint is size, as the probe must be small enough to enter the cell, 
yet large enough to provide enough information for specificity and a prolonged signal.1 
Additionally, the signal must occur selectively where the probe is meant to bind, with 
minimal interfering background.1 Most importantly, the fluorescent probe must bind 
exclusively to the substrate of interest.1  
Turn-on fluorescent dyes, or profluorophores, represent a unique means of 
developing chemical probes. These probes are chemically designed to produce a signal 
after undergoing a particular reaction, which is dictated via the installation of a unique 
handle onto the dye (Scheme 1).2,3 These types of probes have gained increased attention, 
as they produce low background signal in the absence of their cognate partner, improving 
overall signal-to-noise ratios. Furthermore, their cognate partner can be readily installed 
into certain regions of the cells (via UAA mutagenesis, for example), allowing the 
scientist to better control the localization of their fluorescent signal.  
Scheme 10 
+
Profluorophore
Cognate	partner Reaction	induced	 fluorescence
turn-on
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Based on the fluorescent imaging advantages intrinsic to profluorophores, we 
proposed a strategy that utilizes UAAs, in conjunction with biorthogonal chemistry, to 
selectively bind profluorophores to genetically modified proteins that were previously 
described to incorporate UAAs. Such an approach allows for the generation of site-
specificity within the reaction of the protein and the label. This affords a high level of 
control over the process, and the prevention of protein inactivation and loss of function. 
Additionally, this strategy eliminates the background signal, as fluorescence cannot be 
observed unless conjugation has occurred. Finally, the literature contains a myriad of 
profluorophores that have already been synthesized and can be employed. This permits 
for the discovery of dyes of the correct size to provide in vivo diffusion, as well as 
different excitation spectra that can be used for simultaneous labeling of multiple proteins 
within a single organism.  
 The unique functional handles that UAAs can introduce into proteins offer a 
means to tackle these complexities, as well as reduces the challenges associated with 
protein labeling. This strategy is has primarily relied upon upon click chemistry, a 
reaction that proceeds to completion readily and in relatively mild conditions.8 Of 
particular utility is click chemistry involving azides and alkynes that readily undergo a 
Huisgen 1,3-dipolar cycloaddition which produces a stable triazole moiety optimal for in 
vivo conjugation.9 Additionally, the scarcity of azides and alkynes in biologic systems 
makes these two functional groups optimal for use in developing a click chemistry 
strategy of fluorescent labeling, as the chance of cross-reactions are minimal. Moreover, 
research has identified profluorphores, or “turn-on” probes, that become fluorescent only 
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after a successful click reaction has formed the triazole moiety. Indeed, there are a variety 
of click-chemistry compatible turn-on probes in the literature.2–6 
 Recently, our group expanded the role of terminal alkyne in biorthogonal 
chemistry by developing biological variants of the Glaser-Hay and Cadiot-Chodkiewicz 
couplings.7,8 Both reactions produce a covalent diyne linkage. The Glaser-Hay reaction 
involves the coupling of two terminal alkynes in the presence of copper(I). The Cadiot-
Chodkiewicz coupling utilizes a bromoalkyne and a terminal alkyne in the presence of 
copper(I) to produce the diyne linkage, adding a degree of chemoselectivity while also 
minimizing the requisite amounts of copper(I). In order to further expand the utility of 
these chemistries in chemical biology, we sought to explore the potential of these 
reactions for “turn-on” probe labeling of proteins via UAAs. We hypothesized that the 
added conjugation present in the diyne linkage would mirror that found in the triazole 
ring, restoring electron density to the profluorophores and eliciting fluorescence 
following successful conjugation.  
   
Results and Discussion 
 In order to probe the potential of the biorthogonal Glaser-Hay and Cadiot-
Chodkiewicz for “turn-on” probe development, we first attempted to synthesize a variety 
of terminal-alkyne containing profluorophores. Thankfully, a myriad of such compounds 
have already been reported in the literature, possessing a variety of well-defined 
fluorophore cores.3,4,6 As such, we sought to synthesize a benzothiazole-, coumarin-, and 
xanthenone-alkyne containing profluorophroes. 
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Figure	42.	Alkyne-containing	profluorophores	 to	be	 synthesized	 to	probe	 the	application	of	 the	Glaser-Hay	 towards	
turn-on	probes.	 
 The first fluorophore synthesized was ethynylbenzothiazole (1, EBTZ, see 
Experimental for synthetic scheme). Starting from 2-aminobenzothiazole, an iodo group 
was installed 2-iodobenzothiazole, which could then subsequently undergo a Sonogashira 
cross-coupling with trimethylsilylacetylene. Following TMS deprotection using 
potassium carbonate in methanol, column chromatography in 6:1 hexanes:ethyl acetate 
afforded the 2-ethynylbenzothiazole as a brown solid (7% yield). While the compound 
was not initially soluble in the eluent system, a small volume a dichloromethane was used 
to help solubilize the reaction mixture for loading onto the silica gel column. Solubility 
issues were a major roadblock for the synthesis of all profluorophores, likely due the 
highly aromatic nature of many of these fluorophore cores. We hypothesize that tight pi-
stacking between the aromatic rings prevents the solvation of the product. Typically the 
addition of a polar solvent, such as dichloromethane or methanol, to the loading solution 
as well as sonication of the mixture helped solubilize the bulk of the product for flash 
chromatography. 
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 To verify that the synthesized EBTZ was indeed a profluorophore, a click reaction 
was performed using p-azidophenylalanine (pAzF) in water, which mirrored the same 
fluorogenic click reaction reported in the literature. The same “turn on” peak as reported 
in the literature was observed at ~354nm in the click reaction when excited at 285nm. In 
the absence of the copper catalyst system, no real peak was observed, and in the presence 
of solely CuSO4, a different peak at ~430nm was observed, likely due to turn on of the 
fluorophore as it bound the copper salt. Furthermore, unlike the literature, our fluorogenic 
click reaction was run in the presence of the nitrogenous ligand TBTA, which is reported 
to drastically increase the rate of the copper(I)-catalyzed cycloaddition of azides and 
alkynes. As such, based on the fluorimetery data it appears that our reaction reached 
completion within 4 hr, unlike the literature which required ~24 hr to achieve maximum 
signal. 
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 Taken together, the above data verified that the synthesized molecule was indeed 
an alkyne-bearing profluorophore. As such, we next sought to investigate whether our 
recently developed biological Glaser-Hay reaction could also produce a turn-on response 
in the probe. We hypothesized that the added electron density found in the Glaser-Hay’s 
diyne linkage would mimic that found in the copper click’s triazole ring, serving to 
promote the relaxation of excited state electrons through fluorescence.  
 To begin, we performed an organic Glaser-Hay with EBTZ in the presence of 
propargyl alcohol and phenylacetylene, which mimicked the functional groups found in 
our alkyne-bearing UAAs (p-propargyloxyphenylalanine, pPrF, and p-
ethynylphenylalanine, pEtF). Absorption spectra taken on the UV-Vis revealed an 
absorption maxima at ~328 nm for the Glaser-Hay between phenylacetylene and EBTZ, 
with no real absorption peaks found for the reaction with propargyl alcohol. As such, this 
wavelength was chosen to excite the alkyne-bearing UAAs conjugated to EBTZ. 
 Interestingly, the Glaser-Hay control reaction, in the absence of the copper 
catalyst system, with the pEtF had a higher fluorescence response than the Glaser-Hay 
reaction between pEtF and EBTZ, with a maximum emission at ~420nm, which 
corresponded to the same emission profile of the free pEtF in water. These results were 
contradictory to what we expected, as we thought directly conjugating EBTZ to an 
aromatic ring would increase fluorescence response. As such, it appears that the aromatic 
variant of the Glaser-Hay onto the EBTZ profluorophore serves to quench the 
fluorescence intrinsic to the aromatic UAA. There was no fluorescence changed observed 
for the reaction between pPrF and EBTZ.  
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 We attempted the biological Glaser-Hay reaction in a protein context using p-
propargyloxyphenylalanine-GFPTAG151 in the presence of EBTZ. However, our results 
were inconclusive, as even after extended denaturation the GFP signal swamped our 
fluorescence spectra. Future work will attempt the Glaser-Hay using a p-
propargyloxyphenylalanine-UbiquitinTAG47, which is a non-fluorescent small protein that 
will not convolute our fluorescence spectra with its own fluorescent signal. 
In order to verify the potential of the Glaser-Hay reaction to either quench UAAs 
or profluorophores, we sought to synthesize other UAAs to help corroborate our initial 
findings with EBTZ. These syntheses are ongoing, with varying degrees of success. 
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 The next profluorphore we attempted to synthesize from the literature was a 3-
methoxy-6-ethynyl-9H-xanthen-9-one, which possesses a xanthenone core.5 To begin, 
2,2’,4,4’-tetrahydroxybenzophenone was subjected to a microwave-mediated 
condensation reaction in the presence of 10% NaOH to afford 3,6-dihydroxy-9H-
xanthen-9-one. This product was then asymmetrically methylated using methyl iodide in 
a biphasic solvent system of toluene and 50% NaOH.  Unfortunately, we were never able 
to isolate the asymmetrically methylated product, largely due to solubility issues in all 
our available organic and aqueous solvents. If we had, we would have installed a triflate 
group on the free hydroxyl group, which could then undergo a Sonogashira cross-
coupling with trimethylsilylacetylene to yield 3-methoxy-6-(2-(trimethylsilyl)ethynyl)-
9H-xanthen-9-one. This TMS-protected variant could then be deprotected to afford the 
terminal alkyne containing 2. 
 The last proposed profluorophore moiety we are preparing involve ethynyl-
containing coumarin profluorophores. 
 
Conclusion 
 We have begun the synthesis of a variety of profluorohpores to probe the ability 
of the Glaser-Hay to serve as a “turn-on” mechanism for these probes. Our initial studies 
appear to reveal an actual “turn-off” effect when utilizing the Glaser-Hay in conjunction 
with alkyne bearing profluorohpores.  
 
Experimental 
Synthesis of 2-ethynylbenzothiazole (1)3 
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Synthesis of 2-iodibenzothiazole (1a) via a. To a flame dried round bottom and stir bar 
was added 1.875 g (8.085 mmol) of 2-aminobenzothiazole and 7.5 g of p-toluenesulfonic 
acid (39.428 mmol). Meanwhile, a salt solution of 5.25 g of potassium iodide (31.627 
mmol) and 1.75 g of sodium nitrite (25.362 mmol) in 7.5 mL of deionized water was 
prepared. To the round bottom containing the 2-aminobenzothiazole was added 10 mL of 
acetonitrile, and to this was promptly added the salt solution. The mixture was stirred at 
0°C for 2 hr and then stirred at room temperature overnight. The next day 175 mL of 
deionized water were added to the reaction round bottom, and the pH of the mixture was 
adjusted to ~8-9 (as indicated via pH strips) using 1M sodium bicarbonate. A spatula tip 
of sodium thiosulfate was added to this, which caused a brownish precipitate to crash out. 
Any additional sodium thiosulfate was found to hinder the workup procedure. The whole 
mixture was filtered on a Buchner funnel and washed with cold water to give 2.106 g of 
1a as a brown powder (8.066 mmol, 99% yield) as confirmed by 1H NMR in CDCl3 
according to the literature. 
Synthesis of 2-ethynylbenzothiazole (1) via b. & c. To a flame dried round bottom and 
stir bar, flushed with argon beforehand, was added 0.870 g of 1a (3.334 mmol). The 
round bottom was then capped with a septum and flushed with argon. To this round 
bottom was added 7 mL of dry dichloromethane. This solution was degassed using argon 
for 20 minutes, and then 942 µL of trimethylsilylacetylene (0.65 g, 6.618 mmol) and 3.3 
mL of triethylamine (2.409 g, 23.807 mmol) was added via syringe through the cap, 
maintaining the integrity of the argon atmosphere. This mixture was stirred under argon, 
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and the septum was briefly opened to add 47 mg of bis(triphenylphosphine)palladium(II) 
dichloro (0.067 mmol) and 14 mg of copper(I) iodide (0.074 mmol). The reaction was 
then flushed with argon and was allowed to stir at 65°C for 4 hr. After 4 hr, 10 mL of a 
brine solution was added to the mixture. The reaction was then extracted with 
dichloromethane (10 mL x 3) and this organic layer was back extracted using bring (40 
mL x 4). The organic layer was then dried with magnesium sulfate, filtered, and 
concentrated in vacuo to afford 0.463g of 2-trimethylsilyl-ethynylbenzothiazole (1b) 
(2.000 mmol, 60% yield) as a brown powder. To the round bottom containing 1b was 
added a stir bar and 10 mL of methanol to check if this solvent would solubilize the 
compound. If it did, an additional 10 mL portion of methanol was added to 1b, if not, an 
additional 10 mL of dichloromethane was added instead. To the solution was added 1.244 
g of potassium carbonate (9.000 mmol) and the reaction was stirred at room temperature 
for 2-3 hrs. Next, the reaction was extracted in a 1:2 volume of dichloromethane to brine 
(20 mL of dichloromethane x 3, 40 mL of brine total). The organic layer was then back 
extracted one time with 60 mL of brine. The organic layer was then dried with 
magnesium sulfate, filtered, and concentrated in vacuo. Initial attempts to purify the 
reaction with silica gel chromatography in a MeOH:DCM eluent failed. As such the 
reaction mixture was dissolved up in a small volume of DCM and purified via silica gel 
chromatography using a 6:1 hexanes:ethyl acetate as the solvent system. Twenty-two mgs 
of 2-ethynylbenzothiazole (0.138 mmol, 7% yield) were obtained from the column as a 
brown residue that was not fluorescent via TLC. 1H NMR   
Synthesis of 3-methoxy-6-ethynyl-9H-xanthen-9-one (2)5 
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Synthesis of 3,6-dihydroxy-xanthen-9-one (2a) via a. To a microwave vial containing a 
stir bar was added 800 mgs of 2,2’,4,4’-tetrahydroxybenzophenone (3.250 mmol). This 
was dissolved in 4 mL of a 10% NaOH solution (w/v), and then subjected to microwave 
irradiation in dynamic setting (10 mins at 120°C; microwave protocol on Young Lab 
CEM as Profluoro st 1). Next, the reaction was subjected to fixed power setting at 150 W, 
with a max temperature of 180°C for twelve pulses. After the twelve pulses, the reaction 
was diluted with 4 mL of deionized water and acidified with 6 M HCl to give a white, 
viscous gel like substance. This was filtered via Buchner filtration to give 2a as a white to 
off-white powder.  
Synthesis of 3-hydroxy-6-methoxy-9H-xanthen-9-one (2b) via b. To 1.25g of 2a (5.5 
mmol) was added 62.5 mL of toluene, which did not solubilize the material. To this 
mixture was added 1.25 g (5.5 mmol) of benzyl triethyl ammonium chloride followed by 
375 µL (0.781 g, 5.5 mmol) of methyl iodide. Next, 31 mL of a 50% aqueous NaOH 
(w/w) solution was added and the reaction was capped and stirred at 110°C for 6 hr. After 
the 6 hr the separate phases were separated via a separatory funnel, and the aqueous layer 
was collected. The aqueous layer was then acidified with ~12 mL of 12N HCl, which 
produced a color change from cloudy yellow, to clear yellow, to a white/milky precipitate 
formed once a pH = 4 was reached. The acidified layer then sat on ice for 2 minutes and 
filtered via Buchner filtration. The collected crystals sat overnight and were then 
recrystallized in 10 mL of boiling toluene. This gave 725 mgs of an off white product 
which we thought may be the asymmetrically methylated 2b. 
Synthesis of 6-methoxy-9-oxo-9H-xanthen-3-yl-trifluoromethansulfonate (2c) via c. To a 
flame dried round bottom and stir bar was added 0.400g (1.65 mmol) of 2b dissolved in 
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20 mL of DCM. To this was added 665 µL of dry pyridine (0.653 g, 8.25 mmol) and the 
mixture was cooled over ice to 0°C. Everything was flushed with argon while the 
reaction mixture cooled. Then, using a needle and syringe, 416 µL of 
trifluoromethanesulfonic anhydride (which may or may not have been anhydrous; 0.698 
g, 2.475 mmol) dropwise, to the best of my ability. The temperature was gradually raised 
to room temperature and the reaction was stirred for an additional 2 hrs. After the 2 hrs, 
15 mL of deionized water was to quench the reaction. This mixture was stirred for an 
additional 5 mins, and the organic and aqueous phases were then separated. The organic 
layer was washed with a 1N HCl solution in water (15 mL x 2), and it was then washed 
once more with a 15 mL portion of deionized water. The organic layer was then dried 
with magnesium sulfate (which we now believe may be interacting with our 
profluorophores and fluorophores, preventing adequate recovery after this step), filtered, 
and concentrated in vacuo. Silica gel chromatography in 3:1 hexanes:ethyl acetate 
yielded 5 mgs of something that was a single spot on TLC. We were concerned that the 
silica gel may be interacting with the triflate group, binding our product to the column 
during the purification process.  
Cu(I)-Catalyzed Azido-Alkyne Cycloaddition with EBTZ, 1 To a 5 mL SnapCap tube 
was added 2 µL of a 50 mM CuSO4 solution in water, followed by 2 µL of a 50 mM 
TCEP solution in water, then 2 µL of a 5 mM TBTA solution in DMSO, then 2 µL of a 
100 mM solution of p-azidophenylalanine (pAzF) in water, and finally 40 µL of a 1 mM 
solution of 1 in DMSO. All of this was diluted to 3 mL in deionized water. As a control, a 
reaction between pAzF and 1 in the absence on the copper click catalyst system was 
performed. A 1 fluorescent control was prepared by dissolving 40 µL of th solution of 1 
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in 3 mL of deionized water. Finally, the effects of CuSO4 on inducing a turn on response 
in 1 was performed by mixing 2 µL of the 50 mM CuSO4 solution with 40 µL of the 
solution of 1. Fluorescnet profiles of all the 3 mL samples were taken in a quartz cuvette 
by exciting at 285 nm and scanning from 310 to 510 nm with 8 nm excitation and 
emission wavelength slits at a scan speed of 200 nm/min.  
Organic Small Molecule Glaser-Hay with EBTZ, 1 To a flame dried vial and stir bar was 
added ~10-20 mg of CuI, which was subsequently dissolved in 1 mL of pseudo-dry 
tetrahydrofuran (THF). To this mix was added 60 µL of TMEDA and the catalyst system 
was allowed to stir. Meanwhile, 100 µL of a 10 mM solution of 1 in DMSO (16 µg, 
0.100 µmol) was added to the catalyst solution followed by 2 µL of the small molecule 
partner (either propargyl alcohol or phenylacetylene at a >10 molar equivalency). This 
reaction was allowed to stir at 60°C overnight. Following this, both reactions were 
dissolved in an extra 1 mL of THF. Absorbancies were taken for both reactions using a 
UV/Vis to verify the maximum absorption wavelength, which corresponded to the 
maximum excitation wavelength.  
Glaser-Hay with UAAs and EBTZ, 1 To a 3 mL SnapCap tube was added 2 µL of a 500 
mM solution of CuI in water followed by 2 µL of a 500 mM solution of TMEDA. Next 
was added 2 µL of an alkyne containing UAA (either p-propargyloxyphenylalanine or p-
ethynylphenylalanine) and 40 µL of a 1 mM solution of 1 in DMSO. This mix was the 
diluted to 3 mL using deionized water. Catalyst control reactions were set up by mixing 
the UAAs and 1 as above without adding the CuI or TMEDA. These were allowed to 
react overnight, and the 3 mL sample was then added to a quartz cuvette for fluorescence 
analysis. Samples were excited at 328 nm and emission profiles were scanned for from 
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350 to 550 nm using 8 nm excitation and emission wavelengths slits and a scan speed of 
200 nm/min.  
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